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Abstract
Two important biophysical characteristics of proteins, their interaction with
ligands and their post-translational modifications, modulate various biological processes
including signal transduction, chemical synthesis, and cell function. Protein-ligand
interactions include the interactions with protein, peptide, DNA, and metal.
Characterization of the physical properties of these interactions (binding interfaces,
binding affinities, and the protein conformational changes due to the binding) is essential
in understanding the mechanism of related diseases and, more importantly, in future drug
design.
Mass spectrometry, with its own revolution and improvement, becomes a
powerful tool in protein and peptide analysis. In this thesis, we applied two mass
spectrometry-based strategies, proteomics and protein footprinting, to characterize these
biophysical properties of three disease-related proteins, connexin 43 (Cx43), troponin,
and apolipoprotein E (ApoE), and Fenna-Matthews-Olson protein (FMO), which is the
key factor in energy transfer of the photosynthetic system of green sulfur bacteria.
By the combination of standard proteomics workflow and two fragmentation
methods, collision-induced dissociation (CID) and electron transfer dissociation (ETD),
we successfully identified 15 serine residues, including one novel site, in the Cx43-CT
ii

that are phosphorylated by CaMKII, the activity of which may be important in regulating
Cx43 in normal and diseased hearts.
We

further

utilized

hydrogen/deuterium

exchange

(H/DX),

one

mass

spectrometry-based protein footprinting strategy, to examine the binding affinities of
troponin C (TnC), a cardiac disease-related protein, with its four metal binding ligands
(Ca2+), and their binding order. We then expanded this approach to elucidate the
dynamics of TnC within the complex and its interactions with other subunits (TnT and
TnI) at peptide-level resolution. This same approach was also applied to two proteinligand complexes: (1) the interaction of FMO and its binding partner, CsmA baseplate
protein, in which the orientation of FMO between chlorosome and membrane can be
confirmed, and (2) the interaction of ApoE and Aβ40, which are both key factors in
Alzheimer’s disease. Moreover, we improved the spatial resolution of H/DX to residuelevel by conducting ETD fragmentation in the study of ApoE oligomerization. Our
results reveal, for the first time, the amino acid residues involved in its selfoligomerization.
These six applications of mass spectrometry-based approaches show their
potential in the characterization of different protein biophysical properties. The
investigation of a more complex protein system can then be pursued.
iii

Acknowledgements
In the summer of 2007, I stepped in WashU campus cheerfully but was full of
uncertainty. After five years, I step out the campus in the same scene but am full of
enthusiasm for science.
I thank my advisor, Prof. Michael L. Gross, for his full support and guidance
during my five years of thesis research. He provided an outstanding research environment,
the opportunities to collaborate with distinguished scientists, and most importantly, he
allowed me to choose my own research topics, which strengthens my independency and
amplifies my interest in science. He is the father of my research career.
I thank the entire staff scientists in our facility, especially Don L. Rempel and
Henry W. Rohrs for their assistance in data modeling and instrument troubleshooting. I
enjoy the time discussing my results and thoughts with Don in the “late” evenings.
I would like to thank the members, both current and past, in our Mass
Spectrometry Resource (Danforth campus): Joyce Neff, Ilan Vidavsky, Daryl Giblin,
Justin Sperry, Bich Vu, Micah Wilcox, Adam Brustkern, Sandy Kerfoot, Manohari Silva,
Dian Su, Hao Zhang, Brian Gau, Tingting Tu, Jiawei Chen, Qiang Zhang, Cui Weidong,
Jun Zhang, Lisa Jones, Manolo Plasencia, Sergio Castro, Yining Huang, Ying Zhang,

iv

Yuetian Yan, Daniel Weisz, Jing Li, Hanliu Wang, and Ben Niu; (Med school campus):
Prof. Reid Townsend, Petra Gilmore, and Alan Davis.
I thank my collaborators, Prof. Carl Frieden, Kanchan Garai from Departments of
Biochemsitry and Molecular Biophysics, Washington University; Prof. Kathryn Yamada,
James Laing, and Evelyn Kanter from Cardiovascular Division, Washington University
School of Medicine; Prof. Robert Blankenship, Jianzhong Wen, Xinliu Gao, Prof.
Himadri Pakrasi, Haijun Liu from Department of Chemistry and Biology, Washington
University; Brady Summers from University of Missouri-Kansas City, for providing such
interesting research projects.
I thank my Dissertation Advisory and Examination Committee members, Prof.
Robert Blankenship, Prof. Liviu Mirica, Prof. Carl Frieden, Prof. Kathryn Yamada, and
Prof. Gary Patti, for their guidance in my thesis research.
This thesis research is supported by the National Institutes of Health and National
Center for Research Resources (Grant No. 2P41RR000945) and Washington University
Dean’s Dissertation Fellowship (Spring, 2012).
Finally, I thank my mother, Tsai-Yun Chang, for her support, and my brother, YuTin Huang, for being the model of my research career.

v

Table of Contents
Abstract .............................................................................................................................. ii
Acknowledgements ........................................................................................................... iv
Table of Contents ...............................................................................................................vi
List of Figures ..................................................................................................................xiii
List of Tables ..................................................................................................................xvii
Chapter 1
Introduction: Protein-ligand Interaction, Protein Post-translational Modification,
Hydrogen/Deuterium Exchange, and Mass Spectrometry
1.1 Abstract .........................................................................................................................2
1.2 Protein-Ligand Interaction ............................................................................................3
1.3 Protein Post-Translational Modification .......................................................................4
1.4 Resolution of Protein-Ligand Interactions ....................................................................5
1.5 Mass Spectrometry; Review of Basic Principles ..........................................................6
1.5.1

Quadrupole/Time-of-flight .........................................................................7

1.5.2

Linear Ion Trap/Orbitrap ...........................................................................10

1.6 Gas-Phase Fragmentation ...........................................................................................12
1.6.1

Collision-induced dissociation ..................................................................13

1.6.2

Electron transfer dissociation ....................................................................15

1.7 Mass Spectrometry-Based Protein Footprinting .........................................................17
1.8 Hydrogen/Deuterium Exchange ..................................................................................18
1.8.1

Rates of H/DX are pH and temperature dependent ..................................19

1.8.2

Exchange kinetics (EX1 vs. EX2) ............................................................21

vi

1.8.3

H/DX at the Global-level ..........................................................................22

1.8.4

H/DX at the Peptide-level .........................................................................23

1.8.5

H/DX at the Residue-level ........................................................................24

1.9 Study the Biophysical Properties of Proteins by H/DX ..............................................26
1.9.1

Protein dynamics .......................................................................................26

1.9.2

Affinity of protein-ligand interaction ........................................................26

1.10

Scope and Significance of the Thesis ...................................................................29

1.11

References .............................................................................................................32
Chapter 2

Identification of CaMKII Phosphorylation Sites in Connexin43 by High-Resolution
Mass Spectrometry
2.1 Abstract .......................................................................................................................46
2.2 Introduction .................................................................................................................48
2.3 Materials and Methods ................................................................................................51
2.3.1

Cx43 fusion protein ...................................................................................51

2.3.2

In vitro phosphorylation of GST-Cx43-CT by CaMKII ...........................53

2.3.3

Immunoprecipitation .................................................................................53

2.3.4

Phosphopeptide clean-up and enrichment ................................................54

2.3.5

Mass spectrometry ....................................................................................55

2.3.6

Mascot database search and determination of phosphorylation sites .......58

2.4 Results and Discussion ...............................................................................................59
2.4.1

The phosphorylation activity of CaMKII .................................................59

2.4.2

Phosphorylation of Cx43-CT by CaMKII ................................................63

2.5 Conclusions and Limitations .......................................................................................74
vii

2.6 Acknowledgements .....................................................................................................75
2.7 References ...................................................................................................................76
Chapter 3
HD Exchange and PLIMSTEX Determine the Affinities and Order of Binding of
Ca2+ with Troponin C
3.1 Abstract .......................................................................................................................85
3.2 Introduction .................................................................................................................86
3.3 Experimental Procedure ..............................................................................................89
3.3.1

Materials ...................................................................................................89

3.3.2

Apo TnC preparation ................................................................................89

3.3.3

H/D exchange (H/DX) protocol ................................................................90

3.3.4

LC-ESI/MS analysis with a Q-TOF mass spectrometer ...........................91

3.3.5

LC-ESI/MS/MS analysis of protein digests ..............................................92

3.3.6

Mascot database search .............................................................................93

3.3.7

Data analysis .............................................................................................93

3.3.8

Kinetic modeling .......................................................................................94

3.3.9

Titration and species fraction calculation .................................................95

3.4 Results .........................................................................................................................97
3.4.1

H/DX kinetics of apo- and holo-TnC ........................................................97

3.4.2

Affinities for Ca2+ binding of troponin C ................................................100

3.4.3

Fractional species and binding order .....................................................105

3.4.4

Order of Ca2+ binding .............................................................................112

3.5 Discussion .................................................................................................................117
3.6 Acknowledgement ....................................................................................................119
viii

3.7 References .................................................................................................................120
Chapter 4
Hydrogen-Deuterium Exchange Mass-Spectrometry Reveals Troponin C Dynamics
and Binding within the Troponin Complex
4.1 Abstract .....................................................................................................................133
4.2 Introduction ...............................................................................................................135
4.3 Experimental .............................................................................................................138
4.3.1

Materials .................................................................................................138

4.3.2

Troponin complex preparation ................................................................138

4.3.3

H/D exchange (H/DX) protocol ..............................................................139

4.3.4

LC-ESI/MS analysis with a Q-TOF mass spectrometer .........................141

4.3.5

LC-ESI/MS/MS analysis of protein digests ............................................141

4.3.6

Mascot database search ...........................................................................142

4.3.7

Data analysis ...........................................................................................142

4.3.8

Kinetic modeling .....................................................................................143

4.3.9

PLIMSTEX titration ...............................................................................143

4.4 Results and Discussion .............................................................................................144
4.4.1

H/DX kinetics of TnC within the Tn complex ........................................144

4.4.2

PLIMSTEX study of TnI binding of TnC and TnC-TnT complex .........149

4.4.3

H/DX reveals structural changes of TnC, TnI and TnT within the
complex ...................................................................................................153

4.5 Conclusions ...............................................................................................................158
4.6 Acknowledgements ...................................................................................................159
4.7 References .................................................................................................................160
ix

Chapter 5
Hydrogen/Deuterium Exchange and Electron-Transfer Dissociation Mass
Spectrometry Determine the Interface and Dynamics of Apolipoprotein E
Oligomerization
5.1 Abstract .....................................................................................................................168
5.2 Introduction ...............................................................................................................170
5.3 Experimental Procedures ..........................................................................................172
5.3.1

Protein expression ...................................................................................172

5.3.2

Materials .................................................................................................173

5.3.3

Preparation of ApoE stock solution ........................................................173

5.3.4

H/D Exchange (H/DX) Protocol .............................................................174

5.3.5

LC-ESI/MS Analysis with a Q-TOF Mass Spectrometer .......................176

5.3.6

Test of hydrogen scrambling ..................................................................176

5.3.7

LC-ESI/MS/MS Analysis with an Orbitrap-ETD Mass Spectrometer ...178

5.3.8

Mascot database search ...........................................................................179

5.3.9

Data analysis ...........................................................................................180

5.4 Results and Discussion .............................................................................................180
5.4.1

Regions involved in ApoE self-association revealed by H/DX kinetics
study ........................................................................................................180

5.4.2

H/DX-ETD reveals residues involved in self-association of ApoE4 ......189

5.4.3

The structure of ApoE4 ...........................................................................194

5.5 Conclusions ...............................................................................................................204
5.6 Acknowledgement ....................................................................................................205
5.7 References .................................................................................................................206
x

Chapter 6
Hydrogen/Deuterium Exchange Mass Spectrometry Probes the Apolipoprotein Eamyloid-β (Aβ 40) Interactions
6.1 Abstract .....................................................................................................................216
6.2 Introduction ...............................................................................................................218
6.3 Experimental Procedures ..........................................................................................221
6.3.1

Protein expression ...................................................................................221

6.3.2

Materials .................................................................................................221

6.3.3

Preparation of ApoE3-40 complex ...................................................221

6.3.4

H/D Exchange (H/DX) Protocol .............................................................222

6.3.5

LC-ESI/MS Analysis with a Q-TOF Mass Spectrometer .......................224

6.3.6

LC-ESI/MS/MS Analysis with an Orbitrap Mass Spectrometer ............224

6.3.7

Mascot database search ...........................................................................224

6.3.8

Data analysis ...........................................................................................225

6.4 Results and Discussion .............................................................................................225
6.4.1

Examination of the ApoE3-40 complex formation by H/DX pulse
labeling ....................................................................................................226

6.4.2

Peptide-level H/DX kinetics reveals the regions of ApoE3WT involved in
ApoE3WT-40 interactions .................................................................229

6.4.3

H/DX mapped on a ApoE3 monomeric mutant structure .......................234

6.5 Conclusions ...............................................................................................................236
6.6 Acknowledgement ....................................................................................................237
6.7 References .................................................................................................................238

xi

Chapter 7
Hydrogen-deuterium exchange mass spectrometry reveals the interaction of FennaMatthews-Olson protein and chlorosome CsmA protein
7.1 Abstract .....................................................................................................................246
7.2 Introduction ...............................................................................................................247
7.3 Materials and Methods ..............................................................................................251
7.3.1

Materials .................................................................................................251

7.3.2

H/DX Protocol ........................................................................................252

7.3.3

LC-ESI/MS Analysis with a Q-TOF Mass Spectrometer .......................253

7.3.4

LC-ESI-MS/MS Analysis of Protein Digest ...........................................254

7.3.5

Mascot database search ...........................................................................255

7.3.6

Data analysis ...........................................................................................255

7.3.7

Kinetic Modeling ....................................................................................256

7.4 Results .......................................................................................................................257
7.4.1

H/DX kinetics of FMO and FMO/CsmA ...............................................257

7.4.2

The FMO/CsmA binding interface .........................................................260

7.4.3

FMO structural mapping .........................................................................263

7.5 Discussion .................................................................................................................266
7.6 Acknowledgement ....................................................................................................268
7.7 References .................................................................................................................269

xii

List of Figures
Chapter 1
Figure 1-1: Cutaway view of the Orbitrap mass analyzer ...............................................12
Figure 1-2: The fragmentation sites of peptide during gas phase fragmentation .............13
Figure 1-3: The mechanism of CID fragmentation pathway ...........................................15
Figure 1-4: The neutral loss of phosphate group of a phosphorylated peptide during
CID ....................................................................................................................................15
Figure 1-5: A proposed mechanism of ETD fragmentation ............................................16
Figure 1-6: Three types of hydrogen of protein ...............................................................19
Figure 1-7: H/DX rates depend on both pH and temperature ..........................................20
Figure 1-8: H/DX workflow ............................................................................................24
Chapter 2
Figure 2-1: Tandem mass spectrometric coverage of Cx43-CT ......................................52
Figure 2-2: The numbers of phosphorylation sites identified on alpha-casein ................60
Figure 2-3: MALDI spectra of Autocamtide ...................................................................62
Figure 2-4: CaMKII phosphorylation of Cx43-CT at S306 .............................................67
Figure 2-5: CaMKII phosphorylation of Cx43-CT at S330 .............................................69
Figure 2-6: CaMKII phosphorylation of Cx43-CT at a novel site, S244 ........................71
Figure 2-7: CaMKII phosphorylation of Cx43-CT at S314 .............................................72
Chapter 3
Figure 3-1: Kinetics of H/D exchange for rabbit skeletal troponin C ..............................98
Figure 3-2: PLIMSTEX curve of Troponin C titrated with Ca2+ ...................................102
Figure 3-3: “Sharp-break” PLIMSTEX titration curve .................................................102

xiii

Figure 3-4: Relative differences between K’s values before and after each cycle of
fitting ...............................................................................................................................104
Figure 3-5: Fractional species curves .............................................................................107
Figure 3-6: Deuterium-containing isotopic distribution of the triply charged peptic
peptide 100-109 ..............................................................................................................110
Figure 3-7: Deuterium distribution convolved with the native isotopic distribution of
doubly charged peptide 63-73 .........................................................................................113
Figure 3-8: Deuterium distributions of the peptic peptide of EF hands .........................114
Figure 3-9: Normalized relative deuterium uptake of EF hands ....................................117
Chapter 4
Figure 4-1: X-ray crystal structure of chicken skeletal troponin complex ....................136
Figure 4-2: Kinetics of H/D exchange for rabbit skeletal TnC ......................................146
Figure 4-3: PLIMSTEX curve of TnC and TnC-TnT complex titrated with TnI ..........150
Figure 4-4: D uptake of TnC with or without the presence of TnI inhibitor peptide .....153
Figure 4-5: Peptide level D uptake diagrams .................................................................154
Figure 4-6: Peptide-level H/DX mapping on X-ray crystal structure ............................157
Chapter 5
Figure 5-1: Diagram for on-line pepsin digestion device ..............................................175
Figure 5-2: ETD product ion spectrum of standard peptide HHHHHHIIKIIK .............176
Figure 5-3: The deuterium uptake of C ions of the standard peptide after performing the
H/DX-ETD ......................................................................................................................178
Figure 5-4: Peptide-level H/DX kinetics of ApoE4 .......................................................183
Figure 5-5: Comparison of H/DX kinetics of peptide 230-243 and 262-270 among all
three isoforms ..................................................................................................................184
xiv

Figure 5-6: Peptide-level H/DX kinetics of ApoE2 .......................................................187
Figure 5-7: Peptide-level H/DX kinetics of ApoE3 .......................................................188
Figure 5-8: Peptide-level H/DX kinetics of ApoE2, ApoE3 and ApoE4 monomeric
mutant .............................................................................................................................188
Figure 5-9: A diagram of the H/DX-ETD procedure .....................................................189
Figure 5-10: ETD product-ion spectra of peptide 206-214 of ApoE4 after H/DX ........191
Figure 5-11: ETD product-ion spectra of peptide 262-270 of ApoE4 after H/DX ........191
Figure 5-12: The extent of deuterium uptake of amino-acid residues in the C-terminal
domain of ApoE4 ............................................................................................................193
Figure 5-13: The extent of deuterium uptake of each amide of ApoE4 monomeric mutant
after correcting for back exchange ..................................................................................195
Figure 5-14: Residue-level HDX mapping on ApoE4 structure ....................................197
Figure 5-15: Peptide-level H/DX of ApoE2, 3, and 4 in the presence or absence of
GdnCl ..............................................................................................................................198
Chapter 6
Figure 6-1: Global H/DX kinetics of ApoE3WT ...........................................................226
Figure 6-2: Global H/DX pulse labeling of ApoE .........................................................228
Figure 6-3: Peptide-level H/DX kinetics of the N-terminal regions of ApoE3WT .......230
Figure 6-4: Peptide-level H/DX kinetics of the C-terminal regions of ApoE3WT .......231
Figure 6-5: H/DX mapping on the ApoE3MM NMR structure .....................................234
Chapter 7
Figure 7-1: Structure model of the photosystem ............................................................249
Figure 7-2: ESI mass spectrum of denatured FMO .......................................................252
Figure 7-3: H/DX kinetics for FMO from Chlorobaculum tepidum .............................257
xv

Figure 7-4: Sequence coverage of peptic peptides from FMO ......................................261
Figure 7-5: Relative deuterium uptakes for peptic peptides from N- to C-terminus of
FMO ................................................................................................................................262
Figure 7-6: FMO monomer structure mapping ..............................................................263
Figure 7-7: Map of H/DX on the FMO trimer structure ................................................265
Figure 7-8: Orientation of the FMO trimer structure .....................................................265

xvi

List of Tables
Chapter 2
Table 2-1: Serine residues in Cx43-CT phosphorylated by CaMKII ...............................64
Table 2-2: Phosphoserine-containing peptides from Cx43-CT in vitro phosphorylation by
CaMKII ............................................................................................................................65
Chapter 3
Table 3-1: Numbers of amide hydrogen undergoing exchange for D for apo and holo
troponin C .......................................................................................................................100
Table 3-2: Four Ca2+ binding constants of troponin C ...................................................105
Table 3-3: Solution concentrations chosen for H/DX to determine the order of
binding ............................................................................................................................108
Chapter 4
Table 4-1: Numbers of exchangeable amide hydrogens of five TnC complexes with
respect to four fixed exchange rate constants .................................................................148
Table 4-2: TnC-TnI affinities obtained by PLIMSTEX strategy ...................................150
Chapter 5
Table 5-1: Numbers of amide hydrogen undergoing H/DX for wild-type and monomericmutant ApoE’s isoforms .................................................................................................186
Table 5-2: A complete list of deuterium uptake for 132 residues in ApoE4 .................200
Chapter 7
Table 7-1: Numbers of amide hydrogen undergoing deuterium exchange for apo and holo
FMO ................................................................................................................................259

xvii

Chapter 1

Introduction:
Protein-ligand Interaction, Protein Post-translational Modification,
Hydrogen/Deuterium Exchange, and Mass Spectrometry

-1-

1.1 ABSTRACT

One of the essential steps in proteomics is the identification and location of posttranslational modifications. Furthermore, an additional need is the characterization of
protein-ligand interactions. Both are essential in understanding various biological
processes including signal transduction, chemical catalysis, and cellular communication.
The recent evolution and improvement of mass spectrometry (MS) makes it a powerful
technique for the study of protein chemistry. Given that the measurement is fast, and the
sample-size requirement is small, its application has expanded from academic institutes
into biopharmaceutical companies. Mass spectrometry coupled with HPLC separation
and product-ion sequencing (MS/MS) can not only confirm the protein sequence but also
localize chemical modification sites. Moreover, the implementation of MS-based protein
footprinting strategies, including hydrogen/deuterium exchange, enable us to study the
biophysical properties of proteins (e.g. their dynamics, binding affinities, binding
interfaces). The principles and instrumentation of protein/peptides mass spectrometry and
hydrogen/deuterium exchange are introduced in this chapter.

-2-

1.2 PROTEIN-LIGAND INTERACTION
Protein-ligand interactions occur both inside and outside the cell and are the basis
of complex, coordinated, dynamic network systems that coordinate various biological
processes and modulate, for example, cell growth and cell cycles (1). The ligands that
bind proteins include other proteins, peptides, DNA, small organic molecules, and metal
ions. These complex interactions alter protein function and further influence downstream
signal cascades. Malfunctioning of these systems can result in disease (2). Drugs, as a
category of ligands, are designed to interact with proteins and adjust their functions and
prevent unwanted downstream responses (2).
Troponin C, for example, which is one subject of study in this thesis, presents in
both skeletal and cardiac muscle, interacts with Ca2+, and further interacts with other
subunits (troponin I and T). These interactions are the basis of muscle contraction (3).
Any factor that changes the interactions between the various troponins may be involved
in cardiac-related diseases, and some drugs are, therefore, designed to maintain the
multiple functions of troponins (4).
Given that understanding the properties of protein-ligand interaction is the
foundation of drug design, we propose that any method that expedites the study of
protein-ligand interactions will facilitate drug development. Moreover, these methods can
-3-

help us understand the mechanisms of the complex biological networks and further
improve our knowledge of biological therapies for diseases.
1.3 PROTEIN POST-TRANSLATIONAL MODIFICATION
Protein post-translational modification (PTM), a late step in protein biosynthesis
that places a chemical modification on a side chain, is another important element in
biological processes. It regulates protein function, signaling transduction, and cell
behavior. Protein methylation or acetylation, for example, can be the basis for protein
recognition by chromodomains (5). Protein nitration may be involved in cardiovascular
diseases (6, 7). Protein glycosylation, a common PTM, has been recognized as a key
element in protein folding, internalization, binding, and is also crucial to immune
response (8, 9). Protein phosphorylation is involved in protein functional activity, occurs
principally at the hydroxyamino acids, tyrosine, serine, and threonine, and converts a
neutral side chain to a negative charge, thereby mediating cell-signaling transduction (5).
Protein PTMs, especially phosphorylation, normally require kinase activation,
which is another category of protein-protein interaction. It occurs differently under
different biological conditions. Connexin 43 (Cx43), for example, which is also studied
as part of this thesis, is a channel protein that modulates normal electrical and contractile
activity. Cx43 can be phosphorylated by several different kinases, under both normal and
-4-

disease conditions. The modification regulates the gap-junction-channel assembly,
function, and turnover. The locations of the phosphorylation sites on Cx43 with the
activation of calmodulin protein kinase II (CAMKII), however, were unknown prior to
our study. Therefore, understanding protein PTMs either qualitatively or quantitatively,
and especially under different biological environments, is essential for understanding
global protein function in specific biological processes.
1.4 RESOLUTION OF PROTEIN-LIGAND INTERACTIONS
The ability to locate protein-ligand interaction and protein PTMs has been
acknowledged as one of the challenging issues in biomedicine and biophysics owing to
the complex architecture and the lack of a complete suite of approaches.
The qualitative analysis of protein PTMs is often achieved by gel-based analyses
(SDS page staining and western blot), which provide only positive/negative information.
Most of the strategies that are used to predict or characterize protein-ligand interaction,
such as circular dichroism (CD) (10), fluorescence (11), small angle X-ray scattering
(SAXS) (12), size-exclusion chromatography (13), and native gel (14), give global
information on protein structure or size as modified owing to ligand binding. These
techniques provide fast measurements but at low resolution (little if any site specificity).
X-ray crystallography (15) and NMR (16), on the other hand, provide high resolution (~
-5-

2 Å) measurements of protein structures. The protein concentration and sample amount,
however, need to be high (mM or high µM range for NMR, and mg of sample for x-ray).
Furthermore, the protein cannot be large for NMR, and protein dynamics (e.g.,
flexibility) are difficult to measure by X-ray crystallography.
MS, on the other hand, can provide fast measurement for small amounts of
sample (µg). Our goal is to continue to develop MS tool to study protein-ligand
interactions and to utilize MS in the identification and localization of protein PTMs
1.5 MASS SPECTROMETRY; REVIEW OF BASIC PRINCIPLES
The basic functions of MS are to generate ions from either inorganic or organic
compounds, to separate these ions by their mass-to-charge ratios (m/z) and to detect them
according to their respective m/z values. A mass spectrometer is composed of an ion
source, a mass analyzer, and a detector. The majority of application before 1980’s were
the analysis of small molecules. It was not until the late 1980’s, when John Fenn invented
electrospray ionization (ESI) (17), Franz Hillenkamp and Michael Karas developed
matrix-assisted laser desorption ionization (MALDI) (18), and numerous researchers
improved mass analyzers, that the analysis of large bioorganic molecules including
proteins, peptides, carbohydrates, and pieces of DNA and RNA became possible.

-6-

One property of ESI is that it multiply charges the analyte. Under denaturing
conditions, the protein is highly charged and shows a broad distribution. MALDI, on the
other hand, usually gives a dominant singly charged species and minimal multiple
charging. ESI is the dominant ionization method used in the research reported in this
thesis.
Nowadays, the large variety of ionization techniques and mass analyzers makes
the analysis of proteins and peptides feasible and powerful. Moreover, the combination of
different mass analyzers (hybrid mass spectrometers) provides protein measurement and
sequencing in a high-resolution manner.
In conducting this thesis research, two hybrid mass spectrometers were mainly
used (ESI-quadrupole/time-of-flight and ESI-linear ion trap/orbitrap). These are
described in the following sections.
1.5.1

Quadrupole/time-of-flight
A quadrupole mass analyzer consists of four hyperbolically or cylindrically

shaped rod electrodes. The pairs of opposite rods are held at the same polarity, which is
composed of a DC and an AC component. If the applied voltage is composed of a DC
voltage U and a radio frequency (RF) voltage V with the frequency ω, the total potential
Φ is given by equation 1.
-7-

Φ

ω

Eq. 1

The equations of ion motion are given as equation 2 in which the distance between two
rods is 2r0. These differential equations can be expressed as the Mathieu equation, for
which a solution can be found.
2
2

i 0

2

2
2

Eq. 2

2

i 0

The dimensionless form of equation 2 can be written as:
2

Eq. 3

2

where u represents the coordinate axes x and y, ξ is defined as ωt/2, and au and qu are
defined as:
u

u

2

i 0

2

Eq. 4 and 5

i 0

By plotting the parameter a vs. q when the ion trajectory is stable, one obtains the
stability diagram of the two-dimensional quadrupole field. Any ion that stays within the
stability region can be transmitted through the quadrupole analyzer and be detected.
When operating near the tip of the stability diagram, other ions, even those of nearby m/z,
will have unstable trajectories. This property enables a quadrupole to function as a mass
selector in which only ion with specific m/z range can be transmitted to and fragmented
-8-

in the collision cell (usually an octupole). The product ions can then be analyzed by a
sequel mass analyzer. This concatenation is known as mass spectrometry/mass
spectrometry (MS/MS).
In the MS-only mode, the quadrupole is operated under RF only condition (au = 0)
in which all ions can be transmitted and analyzed by the following mass analyzer.
The principle of time-of-flight (TOF), which is the second mass analyzer in the
quadrupole-TOF (Q-TOF) instrument, is that ions of different m/z are dispersed in time
during their flight through a field-free drift path of known length. Provided all the ions
are given the same kinetic energy, lighter ions will arrive earlier at the detector than the
heavier ions. Given that an ion with electric charge q and mass m at high electrical
potential U is accelerated, converting its potential energy into kinetic energy (Ek), we can
equate two types of energy as:
Eq. 6
The velocity (v) of the ion in the flight tube, therefore, can be obtained.
Eq. 7
This characteristic of ion movement in the flight tube, however, demands that ions
emerge from a pulsed ion source, such as MALDI, in which all the ions start their journey
at the same time or at least within a sufficiently short time interval. This arrangement is
-9-

not suitable for continuous ion sources such as ESI because the ions will overlap.
Incompatibility between continuous ion sources and pulsed ToF instruments was resolved
in early 1990’s. The solution is an orthogonal TOF in which ions are introduced into the
TOF mass analyzer along an axis perpendicular to their initial direction of motion. By
taking advantage of this orthogonal design, quadupole and ToF mass analyzers can be
combined to form the basis of a powerful tandem mass spectrometer. To complete the
MS/MS design, we need only to incorporate some means of causing ions selected by the
Q to be activated and undergo fragmentation.
If the TOF is coupled with a reflectron, the dispersion of kinetic energy of ions
having the same mass is minimized, and the mass resolving power is improved
significantly. A modern Q-TOF instrument can have mass resolving power as high as
40,000 over a wide mass range or even higher; such high resolving power is an asset in
protein analysis.
1.5.2

Linear ion trap/Orbitrap
A linear ion trap, or linear quadrupole ion trap (LIT or LTQ), functions similarly

as a quadrupole mass analyzer but uses a trapping potential well formed by placing
electrodes of slightly higher potential adjacent to the front and rear ends of the multipole.
This property enables the LTQ to trap ions with high capacity, accumulate ions until a
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population suitable for the sequel analyzer is reached, select ions of interest, and
fragment ions with relatively higher efficiency as compared to the quadrupole.
The orbitrap, also known as the Kingdon trap (19), is a type of Fourier transform
(FT) mass analyzer. It incorporates a straight electrode along the axis of a surrounding
cylindrical electrode (Figure 1-1). Ions tangentially approaching the central electrode
that is set to an attractive electric potential do not hit the electrode but become captured in
a rotational motion around it, owing to a balance of an outward centrifugal forces and an
inward electrical force. Their trajectory is defined by an equilibrium of the centrifugal
force and the electrostatic force generated by applying a voltage between central
electrode and enclosing cylinder. The oscillation of ions, thus, creates an image current as
detected by a differential amplifier connected to the halves of the outer electrode; the
image current is then transformed to frequency-based signal. The correlation between the
frequency of harmonic axial oscillation ωz with field curvature k and ion with mass mi
and charge q can be defined as:
z

i

Eq. 8

The combination of an LTQ and an orbitrap provides extremely high resolving
power (100,000 at m/z 400, accurate mass measurement (0.5 - 5 ppm), and efficient
MS/MS capability that increases the confidence in protein and peptide identification, for
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example. For this reason, we conducted much of the research reported in this thesis with
the LTQ-Orbitrap.

Figure 1-1. Cutaway view of the Orbitrap mass analyzer. Ions are injected into the
Orbitrap at the point indicated by the red arrow. Taken from Perry et al. 2008. Mass
Spectrometry Reviews.
1.6 GAS-PHASE FRAGMENTATION
The ability to induce ion fragmentation in tandem mass spectrometry (MS/MS) is
important to identify peptides and proteins with high confidence, especially when dealing
with complex protein mixtures. Moreover, it allows one to localize protein modification
sites such as phosphorylation, which will be important in chapter two of the thesis.
Peptide ions that are fragmented in the gas phase produce a series of product ions
indicated by a, b, or c if the charge is retained on the N-terminus and by x, y or z if the
- 12 -

charge is maintained on the C-terminus (Figure 1-2). Obtaining these sequential ions is
essential to reconstruct peptide sequences.

Figure 1-2. The fragmentation sites of peptide during gase-phase fragmentation.
There are two types of fragmentation strategies, collision-induced dissociation, or
collisionally activated dissociation (CID/CAD), and electron transfer or electron capture
dissociation (ETD/ECD). They are now widely used in general proteomics approaches
(20, 21).
1.6.1

Collision-induced dissociation
Collision-induced dissociation (CID) occurs when an ion beam passes through a

collision cell where an inert collision gas (e.g., He, N2, Ar) is set to a pressure
approximately 1000 times above that of the surrounding high vacuum. Ions with initial
internal energy will take up energy by making collisions with the inert gas atoms or
- 13 -

molecules and dissociate along any fragmentation pathway available at this specific level
of internal energy.
CID typically yields fragment ions whereby a peptide bond is cleaved to produce
y and b-type ions (Figure 1-3) (22). Given that a basic requirement for the CID process is
the collision gas, which is used in most of the tandem mass spectrometers, CID has
become a standard and routine fragmentation strategy in the proteomics work flow (20).
The propensity to lose labile functional groups during CID, however, has been
recognized as an obstacle in localizing protein post-translational modifications.
Phosphorylated peptides, for example, can easily lose their phosphate group (as H3PO4)
during CID (Figure 1-4) (22). This phenomenon makes an unambiguous identification of
multiple phosphorylation sites on a single peptide difficult, especially when
unphosphorylated peptides that undergo water loss are present in the same ion cluster. It
was later found that a unique electron-based fragmentation strategy, electron transfer
dissociation (ETD) or electron-capture dissociation (ECD), can prevent this phenomenon.
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Figure 1-3. The mechanism of CID fragmentation pathway, which yields y and b-type
ions. Taken from Syka et al. 2004. PNAS.

Figure 1-4. The neutral loss of phosphate group (H3PO4) of a phosphorylated peptide
during CID. Taken from Syka et al. 2004. PNAS.
1.6.2

Electron transfer dissociation
Electron transfer dissociation (ETD) was invented in early 2000’s by Hunt, Syka,

and Coon (23). ETD employs a radical anion in the gas phase to transfer an electron to a
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peptide ion of interest, leading to a unique fragmentation pathway that produces z and ctype ions (Figure 1-5). The Thermo LTQ-Orbitrap XL (ETD) instrument, for example,
which was used to conduct much of the research in this thesis, utilizes fluoranthene as the
reagent and produces fluoranthene radical anions via a chemical ionization (CI) process
(called electron capture). The electron-transfer process then takes place in the linear ion
trap whereby the radical anion transfers an electron to the positively charged peptide or
protein in a process that is promoted by the opposite charges of the two species.

Figure 1-5. A proposed mechanism of ETD fragmentation, which yields z and c-type
ions. Taken from Syka et al. 2004. PNAS.
ETD cleaves randomly along the peptide backbone while side chains and
modifications such as phosphorylation remain intact. The technique only works well for
- 16 -

higher charge state ions (z > 2). Relative to CID, ETD is advantageous, however, for the
fragmentation of longer peptides or even entire proteins. This makes the technique
important for top-down proteomics.
Although a number of workers have investigated ETD, its mechanism is still
under debate (24, 25). The advantage of ETD in the identification of protein posttranslational modifications, especially phosphorylation, is unquestioned (22, 26). An
example of the combination of CID and ETD in the identification of phosphorylation
sites on Cx43 under the activation of CaMKII is described in this thesis.
1.7 MASS SPECTROMETRY-BASED PROTEIN FOOTPRINTING
Mass spectrometry-based protein footprinting (27-29) is a modern strategy that
utilizes the advantages of MS and chemical modification (hydrogen/deuterium exchange,
hydroxyl-radical oxidative modification, chemical crosslinking, etc.) to generate a mass
shift that is readily seen by MS. Footprinting can capture minor changes in protein
solvent accessibilities that are induced by interactions or by the presence of PTMs. These
approaches can probe protein conformational changes associated with protein-ligand
(ligand: protein, DNA, peptide, drug etc.) interactions and protein dynamics.
Hydrogen/deuterium exchange is considered here to be a footprinting strategy because
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like other strategies, it introduces new covalent bonds in a protein. The modifications,
however, are reversible.
1.8 HYDROGEN/DEUTERIUM EXCHANGE
Kaj Ulrik Linderstrøm-Lang in late 1940’s first developed hydrogen/deuterium
exchange (H/DX) by measuring the small molecular mass increments that occur
following uptake of D. Given that hydrogen and deuterium nuclei are grossly different in
their magnetic properties, nuclear magnetic resonance (NMR) soon became the main
means to measure the extent of deuterium uptake (30). In the 1990’s, mass spectrometry
began to evolve as another powerful tool in protein analysis and H/DX. The utilization of
hydrogen/deuterium exchange MS (H/DX-MS) for the study of protein-ligand
interactions, protein dynamics, and protein folding is now an accepted approach (28, 3133).
Proteins have three types of hydrogens with different deuterium exchange rates
(Figure 1-6). The first class includes amide hydrogens that exchange with deuterium at
middle rates (half lives of seconds to hours). A second class are hydrogens attached to the
functional groups of side chain, and they exchange with deuterium at very fast rates (half
lives of µs), and they are easily back-exchanged to hydrogen by returning the protein to a
protic solvent. The third class includes hydrogens covalently bonded to carbon. These are
- 18 -

essentially not exchangeable with deuterium in D2O. These characteristics of H/DX
enable us to measure the extent of deuterium uptake of the amide residues (amino acids)
on a reasonable time frame, thereby revealing a wide range of protein dynamics.

Figure 1-6. Proteins have three types of exchangeable hydrogens: (1) amide hydrogens,
green; (2) carbon hydrogens, blue; (3) side-chain hydrogens, red.
1.8.1

Rates of H/DX are pH and temperature dependent
H/DX is an acid and base-catalyzed reaction. The intrinsic rate of exchange is

expressed as equation 9:
-

Eq. 9

Given that the rate of water catalysis is six orders of magnitude smaller than that of acid
catalysis and 13 orders of magnitude smaller than that of base catalysis, this term is
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usually ignored. Although the amide hydrogens of different amino acids have different
intrinsic exchange rates, the overall exchange rate reaches its lowest value near pH 2.5
and 0 ºC (Figure 1-7) (34). Therefore, H/DX can be quenched by adding sufficient acid
to bring the pH to 2.5 and by cooling in ice water prior to MS analysis.

Figure 1-7. The rates of H/DX depend on pH (A) and temperature (B). Taken from
HXMS website: http://www.hxms.neu.edu/research/tutorial_theory.htm.
The overall half life of H/DX, however, is relatively short as compared to other
covalent labeling strategies even under the quenching condition (overall half life ~ 40
min) (31). Thus, it is essential to keep the analyzing time short, within 10 min, to obtain
sufficient information of deuterium uptake. One can correct the extent of back exchange
by incorporating a 100% deuterated sample under the same analysis process and follow
equation 10:
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0
100

0

Eq. 10

where D is the adjusted deuterium level, N is the total number of exchangeable amide
hydrogens, m is the experimentally measured mass, m0% is the mass of the undeuterated
protein/peptide, and m100% is the mass of the fully deuterated protein/peptide (31).
1.8.2

Exchange kinetics (EX1 vs. EX2)
In the H/DX experiment, the concentration of D2O present at the equilibrium is

much greater than that of water. Therefore, H/DX follows pseudo-first order kinetics in
which the correlation between the number of deuteriums taken up and the exchange rate
can be illustrated as:
Eq. 11
where D is the deuterium level, N is the total number of exchangeable amide hydrogens,
k is the exchange rate, and t is the exchange time. One can calculate the number of amide
hydrogens at different exchange rates by fixing the rate constants and using kinetic curve
fitting processes, or calculate the exchange rates corresponding to different groups of
amide hydrogens that are defined prior to the fitting process (31).
H/DX kinetics, sometimes, becomes more complex according to different
characteristics of protein folding. The most popular model for hydrogen exchange of
native proteins dissolved in D2O is:
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Hcl

op

Hop

kcl

rc

D Eq. 12

in which the opening motion of protein proceeds with the rate constant kop and the closing
motion with the rate constant kcl. In the open form, deuterium exchange can occur with
the rate constant krc. Therefore, the observed exchange rate kex can be described as (35):
e

op rc
cl

Eq. 13

rc

When krc << kcl, equation 13 simplifies to kex = krc(kop/kcl). Proteins having this
behavior, called EX2 kinetics, give one major group of deuterium uptake distribution in
H/DX experiments, and one can obtain the overall information of H/DX kinetics of the
protein. The apparent free energy of opening or exchange, ΔGHX, is expressed as -RTln
Kop and can be calculated with data from EX2 exchange. Thus, hydrogen exchange in the
EX2 model provides thermodynamic data. Most proteins, including those discussed in
this thesis, follow EX2 behavior.
When kcl << krc, then kex = kop. Proteins having this behavior, called EX1, give
mutiple groups of deuterium uptake distribution in H/DX experiments, making the data
interpretation difficult. The information of protein folding/unfolding, however, can be
obtained under this condition. The shortest H/DX time in solution that has been captured
by MS, thus far, is in the range of µs (36).
1.8.3

H/DX at the Global-level
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The extent of deuterium uptake of a protein can be measured globally by
investigating the average differences between the masses of the deuterated protein and
the undeuterated protein. H/DX is initiated by diluting the proteins in D2O buffer at
physiological pH (or any suitable pH) and held for various times at 25 °C (or other
suitable temperatures) before quenching the exchange by adding acid to decrease the pH
to 2.5 and by lowering the temperature to 0 °C. The deuterated samples are loaded onto a
C8 or C18 trap column, allowing labile side-chain sites to back exchange and salts and
ionic buffers to be removed. After elution from the column, the protein may be purified
further via a cooled HPLC system and analyzed by mass spectrometry. This strategy
enables us to monitor the global changes of hydrogen bonding and solvent accessibility
of the protein of interest owing to various perturbations including ligand binding.
1.8.4

H/DX at the Peptide-level
Protein conformational changes sometimes occur only at small regions of a large

protein, and in that case, differences reported by H/DX are very often “washed out” by
investigating the whole protein. To reveal these minor changes, we need higher spatial
resolution provided by H/DX-MS. H/DX coupled with enzymatic digestion prior to mass
spectrometry analysis, as mentioned above, affords spatial resolution at the “peptide-level”
(i.e., to regions of the protein that are 6-10 amino-acid residues in length (37)) (Figure 1- 23 -

8). The uptake extent of deuterium is measured as the mass-to-charge differences
between the centroid of the isotopic distribution of the deuterated peptide and the
undeuterated peptide. The enzymes used to achieve peptide resolution in H/DX are
mainly acidic proteases, such as pepsin or protease XIII, which are active under the
quenching conditions (pH ~ 2.5).

Figure 1-8. H/DX workflow that provides “peptide-level” information. Taken from
Chalmers et al. 2011. Expert Review Proteomics.
1.8.5

H/DX at the Residue-level
To refine the spatial resolution to the “residue (amide) level”, one can incorporate

multiple enzymatic digestions and analyze overlapping peptides (38), or apply
appropriate gas-phase fragmentation of the deuterated peptides released upon pepsin
digestion.
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Gas-phase hydrogen scrambling, however, is an obstacle to achieving this goal,
especially when using collision-induced dissociation (CID) or collisionally activated
dissociation (CAD) to fragment the peptide (39-44). Scrambling of H and D in the gas
phase, however, can be largely prevented by fragmenting the peptides with electrontransfer dissociation (ETD) or electron-capture dissociation (ECD) (45, 46).
To provide assurance that the conditions are accompanied by minimal scrambling,
Jørgensen (44-46) established a set of standard peptides that can be evaluated as test
cases for scrambling. Several other methods were also established for the same purpose
(47, 48). Two approaches, top-down (49-53) and bottom-up H/DX (54, 55), allow singleresidue resolution to be achieved. The former strategy does not require an enzymatic
digestion step, thereby shortening the time of the experimental protocol and lowering the
extent of back exchange, but it does require that the protein be pure and fragmentation be
complete and the coverage be good. Both are difficult to achieve as protein size becomes
larger. The latter strategy, on the other hand, utilizing enzymatic digestion, LC/MS
analysis, and tandem mass spectrometry (ETD or ECD), provides information with fewer
restrictions and more confidence that the results are not compromised by scrambling. An
example of utilizing bottom-up H/DX for the study of ApoE oligomerization is included
in this thesis.
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1.9 STUDY THE BIOPHYSICAL PROPERTIES OF PROTEINS BY H/DX
1.9.1

Protein dynamics
Protein conformational changes affect many biological functions, including

enzymatic catalysis and selective interactions of macromolecules. Proteins consisting of
multiple domains joined by flexible linkers can undergo large movements that result in
the repacking of adjacent domains. The slow dynamics of protein conformational changes
usually involve breaking and making relatively strong hydrogen bonds, and they are
associated with low-solvent accessibility at short times of exchange. Therefore, H/DX
kinetics has the potential to identify, with reasonable resolution, domain-packing
interactions that correspond to different protein conformational states in large proteins.
1.9.2

Affinity of protein-ligand interaction
Measuring the affinity of protein-ligand interactions is important in many areas

of biophysics and in the design of future drugs. Several methods can be used to measure
binding affinities including FRET (fluorescence resonance energy transfer) (56), NMR
(57), CD (circular dichroism) (58), calorimetry (59), SPR (surface plasmon resonance)
(60, 61), and ESI mass spectrometry (62).
There are two approaches that utilize H/DX to measure the thermodynamic
properties of protein-ligand interactions: SUPREX (Stability of Unpurified Proteins from
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Rates of H/D Exchange) (63, 64), and PLIMSTEX (Protein-Ligand Interactions by Mass
Spectrometry, Titration, and H/D Exchange) (65-67). One may ask why MS methods
could play a role in this well-developed area. The answer is MS can provide site
specificity.
SUPREX incorporates different amounts of denaturants (urea or guanidinium
chloride) in the solution of a protein. A SUPREX curve can be obtained by plotting the
deuterium uptake of protein (at constant exchange time) as a function of increasing
amounts of denaturant. Because proteins unfold in the presence of denaturants, increasing
deuterium uptake occurs with the unfolding. Once a binding ligand is present in solution,
the protein stability usually increases compared to the protein in the apo state, causing the
SUPREX curve to shift to higher denaturant concentrations. By measuring the differences
of C

1/2

SUPREX,

which is the midpoint of the transition between the native state and

unfolded state, and by following equation 14 and 15, one can obtain the dissociation
constant of the protein-ligand complex.
int

0

f

n

Eq. 14

n-1

n-1

0

f

Eq. 15
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One disadvantage of SUPREX is that the presence of denaturant may influence the
protein-ligand interactions; after all, proteins in vivo do not bind ligands in solutions
containing denaturants.
PLIMSTEX, developed in the M. Gross group, utilizes deuterium uptake
differences between apo (absence of ligand) and holo states (ligand bound). A
PLIMSTEX curve can be obtained by titrating a protein solution with increasing amounts
of ligand followed by subjecting the protein to H/DX for a given, constant time, a time
for which H/DX is relatively constant and for which small errors in sampling time would
have minimal impact on the titration.
The fitting process of the PLIMSTEX curve involves three parameters (D0, ΔDi,
and βi) in which D0 is the deuterium uptake of the apo state, ΔDi is the decrease of
deuterium uptake due to each ligand binding, and βi (i = 1 to n) is the overall binding
constant. To fit the data, a model must build a relationship between the overall deuterium
shift and the total ligand concentration as shown in equation 16.
-

Eq. 16

ΔDi is weighted by its binding fraction [Prot-Ligt]/[ProtT], which is a function of total
ligand concentration [LigT] and the overall binding constant βi. βi is the product of all the
stepwise equilibrium constants as shown in equation 17.
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Eg. 17
The binding fraction in equation 16 for each protein-ligand species can then be expressed
as:
-

i

i

i

T

i

Eg. 18

i

The calculation of the binding fractions requires the free-ligand concentration, [Lig],
which can be inferred from the total ligand concentration and the extent of complexation.
The analytical derivative of [Lig] with respect to [LigT], which is a function of [Lig],
[ProtT], and βi, can be written as:
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Eg. 19

We applied the concept of PLIMSTEX to troponin C, a Ca2+ binding protein, and
to the troponin C-troponin I interactions, and described the outcomes in this thesis.
1.10

SCOPE AND SIGNIFICANCE OF THE THESIS
Mass spectrometry, introduced in this chapter, is now a powerful tool in the

characterization of both protein post-translational modifications and protein-ligand
interactions. Mass spectrometry-based proteomics and protein footprinting are two
strategies with significant growth rates, and they are now widely used to address various
biochemical/biophysical issues including protein dynamics, folding and unfolding, and
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protein interactions. We are interested in utilizing and expanding these two approaches to
gain a better understanding of three disease-related proteins, connexin 43, troponin, and
apolipoprotein E, and another protein (Fenna-Matthews-Olson protein) that is important
in the photosynthetic system of green sulfur bacteria.
Thus, we first describe in the thesis a mass spectrometry-based proteomics
strategy to identify the phosphoylation sites of connexin 43 in vitro, under the activation
of CaMKII, and in vivo. The neutral loss of the phosphate group from phosphorylated
peptide ions under CID gas-phase fragmentation, however, presented an obstacle to the
unambiguous identification of multiple phosphorylation sites on a single peptide. We
show that the combination of CID and ETD offers complementary identification of the
phosphorylation sites on this heavily phosphorylated protein. This strategy, therefore, is
becoming a standard platform for future studies of protein phosphorylation.
We then utilized hydrogen/deuterium exchange (H/DX), one of the mass
spectrometry-based protein footprinting strategies, to study the biophysical properties
(binding interfaces, binding affinities, and protein dynamics) of five protein-ligand
interaction systems. These systems are: (1) troponin C and its interaction with four Ca2+
ions, (2) troponin C dynamics within the troponin complex and the interactions of the
three subunits (TnC, TnI, and TnT) with each other, (3) the oligomerization of human
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apolipoprotein E as compared to a mutant-forced monomer, (4) the apolipoprotein EAβ40 interactions, and (5) the interactions between Fenna-Matthews-Olson protein
(FMO) and CsmA baseplate protein. We also applied ETD, a newly explored
fragmentation method that can provide H/DX information at the residue-level, in the
study of ApoE oligomerization.
Our results show that H/DX is, indeed, a powerful strategy that can provide the
investigation of protein-ligand interaction in a high-resolution manner and provide
solutions to important biochemical problems.
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Chapter 2*

Identification of CaMKII Phosphorylation Sites in Connexin43 by
High-Resolution Mass Spectrometry

*

This chapter is based on recent publication: Huang, R. Y. C., Laing, J. G., Kanter, E. M.,

Berthoud, V. M., Rohrs, H. W., Townsend, R. R., Bao, M., and Yamada, K. A.
Identification of CaMKII Phosphorylation Sites in Connexin43 by High-Resolution Mass
Spectrometry. Journal of Proteome Research, 2011, 10, 1098-1109. Copyright 2011
American Chemical Society (Huang, R. Y. C., and Laing, J. G. contributed equally to this
work.)
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2.1 ABSTRACT

Connexin43 (Cx43), a major cardiac gap junction channel protein, plays an
important role in normal electrical and contractile activity. Phosphorylation of Cx43,
under both normal and disease conditions, regulates the gap junction channel assembly,
function and turnover. The C-terminal domain of Cx43 contains numerous amino acid
residues that are phosphorylated by protein kinases. Our knowledge of the specific
residues and kinases involved, however, is incomplete. The objective of this study is to
identify amino acid residues in the Cx43-CT that are targets of the multi-functional
protein kinase, Ca2+/calmodulin protein kinase II (CaMKII), an enzyme known to play
critical roles in Ca2+ homeostasis, transcription, apoptosis and ischemic heart disease.
We subjected fusion protein containing the Cx43-CT to phosphorylation by CaMKII in
vitro, digestion with Lys-C and trypsin followed by enrichment of phosphorylated
peptides using TiO2, and analysis with a combination of two fragmentation strategies
(collision-induced dissociation (CID) and electron transfer dissociation (ETD)) in an
LTQ Orbitrap. We deduced the sites of modification by interpreting tandem spectra from
these “orthogonal” methods of gas phase peptide fragmentation. We have identified 15
serine residues, including one novel site, in the Cx43-CT that are phosphorylated by
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CaMKII, the activity of which may be important in regulating Cx43 in normal and
diseased hearts.
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2.2 INTRODUCTION
Cardiovascular gap junctions, formed by 2 docking hemichannels, each composed
of 6 connexin subunits, are large specialized aggregates of intercellular channels and are
important in cell-to-cell communication (1). There are five different connexins expressed
in cardiac muscle and vasculature (1-3). Connexin43 (Cx43) is the predominant connexin
expressed in working myocardium (2). Cx43 is not only responsible for electrical
propagation throughout the chamber walls, and thus for normal electrical activation and
subsequent ventricular contraction, but it is also a critical determinant of abnormal
propagation, contractile dysfunction and arrhythmia secondary to pathophysiological
remodeling during disease states (4, 5).
The expression, trafficking, distribution, turnover, permeability and gating of
Cx43 are regulated primarily by phosphorylation (6, 7). There are eighteen serine
residues in the carboxyl terminal tail of Cx43 that have been reported as sites of protein
phosphorylation (6, 8-10), the majority of which have been identified as targets of a
variety of kinases including mitogen-activated protein kinase (MAPK), protein kinase C
(PKC), cyclin-dependent kinase p34cdc2, casein kinase (CK) and protein kinase A (PKA)
(6). Interestingly, four serine residues in the carboxyl terminus of Cx43 show a complex
time-dependent pattern of both phosphorylation and dephosphorylation during
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myocardial ischemia. Specifically, S306 is dephosphorylated and S330 is phosphorylated
early after ischemia; subsequently, S297 and S368 are dephosphorylated during the
critical time when gap junction uncoupling occurs (8). Finally, S330 is also
dephosphorylated during the later stages of ischemia (8). Correspondingly, Lampe et al.
have observed an 8-fold reduction in phosphorylated (p)S325/S328/S330 in ischemic
tissue (11).
Details pertaining to the phosphorylation and dephosphorylation of the eighteen
serine residues in the carboxyl terminus of Cx43 are incomplete and, at times,
contradictory. Phosphorylation of S368, for example, the most widely studied
phosphorylated residue, has been associated with reduced gap junction intercellular
communication via a PKC-dependent mechanism in epithelial cells and fibroblasts (12).
Changes in gap junctional conductance in response to PKC activation, however, depend
on cell type and the state of phosphorylation of Cx43. Furthermore, the exact role of
phosphorylation of S368 in ischemia and ischemic preconditioning is not clear because
conflicting results have been reported (8, 13-16). The availability, affinity and specificity
of commercial antibodies directed toward phosphorylated residues in Cx43 may, in part,
limit the studies on alterations in the phosphorylation state of different amino acid
residues.
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With the recent evolution and improvement of mass spectrometry, it now appears
to be a powerful technique that can be used as a tool to identify the modified amino acid
residues

in

phosphorylated

peptides.

Collision-induced

dissociation

(CID),

a

fragmentation strategy utilized in the general proteomics workflow, will cause the neutral
loss of the phosphate group from phosphorylated peptide, thus making an unambiguous
determination of muti-phosphorylated sites difficult. Electron transfer dissociation (ETD)
and electron capture dissociation (ECD), as introduced in chapter 1, leave posttranslational modifications intact during fragmentation and prevent this phenomenon
(17).
We report here the use of high-resolution tandem mass spectrometry with the
combination of CID and ETD to identify targets of the multifunctional protein kinase,
Ca2+/calmodulin-dependent protein kinase II (CaMKII) (18), on the carboxyl terminus of
Cx43. CaMKII plays a central role in regulating a variety of cellular functions in the heart
such as Ca2+ homeostasis, transcription and apoptosis (18, 19). In addition, increased
expression and/or activation of CaMKII have been shown to occur in cardiac disease
states such as hypertrophy, heart failure, myocardial ischemia and infarction, and are
thought to promote disease pathogenesis (20-24). Recently, we have found that CaMKII
co-localizes with Cx43 at intercellular junctions in the infarct border zone (25). Cx43,
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however, has never, to our knowledge, been shown to be a target of CaMKII. De PinaBenabou et al. (26) hypothesized that CaMKII phosphorylation of the carboxyl terminus
of Cx43 was the mechanism by which K+ produced an increase in coupling between
spinal cord astrocytes, and they predicted four serine residues that could be potential
phosphorylation targets for CaMKII based on the consensus sequence RXXSX.
Although Cx43 has not been shown to be a substrate for CaMKII, this enzyme has been
shown to phosphorylate Cx32 in hepatocytes and Cx36 in neurons (27, 28). The specific
CaMKII phosphorylation sites, however, have not been identified in Cx32, and the
phosphorylation sites identified in Cx36 do not share homology with Cx43.
The current study, therefore, was performed to test the hypothesis that the
carboxyl terminus of Cx43 is subject to phosphorylation by CaMKII. We found that
CaMKII phosphorylates a variety of reported residues, and one novel serine residue, in
the carboxyl terminus of Cx43 in vitro. These results suggest that Cx43 may be a
substrate for CaMKII in vivo. The data will be discussed in the context of remodeling of
Cx43 during the pathogenesis of chronic ischemic heart disease.
2.3 MATERIALS AND METHODS
2.3.1

Cx43 Fusion Protein
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A DNA construct coding for a fusion protein containing amino acids 237-382 of
the carboxyl terminus (CT) of rat Cx43 (GI:6978896) subcloned in frame with GST in
pGEX-2T (GST-Cx43-CT, MW 42,122 g/mol) was grown in BL21-CodonPlus
competent cells (Stratagene/Agilent Technologies, Santa Clara, CA). The fusion protein
was purified using a B-PER GST Fusion Protein Purification Kit (Pierce/Thermo
Scientific, Rockford, IL) and subsequently dialyzed against Tris-buffered saline for 48 hr.
The sequence of the fusion protein was confirmed at the Washington University Protein
and Nucleic Acid Chemistry Laboratories. The amino acid sequence of the Cx43-CT
present in the fusion protein is shown in bold in Figure 2-1.

Figure 2-1. Tandem mass spectrometric coverage of Cx43-CT. The N-terminal,
transmembrane, extracellular loop and intracellular loop domains of the protein are
indicated in grey. The amino acids of the Cx43-CT present in the fusion protein used in
this study are indicated in bold black or red (98% coverage). Amino acids in red were
positively identified by tandem mass spectrometry. The 15 serine residues underscored
and highlighted in yellow were phosphorylated by CaMKII in vitro.
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2.3.2

In vitro Phosphorylation of GST-Cx43-CT by CaMKII
GST-Cx43-CT fusion protein was subjected to in vitro phosphorylation using

CaMKII ( ew England Biolabs, Ipswich, MA) per the manufacturer’s instructions.
Briefly, GST-Cx43-CT fusion protein (1 – 8 μg) was incubated with 1.2 μmol/L
calmodulin, 2 mmol/L CaCl2, 210 μmol/L ATP and 1,500 U CaMKII in a final volume of
10.5 μL at 30ºC for 24 h, after which the reaction was stopped on ice and phosphatase
inhibitors were added to a final concentration of 1 mmol/L NaF and 2 mmol/L Na3VO4.
Control reactions contained fusion protein, calmodulin, CaCl2, ATP and buffer, but no
CaMKII. In one experiment we used CK1 (New England Biolabs, 1,500 U, 24 h) per the
manufacturer’s instructions to test a protein kinase known to phosphorylate the C 43-CT
(11).
2.3.3

Immunoprecipitation
Mouse ventricles flash-frozen in liquid N2 were pulverized and homogenized in

lysis buffer containing 1.5% NP-40 (Surfact-Amps NP-40, Pierce) in phosphate-buffered
saline (PBS, Diamedix), rotating for 30 min at 4ºC.
Monoclonal anti-C 43 (50 μg, Millipore/Chemicon) or mouse IgG (50 μg, Santa
Cruz, negative control) antibody was crosslinked to 200 μL of protein G-bound magnetic
Dynabeads (Invitrogen) using dimethyl pimelimidate (DMP, Pierce) and triethanolamine
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(Sigma) in silanized (10% dimethyldichlorosilyl, P.J. Cobert) tubes. The crosslinked
beads were washed in PBS, citrate buffer (pH 5.0), sodium phosphate buffer (pH 8.1),
sodium deoxycholate (0.5%) and Tween-20 (0.1%). Each set of antibody-crosslinked
beads was incubated with protein from the right and left ventricles of one mouse heart,
NaF (1 mM), Na3VO3 (2 mM) and protease inhibitor cocktail (1:100, Sigma) for 2 h at
4ºC, rotating. Immunoprecipitated protein was eluted with Rapigest (1.7%, Waters) and
8 M urea in 100 mM Tris buffer (pH 8.5) at 60ºC for 5 min; the elution was repeated and
the two volumes were combined. The eluent was dialyzed (Slide-A-Lyzer, Thermo)
against 1 L of water for 2 h at 4ºC followed by dialysis against 1 L of water overnight at
4ºC.
2.3.4

Phosphopeptide Clean-up and Enrichment
In vitro phosphorylated GST-Cx43-CT fusion protein or immunoprecipitated full-

length native Cx43 was precipitated by using a 2-D Clean-Up Kit (GE Healthcare
Waukesha, WI) and resolubilized in 20 μL of 8 M urea in 100 mM Tris, pH 8.5. Proteins
were then reduced with 10 mM Tris(2-carboxyethyl)phosphine (TCEP, Thermo Fisher,
Rockford, IL) at 25ºC for 30 min followed by alkylation with 20 mM iodoacetamide
(Sigma-Aldrich, St. Louis, MO) at 25ºC for 30 min in the dark and quenched with 10 mM
dithiothreitol (DTT, Thermo Fisher) at 25ºC for 15 min. The proteins were digested with
- 54 -

1 μg endoproteinase Lys-C (Roche, Mannheim, Germany) at 37ºC overnight, diluted 1:4
with 100 mM Tris pH 8.5, and further digested with 1 μg trypsin (Sigma-Aldrich) in 1
mM triethylammonium bicarbonate, pH 8.5 (TEAB, Sigma-Aldrich) at 37ºC overnight.
The peptide solutions were acidified with 2% trifluoroacetic acid (TFA) (Sigma-Aldrich).
Phosphopeptide samples were enriched using TiO2 tips (Glygen, Columbia, MD) that
were equilibrated in 0.1% TFA before drawing each sample onto the media. Tips were
washed with 100 mM glutamic acid at pH 2.0 and the bound peptides eluted with 1.5%
ammonium hydroxide. The eluates were desalted using carbon NuTips (Glygen),
lyophilized, and resuspended in 20 mL of 1% formic acid and 1% acetonitrile.
To verify the activity of CaMKII in vitro, 1.5 μg of autocamtide
(KKALHRQETVDAL, Calbiochem/EMD Chemicals, Gibbstown, NJ) was incubated
with CaMKII for 24 h as described above to produce phospho-autocamtide
(KKALHRQEpTVDAL). Commercially available phospho-autocamtide (AnaSpec,
Fremont, CA) was run as a positive control.
2.3.5

Mass spectrometry
Autocamtide phosphorylation was verified by using matrix-assisted laser

desorption ionization (MALDI). Peptide solution was mixed 1:1 with α-cyano-4hydroxycinnamic acid (CHCA, Sigma-Aldrich). For MALDI analyses using an ABI 4700
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Proteomics Analyzer (Applied Biosystems, Framingham, MA) equipped with an
Nd:YAG laser (355 nm, 3 to 7 ns pulses), the instrument was operated in reflector,
positive-ion mode with an acceleration voltage of 20 kV. Spectra were averaged from
1000 laser shots at 200 Hz for each spot.
For analysis with a Thermo LTQ Orbitrap XL with electron transfer dissociation
(ETD) and/or collision-induced dissociation (CID) (Thermo Fisher, San Jose, CA),
samples were loaded and eluted using an autosampler and an Ultra 1D+ UPLC (Eksigent,
Dublin, CA). The 75 μm diameter columns were pulled (Sutter Instruments,

ovato, CA)

and a 12-cm length was packed with Magic C18AQ reverse phase media (Michrom
Bioresources, Auburn, CA) (29). Columns were mounted in a PicoView nanospray
source (New Objective, Woburn, MA) and eluted with a 60 min gradient from 2% - 60%
acetonitrile with 0.1% formic acid. Fluoranthene anion was used for ETD (30). One full
mass spectrometry acquisition was used to trigger 3 alternating scans each of CID and
ETD. The Orbitrap parameters were: spray voltage, 2.0 kV; capillary temperature, 200ºC;
tandem mass spectrometry (MS2) selection threshold, 1000 counts; activation q, 0.25;
activation time, 30 ms for CID and 100 ms for ETD. For ETD, isolation width was 3.0
m/z and reaction time was set as charge-state dependent. Supplemental activation was
enabled. MS2 data were centroided during acquisition.
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For analysis with an LTQ-FT Ultra (Thermo Fisher, San Jose, CA), samples were
loaded onto a C18 75 μm diameter column using a NanoLC-1D (Eksigent). They were
eluted with a 180 min analytical gradient from 2% - 50% acetonitrile containing 0.1%
formic acid at 260 nL/min. The solution was sprayed into the mass spectrometer by using
a PicoView nanospray source (New Objective). One full MS acquisition was used to
trigger 8 CID scans. The FT parameters were: spray voltage, 2.0 kV; capillary
temperature, 200ºC; MS2 selection threshold, 500 counts; activation q, 0.25; activation
time, 30 ms. MS2 data were centroided during acquisition.
Alpha and beta casein (Sigma-Aldrich) and/or bovine serum albumin (BSA,
Michrom Bioresources) were analyzed as controls in each experiment. In addition, casein
was used to determine the optimal amount of protein to be used for detection of
phosphopeptides.
Tryptic peptides from immunoprecipitated full-length native Cx43 were analyzed
as above with the following exceptions. A 180 min gradient from 2% - 60% acetonitrile
with 0.1% formic acid was used for separation. Both data dependent (discovery) and
data-directed (inclusion list) methods were used to acquire mass spectra on the Thermo
LTQ Orbitrap XL with ETD and CID (31). Parent mass lists for the latter experiment
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were created from all doubly, triply and quadruply charged phosphopeptide ions
identified in the in vitro experiments.
2.3.6

Mascot database search and determination of phosphorylation sites
Thermo RAW files were processed by using extract_msn (2007 version 4.0,

Thermo Fisher, San Jose, CA) with a grouping tolerance of 0.8 Da, an intermediate scan
setting of 1, and a minimum of 1 scan per group. The NCBI nonredundant database
(version 20090105, restricted to mammals) was searched using MASCOT 2.2.06 (Matrix
Science, Oxford, U.K.) with the following settings: enzyme, trypsin; MS tolerance, 10
ppm; MS/MS tolerance, 0.6 Da; maximum number of missed cleavages, 3; peptide
charge of 1+, 2+ and 3+; variable modifications were carbamidomethylation of C,
oxidation of M, phosphorylation of Y, T, and S, and deamidation of N-terminal Q to E.
All identifications of phosphopetides were manually analyzed as described below.
Tryptic peptides containing S, T, or Y, including those with up to 3 missed
cleavages, were predicted by in silico digestion (Protein Prospector MS-Digest,
prospector.ucsf.edu). Theoretical MS2 spectra were generated (Protein Prospector MSProduct, prospector.ucsf.edu) for phosphopeptides that were identified in the Mascot
search. When there were multiple possibilities for phosphorylation (e.g., more than one S,
T, or Y in a singly-phosphorylated peptide, or more than two S, T, or Y in a doubly- 58 -

phosphorylated peptide) a table of ions was made for each possible phosphopeptide. The
product ion spectrum was manually compared to each table and the best match was
identified. In cases where the elution profiles of phosphopeptides overlapped, they were
separated using extracted ion chromatograms for diagnostic product ions.
2.4 RESULTS AND DISCUSSION
The amino acid sequence of carboxyl terminal domains varies widely across
connexins and is thought to confer specific properties to the channels composed of
different connexin subtypes (32). The carboxyl terminal domain of Cx43 is structurally
disordered, this intrinsically flexible property is important in both cell signaling and
regulatory activity (33, 34). It has been shown that this region is involved in intra- and
intermolecular interactions (35, 36). Phosphorylation of this region regulates the protein
structure, subcellular distribution and function (6-8, 11-16). Seventeen serine and two
tyrosine residues in the Cx43-CT have been shown to be targets of various protein
kinases under control, stimulated and pathological conditions. Phosphorylation of the
Cx43-CT by CaMKII, however, has not been reported.
2.4.1

The phosphorylation activity of CaMKII
To identify sites of CaMKII phosphorylation in the Cx43-CT under controlled

conditions in vitro, we first optimized the amount of fusion protein required for recovery
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of phosphopeptides and identification of phosphorylated amino acid residues using
casein, a known phosphoprotein, at 3 different concentrations: 0.3 μg/20 μL, 1 μg/20 μL
and 3 μg/20 μL. We identified 10 phosphorylation sites in casein (Figure 2-2), and
determined that 3 μg casein in 20 μL reaction volume yielded the best results.

Figure 2-2. The numbers of phosphorylation sites identified on alpha-casein (total 11
phosphorylation sites) with respect to different protein amounts as starting material (0.3,
1.0, 3.0 ug).
To validate the in vitro conditions used for the CaMKII reactions, we incubated a
peptide containing the threonine autophosphorylation site of CaMKII, nonphosphorylated
autocamtide (KKALHRQETVDAL), with CaMKII in the presence of ATP, Ca2+ and
calmodulin as described in Materials and Methods. We used nonphosphorylated
autocamtide in the absence of CaMKII as a negative control, and phospho-autocamtide
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(KKALHRQEpTVDAL) as a positive control. The MALDI spectrum obtained from
autocamtide subjected to in vitro phosphorylation demonstrated a phosphopeptide that
was identical to that observed from phospho-autocamtide obtained from AnaSpec
(Figure 2-3). No phosphopeptide was detected in the reaction performed in the absence
of CaMKII.
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Figure 2-3. MALDI spectra of Autocamtide. (A) Positive control shows the
phosphorylated peptide (KKALHRQEpTVDAL) of m/z 1588.6028. (B) Negative control
shows the non-phosphorylated peptide (KKALHRQETVDAL) of m/z 1508.7915. (C) In
vitro phsohphorylation shows the phosphorylated peptide (KKALHRQEpTVDAL) of m/z
1588.8795.
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2.4.2

Phosphorylation of Cx43-CT by CaMKII
We next incubated GST-Cx43-CT fusion protein with CaMKII and subjected the

reaction products to enzymatic digestion with Lys-C followed by trypsin and mass
spectrometric analysis to identify the amino acid residues that are phosphorylated by
CaMKII. Tandem mass spectrometry yielded 98% coverage of the Cx43-CT (Figure 21). Coverage was comparable for results obtained by using CID and ETD; however, two
phosphorylation sites were identified by ETD alone (see below). This is not surprising
because ETD-derived alternative fragmentation patterns that complement CID-derived
data have been reported previously (37). The sequence corresponding to amino acid
residues 259-293, a non-phosphorylated region, was only identified in one experiment,
possibly because we used TiO2 to enrich for phosphopeptides (38). The lack of
phosphorylated residues observed in this sequence agrees with previous reports that
S262, S279 and S282 are targets of protein kinases other than CaMKII (39, 40).
Four independent phosphorylation experiments were performed followed by
digestion and tandem mass spectrometry. No serine residues were phosphorylated in the
negative control samples that were incubated in the presence of Ca2+, calmodulin and
ATP, but in the absence of CaMKII. Amino acid residues in Cx43-CT that were
identified as being phosphorylated by CaMKII are reported in Table 2-1, and the
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diagnostic ions for these identifications are listed in Table 2-2. Several interesting
observations can be made from these data.

Table 2-1. Serine residues in Cx43-CT phosphorylated by CaMKII with previously
published kinase information where available.
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Table 2-2. Phosphoserine-containing peptides from Cx43-CT in vitro phosphorylation by
CaMKII.
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One previously identified phosphorylation site, S306, was identified in each of the
four experiments (Figure 2-4). This serine is dephosphorylated in response to global
ischemia in Langendorff perfused rat hearts (8). Dephosphorylation of S306 has recently
been shown to contribute to reduce coupling (41). CaMKII and other protein kinases
were tested by Axelsen et al. (8) in the in vitro phosphorylation assays using synthetic
peptides containing this site; however, they could not identify the kinase(s) responsible
for this phosphorylation. The discrepancy between their results and ours is likely due to
their use of a short peptide containing amino acid residues 291-313 (with cysteine 298
substituted with an alanine (8)) instead of a protein containing the full length of the
carboxyl terminus of Cx43 as substrate for the CaMKII in vitro phosphorylation reaction.
We can only speculate that the presence of C298 or a more extensive surrounding
sequence may allow the protein to adopt a conformation required for phosphorylation of
S306 by CaMKII.
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Figure 2-4. CaMKII phosphorylation of Cx43-CT at S306. (A) Extracted chromatogram
of m/z 988.3930-988.3990. (B) MS spectrum of m/z 988.4019 represents doubly charged
peptide QASEQNWANYSAEQNR (one phosphorylation site). (C) CID MS2 spectrum
indicates phosphorylation on S306. (D) Extracted chromatogram of m/z 659.2617659.2717. (E) MS spectrum of m/z 659.2708 represents triply charged peptide
QASEQNWANYSAEQNR (one phosphorylation site). (F) ETD MS2 spectrum indicates
phosphorylation on S306.
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Another substrate for CaMKII was the previously identified serine residue at
position 330 (Figure 2-5). S330 is one of three serine residues (S325/S328/S330) that has
been shown by Lampe et al. (11) to be phosphorylated on Cx43 localized at intercalated
disks, and that are involved in the electrophoretic mobility shift of Cx43 to the slowest
migrating phosphorylated form (P2) in immunoblots (7). S330 is phosphorylated after 7
min of global ischemia, and subsequently dephosphorylated between 30 and 45 min of
ischemia (8). Cooper and Lampe found that S325/S328/S330 are phosphorylated by CK1
(42). Interestingly, we observed phosphorylation of S325/S328/S330 by CaMKII (Figure
2-5), but not by CK1. Although we could not detect phosphorylation of S325/S328/S330
by CK1, we found that this kinase phosphorylated S306 and S296. Additional studies will
be required to determine whether CaMKII and CK1 compete for target sites on Cx43 in
vivo. One e ample in which these two kinases share target sites is in the Alzheimer’s
disease protein, tau (43-46).
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Figure 2-5. CaMKII phosphorylation of Cx43-CT at S330. (A) Extracted chromatogram
of m/z 953.7332-953.7428. (B) MS spectrum of m/z 953.7358 represents triply charged
peptide MGQAGSTISNSHAQPFDFPDDNQNAK (one phosphorylation site, two
deamidated sites). (C) CID MS2 spectrum indicates phosphorylation on S330. (D) ETD
MS2 spectrum indicates phosphorylation on S330.
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Importantly, we found one novel serine phosphorylation site that has not been
reported previously, S244, and a second site, S314, that has recently been described in the
mouse brain synaptosomal preparations (9) and human embryonic stem cells (10) (Table
2-1). The spectra identifying these residues are shown in Figures 2-6 and 2-7,
respectively. We also identified S257, S296 and S297, which have not been linked
previously to a specific kinase, as phosphorylation sites for CaMKII. Moreover,
phosphorylation of S255, S364, S365, S369, S372 and S373, which have been reported
previously to be directly or indirectly associated with other protein kinases was also
identified in the GST-Cx43-CT fusion protein after in vitro phosphorylation by CaMKII.
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Figure 2-6. CaMKII phosphorylation of Cx43-CT at a novel site, S244. (A) Extracted
chromatogram of m/z 617.6179-617.6203. (B) MS spectrum of m/z 617.6193 represents
triply charged peptide GRSDPYHATTGPLSPSK (one phosphorylation site). (C) CID
MS2 spectrum indicates phosphorylation on S244. (D) ETD MS2 spectrum indicates
phosphorylation on S244.
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Figure 2-7. CaMKII phosphorylation of Cx43-CT at S314. (A) Extracted chromatogram
of m/z 659.2613-659.2717. (B) MS spectrum of m/z 659.2708 represents triply charged
peptide QASEQNWANYSAEQNR (one phosphorylation site). (C) CID MS2 spectrum
indicates phosphorylation on S314. (D) ETD MS2 spectrum indicates phosphorylation on
S314.
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In summary, we identified a total of 15 putative serine phosphorylation sites for
CaMKII in the carboxyl terminus of Cx43, bringing the total number of reported
phosphorylation sites in the carboxyl terminus of Cx43 to 21 (19 Ser and 2 Tyr).
Interestingly, two of these sites, S328 and S369, were identified by ETD alone. In each
case, the phosphorylated serine is part of a multiply phosphorylated peptide fragment,
therefore hampers the unambiguous identification under CID fragmentation. This is an
example in which combined use of CID and ETD as complementary fragmentation
techniques provides enhanced identification of post-translationally modified amino acid
residues. Because no phosphopeptides were identified in the control, CaMKII-free
reactions, it is unlikely that phosphorylation of these residues was non-enzymatic or
nonspecific.
In one experiment, we identified phosphorylation of S306, S372 and S373 in fulllength native Cx43 immunoprecipitated from murine ventricular myocardium.
Additional studies will be required to determine whether the serine residues in Cx43-CT
identified in the present study, both in vitro and in vivo, are phosphorylated by CaMKII
in vivo. Our data suggest that some residues may be targets for multiple protein kinases,
implying that modulation of gap junction assembly and/or intercellular communication
may depend on the combined levels of activity of the different protein kinases under
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different pathophysiological conditions. It also remains to be determined not only which
protein kinase pathways are activated in the initial phases of ischemic injury that result in
phosphorylation of Cx43, but also which pathways are activated subsequently that lead to
dephosphorylation of Cx43 during ischemia and subsequent rephosphorylation in postischemic tissue.
2.5 CONCLUSIONS AND LIMITATIONS
Mass spectrometry is a powerful technique that has allowed for identification of
several phosphorylation sites, including a novel site at S244, that are targets of an
important, biologically relevant protein kinase, CaMKII. In the present study, we
identified four putative CaMKII serine phosphorylation sites (S296, S365, S369 and
S373) that had been postulated by Payne et al. (47) and confirmed by Pearson et al. (48)
as CaMKII phosphorylation sites based on an RXXS consensus sequence. Two CaMKII
sites identified in our study (S244 and S306) conform to a KXXS sequence, which is also
a consensus sequence for PKC (49). Utilization of ETD can potentially enhance the
ability in phosphorylation site localization, particularly when multiple potential
phosphorylation sites are present in a given peptide. It should be noted that conditions
used in the present study were to drive the phosphorylation reaction to completion, and
that steady state phosphorylation of Cx43 by CaMKII was not meant to represent
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transient signaling activity of CaMKII. Thus, residues observed to be phosphorylated in
the present study exist in different structural environments and may not be
phosphorylated by CaMKII in vivo under the same physiological or pathophysiological
condition or time frame. Finally, because CaMKII activity levels exhibit dynamic
changes during acute and chronic ischemia, the mass spectrometric analyses performed in
our study should be applied to full-length protein isolated from native cardiac tissue
subjected to various pathophysiological conditions to elucidate whether and to what
extent CaMKII regulates the phosphorylation state of Cx43 in diseased myocardium. For
example, analysis of Cx43 extracted from CaMKII transgenic mice subjected to
myocardial infarction (50) would reveal how activation and inhibition of CaMKII
influence

phosphorylation

of

Cx43

associated

with

cardiac

dysfunction

or

arrhythmogenesis during myocardial ischemia in vivo.
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Chapter 3*

HD Exchange and PLIMSTEX Determine the Affinities and Order of
Binding of Ca2+ with Troponin C

*

This chapter is based on recent publication: Reproduced with permission from Huang, R.
Y. C., Rempel, D. L., and Gross, M. L. HD Exchange and PLIMSTEX Determine the
Affinities and Order of Binding of Ca2+ with Troponin C. Biochemistry, 2011, 50, 54265435. Copyright 2011 American Chemical Society
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3.1 ABSTRACT

Troponin C (TnC), present in all striated muscle, is the Ca2+-activated trigger that
initiates myocyte contraction. The binding of Ca2+ to TnC initiates a cascade of
conformational changes involving the constituent proteins of the thin filament. The
functional properties of TnC and its ability to bind Ca2+ have significant regulatory
influence on the contractile reaction of muscle. Changes in TnC may also correlate with
cardiac and various other muscle-related diseases. We report here the implementation of
the PLIMSTEX strategy (Protein Ligand Interaction by Mass Spectrometry, Titration and
H/D Exchange) to elucidate the binding affinity of TnC with Ca2+ and, more importantly,
to determine the order of Ca2+ binding of the four EF hands of the protein. The four
equilibrium constants, K1 = (5 ± 5) x 107 M-1, K2 = (1.8 ± 0.8) x 107 M-1, K3 = (4.2 ± 0.9)
x 106 M-1, and K4 = (1.6 ± 0.6) x 106 M-1, agree well with determinations by other
methods and serve to increase our confidence in the PLIMSTEX approach. We
determined the order of binding to the four EF hands to be III, IV, II, and I by extracting
from the H/DX results the deuterium patterns for each EF hand for each state of the
protein (apo through fully Ca2+ bound). This approach, demonstrated for the first time,
may be general for determining binding orders of metal ions and other ligands to proteins.
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3.2 INTRODUCTION
The basis of muscle contraction has been well studied over four decades. There
are primarily two types of proteins involved in this process: troponin and tropomyosin (111). Muscle contraction is initiated by an increase in intracellular free Ca2+ concentration
and is controlled by the binding of Ca2+ to troponin (1-3, 8-10, 12-17). Troponin, which is
present in skeletal and cardiac muscle of various species of mammals, birds, and some
invertebrates, has three subunits: troponin C (TnC), troponin T (TnT), and troponin I (6).
Each subunit plays a special rule in modulating the movement of muscle filament.
Troponin C, which is the subject of this study, is an 18 kDa protein that is
structurally homologous in skeletal and cardiac muscle (1, 3) but has different Ca2+
stoichiometry in these two tissues. Skeletal troponin C has four helix-loop-helix motifs
(EF hands) that bind to Ca2+. The EF-hand motif, which is a conserved structure first
identified in parvalbumins (18), allows Ca2+ to interact with carboxyl and hydroxyl
groups of amino-acid sidechains located at positions 1, 3, 5, 7, 9, and 12 of a 12membered loop (1, 19). One of the EF hands (EF-I) in cardiac troponin C is defunct so
the protein binds only three Ca2+ (1, 2, 7, 20-23). In skeletal troponin C, two of four EF
hands are located in the C-terminal (EF-III and EF-IV) and have higher affinities for Ca2+
(Ka ~ 107 M-1) than the other two EF hands; they are usually saturated with Ca2+ or Mg2+
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in tissue. The binding of Ca2+ at these two sites helps maintain the interaction between the
C-terminus of troponin C, the N-terminus of troponin I, and the C-terminus of troponin T
(1, 24-27). The latter subunit binds to tropomyosin on the muscle thin filament, serving
as a key in complex formation. When the two N-terminal EF hands (EF-I and EF-II),
which have lower affinities for Ca2+ (Ka ~ 105-106 M-1), bind to Ca2+, troponin C
undergoes a conformational change to form a hydrophobic core (15, 23, 26, 28-30). The
inhibitor region on the C-terminus of troponin I then interacts with this core and releases
tropomyosin and actin. The free actins are able to interact with the myosin heads on the
thick filament and produce muscle contraction (1-3).
The Ca2+ binding to troponin C and its relation to muscle-contraction disorders
have implications in cardiac-related diseases. The amino-acid sequence of troponin C and
the phosphorylation of troponin I induced by over-activation of protein kinase A and C
(31, 32) affect the binding of Ca2+ to troponin C. Newly designed drugs interact with
troponin C and adjust its affinities to Ca2+ (33, 34).
The Ca2+-binding and protein-target binding properties of troponin C have been
the subjects of numerous studies using NMR (21, 25, 35-37), calorimetry (38) and
fluorescence (26). Hydrogen/deuterium exchange (H/DX) coupled with mass
spectrometry is another powerful method to study protein conformation, protein-protein
- 87 -

or protein-ligand interactions (39-46). With H/DX, one can measure the relative rates of
exchange of backbone amide hydrogen with deuterium and thereby follow changes in Hbonding, which often is parallel to relative solvent accessibilities. Recently, H/DX was
applied to study the regulatory function of human cardiac troponin complex and the
conformational changes of troponin complex induced by Ca2 binding (47, 48).
We describe here the use of PLIMSTEX (Protein–ligand interactions by mass
spectrometry, titration, and H/D exchange) (49-51) to determine again the affinities of
Ca2+ to rabbit skeletal troponin C. The purpose of the determination is to test the ability of
PLIMSTEX to extract these values in a complex 4:1 interaction. From the determined
affinities (equilibrium constants), we calculated the fractional species for the variousTnCCa2 states as a function of [Ca2+]. The deuterium exchange patterns of four peptic
peptides representing the four EF hands of rabbit skeletal troponin C (EF-I peptide 28-44:
DADGGGDISVKELGTVM; EF-II peptide 63-73: EVDEDGSGTID; EF-III peptide 100109: FRIFDRNADG; EF-IV peptide 136-149: MKDGDKNNDGRIDF) were then
measured. Guided by the fractional species calculation, the deuterium patterns for each
EF-hand were measured as a function of the various Ca2+ binding states (i.e., 0, 1, 2, 3,
and 4) to determine how D distributions change as a function of the binding states.
Previous efforts to elucidate the binding properties of Ca2+ to troponin C used NMR,
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fluorescence measurement, Ca2+ ion-selective electrode measurements, and mutagenesis
(36, 37, 52, 53). Although some insights were achieved, a full understanding on the Ca2+
binding order is still lacking. Our strategy provided data that, for the first time, gives the
binding order of Ca2+ to full length troponin C in a single and relatively simple
experiment. Our ultimate goal is to extend the approach to study the effect of troponin I
and troponin T on the affinities and orders of binding of Ca2+ to troponin C.
3.3 EXPERIMENTAL PROCEDURE
3.3.1

Materials
Rabbit skeletal Troponin C (TnC) was purchased from Ocean Biologics Inc

(Seattle, WA). Potassium chloride, calcium chloride, EGTA tetra sodium salt [ethylenebis(oxyethylenenitrilo)tetraacetic acid tetrasodium], and HEPES hemisodium salt [N-(2hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) hemisodium salt] were purchased
from Sigma-Aldrich (St.Louis, MO). Deuterium oxide was purchased from Cambridge
Isotope Laboratories Inc (Andover, MA). Immobilized pepsin on agarose was purchased
from Pierce (Rockford, IL).
3.3.2

Apo TnC preparation
TnC was dialyzed against EGTA to obtain apo-TnC. A 1 mL protein solution

containing 180 μg of TnC was prepared in 10 mM HEPES and 150 mM KCl. The
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solution was dialyzed by using Slide-A-Lyzer Dialysis Cassettes 7000 MWCO (Pierce,
CA). The dialysis membrane was first boiled two times in 10 mM EGTA for 10 min to
remove heavy metals from the membrane and then soaked in deionized H2O for 10 min.
The protein solution was then injected into the cassette and dialyzed against 10 mM
HEPES, 150 mM KCl and 1 mM EGTA for 2 h. The buffer was exchanged for fresh
buffer, and the solution was dialyzed overnight at 4 °C. The protein solution was then
dialyzed against 10 mM HEPES, 150 mM KCl for 3 h, fresh buffer was added, and the
protein was dialyzed again for 3 h at 4 °C. The concentration of the final protein solution
was measured by using a UV spectrophotometer at 280 nm absorption (a = 0.2 (mg/mL)-1
cm-1). The protein solution was stored at -80 °C.
3.3.3

H/D exchange (H/DX) protocol
H/DX was initiated by diluting the protein solution 1:40 into D2O buffer (10 mM

HEPES, 150 mM KCl) at 25 °C. At various times, H/DX was quenched by adding
sufficient 1 M HCl at 0 °C to give a final pH of 2.5.
For Global protein H/DX experiments, a quenched protein solution was loaded
onto a C8 guard column (1 mm x 15 mm, Optimize Technologies, Oregon, City, OR).
The column was pre-equilibrated with 200 μL 0.2

formic acid in water (0 °C). After

loading the protein solution, the column was washed with 250 μL 0.2
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formic acid in ice

cold normal water (0 °C) to back-exchange the labile sites on side chains. The protein
was eluted by using a gradient from 5% to 40% solvent B in 3 min, 40% to 100% solvent
B in 3 min and back to 5% solvent B in 2 min. (Waters CapLC, Manchester, U.K; solvent
A, water containing 0.1% formic acid; solvent B, acetonitrile containing 0.1% formic
acid).
For peptide-level H/DX experiments, 5 μL of immobilized pepsin on agarose was
added to the solution. Protein digestion took place at 0 °C for 3 min. The final solution
was centrifuged for 2-3 s to bring down the agarose beads. The peptide-containing
supernatant was then loaded onto a C18 guard column (1 mm x 15 mm, Optimize
Technologies, Oregon, City, OR). The column was pre-equilibrated with 200 μL of 0.2
formic acid in water (0 °C). After loading, the column was washed with 250 μL of
aqueous 0.2% formic acid (H2O) to back-exchange the labile sites. The protein was
eluted by using a gradient from 5% to 35% solvent B in 3 min, 35% to 80% solvent B in
4 min, 80% to 100% solvent B in 1 min and back to 5% solvent B in 2 min. All LC
connection lines were immersed in a water-ice (0 °C) bath. (Waters nanoACQUITY
UPLC, Manchester, U.K; solvent A, water containing 0.1% formic acid; solvent B,
acetonitrile containing 0.1% formic acid).
3.3.4

LC-ESI/MS analysis with a Q-TOF mass spectrometer
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Global protein H/DX results were acquired on a Waters (Micromass)
(Manchester, U.K.) Q-TOF Ultima spectrometer equipped with a Z-spray ESI source.
The instrument settings were: capillary voltage, 3.0 kV; cone voltage, 80 V; source and
desolvation temperatures, 80 °C and 180 °C, respectively. The cone and desolvation gas
flow rates were 40 and 400 L/h, respectively. The MS profile used for quadrupole
transmission was: scan from m/z 500, dwell for 5% of the scan time, ramp to m/z 1000 for
45% of the scan time, and then dwell at m/z 1000 for 50% of the scan time.
Peptide-level H/DX results were acquired on a Maxis (Bruker) (Bremen,
Germany) Q-TOF spectrometer. The instrument settings were: capillary voltage, 3.8 kV;
nebulizer gas, 0.4 Bar; drying gas flow rate and temperature, 4.0 L/min and 180 °C;
funnel RF, 400 V(pp).
3.3.5

LC-ESI/MS/MS analysis of protein digests
To establish the peptide profile from the pepsin digestion of TnC, 100 pmol TnC

was digested with pepsin for 3 min, and the peptides were identified by accurate mass
and sequencing by product-ion analysis on a Thermo LTQ XL Orbitrap (Thermo Fisher,
San Jose, CA). Samples were loaded and eluted by using an Ultra 1D+ UPLC and
autosampler (Eksigent, Dublin, CA). A 75 μm diameter column was pulled with a laserbased column puller (Sutter Instruments, Novato, CA) and packed with 12 cm of Magic
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C18AQ reverse-phase media (Michrom Bioresources, Auburn, CA). The column was
interfaced via a nanospray source (New Objective, Woburn, MA) and eluted with a 60
min gradient from 2-98% solvent B (acetonitrile with 0.1% formic acid). The spray
voltage was 2.0 kV, and the capillary temperature was 200 °C. One full mass spectral
acquisition triggered six scans of MS/MS whereby the most abundant precursor ions were
activated for sequencing. The product-ion spectra (MS/MS) data were centroided during
the acquisition.
3.3.6

Mascot database search
Thermo RAW files were processed using extract_msn (2007 version 4.0, Thermo

Fisher, San Jose, CA) with a grouping tolerance of 0.8 Da, an intermediate scan setting of
1, and a minimum of 1 scan per group. The NCBI nonredundant database (version
20080718, restricted to mammals) was searched by using MASCOT 2.2.06 (Matrix
Science, Oxford, U.K.) with the following settings: enzyme, none; MS tolerance, 10 ppm;
MS/MS tolerance, 0.8 Da; maximum number of missed cleavages, 3; peptide charge of
1+, 2+ and 3+; oxidation of methionine was set as variable modification.
3.3.7

Data analysis
The uptake of deuterium by the global protein was the average mass differences

between the masses of the deuterated protein and the undeuterated protein. The back- 93 -

exchange rate was measured to be one deuterium loss per minute (45). No correction for
back exchange was applied because the time between sample quench and the
measurement with the mass spectrometer was less than 3 min, and all data were treated
consistently. For global protein analysis, deconvoluted spectra were generated by using
the MaxEnt1 algorithm (MassLynX version 4.0). The parameter settings were: resolution,
1.00 Da/channel; uniform Gaussian width at half height, 1.00 Da; minimum intensity
ratios, 33% for left peaks and right peaks.
3.3.8

Kinetic modeling
The global protein kinetic data were fit with a fixed-rate-constant binning model

by MathCAD (Math-Soft. Inc. Cambridge, MA) in which the root mean square (RMS)
was minimized (50, 51). All e changeable H’s were separated into four fi ed rateconstant bins (k = 10, 1, 0.1, 0.01 min-1). These rate constants were selected because the
rates of exchange change measurably in the time frame 0.17 min to 540 min, and the
H/DX became relatively constant after 60 min; hence the brackets of 10 min-1 (fast
exchangers, half-life ~0.07 min) and 0.01 min-1 (slow exchangers, half-life ~69 min)
were chosen. Although the largest rate constant for H/DX is >100 min-1 for unstructured
peptides (54), we are yet unable to obtain data at the short times that correspond to this
rate constant. Three trials were fit separately, and the results were averaged and reported
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with standard deviations.
3.3.9

Titration and species fraction calculation
The method for fitting the titration curve was described previously (51). Briefly,

there are nine parameters involved in the 1:4 protein-ligand binding systems: Ka1, Ka2,
Ka3, Ka4, D0, ΔD1, ΔD2, ΔD3, ΔD4; Ka is the binding constant; D0 is the deuterium uptake of
protein in the absence of ligands (Apo form); ΔDx is the difference between the average
of deuterium uptake of the complex in the presence of x ligands and that of the apo form.
The non-linear least squares fitting utilized the “Minimize” function of MathCAD (MathSoft. Inc. Cambridge, MA) to minimize the root mean square (RMS) of all inputs by
optimizing the parameters being searched. To obtain the nine parameters in single fitting
cycle with acceptable precision, a significant number of titration points would be needed
(>500) by applying a resampling statistical method (51). Because it was difficult to fit the
titration curve by varying all nine parameters in one fitting cycle, a repeat fitting cycle
strategy was used to obtain the K’s and ΔD’s values reported here.
The fitting process was started by making a guess of the D’s (D0, ΔD1, ΔD2, ΔD3,
ΔD4) values. The initial values for D0 was set as experimental data, and the values for
ΔD1, ΔD2, ΔD3, ΔD4 were obtained through a PLIMSTEX experiment at high-protein
concentration (100 times the 1/Ka or Kd as reported previously) (Figure 3-3). We fixed
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these D’s values and searched for K’s in the initial fitting process. After the four K’s (Ka1,
Ka2, Ka3, Ka4) were obtained, the repeat-fitting processes were then started. In the first
half cycle, we fixed the K’s obtained in the initial process and searched for the D’s. We
then fixed the ΔD1, ΔD2, ΔD3, and searched for Ka1, Ka2, Ka3, Ka4, D0, and ΔD4 to finish the
cycle. This fitting cycle was repeated until the relative differences between K’s values
before and after each cycle of fitting were less than 10%. Three trials of experiments
were applied with this strategy separately, and the results were averaged and reported
with standard deviations.
Once the binding affinities of Ca2+ were determined, the information for
fractionally bound TnC species as a function of Ca2+ was obtained and presented as a
deuterium pattern (d0, d1, . . .) in which other isotopes (e.g.,13C,

15

N,

18

O) had been

removed by using an isotopic pattern calculation. To obtain these patterns, each mass list
from three experimental trials was extracted from their individual spectra as an x,y file (x:
mass-to-charge ratio; y: intensity). A program in MathCAD was applied to find the
isotopic peak envelope among the list by providing the chemical formula and charge state
of the target peptide. The peak area in each envelope was applied for fractional species
calculation, and the isotopes (13C, 15N, 18O) were removed from the output by using the
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information provided via the Isotope Simulation function in Qual Browser 2.0.7
(Xcalibur, Thermo Fisher, San Jose, CA).
3.4 RESULTS
3.4.1

H/DX kinetics of apo- and holo-TnC
Binding of four Ca2+ induces a conformational change in troponin C. Previous

studies showed that the structure of the holo (Ca2+ saturated) state of skeletal troponin C
is more structurally open than the semi-apo state (two Ca2+ bound). The center partialloop structure between the N and C-terminal EF hands forms a less flexible helix whereas
the Ca2+ is bound to the two EF hands near the N-terminus (EF-I and EF-II) (1, 4, 12, 55).
A detailed structure of apo-troponin C has eluded determination owing to the
unstructured C-terminus in the absence of Ca2+ (37, 56).
We began our study by measuring the kinetics of H/DX of rabbit skeletal troponin
C in the Ca2+ saturated (holo) and Ca2+ absent (apo) states (Figure 3-1); the output is a
plot of deuterium uptake as a function of exchange times (10 s to 9 h). To generate the
holo state of troponin C, we made the protein stock solution (40 μM) containing 10 mM
HEPES, 150 mM KCl, and 1 mM CaCl2, pH 7.4. Using KCl mimics physiological
conditions, and excess Ca2+ (the ratio of Ca2+ concentration to protein concentration was
25) insures that the four EF hands of troponin C are saturated with Ca2+. To generate the
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apo state of troponin C, we replaced CaCl2 with 3 mM EGTA to insure that no Ca2+ was
present in the protein.

Figure 3-1. Kinetics of H/D exchange for rabbit skeletal troponin C. Apo-troponin C in 3
mM EGTA (squares, red) shows more extensive D uptake than holo troponin C in 1 mM
CaCl2 (diamonds, black). The fitted curves are shown as solid lines.
Rabbit skeletal troponin C has 158 exchangeable amide protons (excluding one
proline). Because the percentage of D2O in the experiment was 97%, the maximum
number of observable exchange events is 153. After 20 min of H/DX, the mass of apo
troponin C shifted by 116 ± 1 Da, indicating that ~75% of the amide sites are
exchangeable at this time. This high level of exchange is in accord with the general view
that troponin C in solution is highly flexible, dynamic, and solvent-exposed in the
absence of Ca2+. In the presence of Ca2+, the number of amides undergoing H/DX
- 98 -

decreased to 83 ± 1 Da after 20 min of exchange, indicating that ~32 amide sites no
longer exchange as a consequence of Ca2+ binding. A more stabilized secondary structure,
an increase in hydrogen bonding, a decrease in solvent accessibility of some amide sites,
and/or a combination of these factors decreased the H/DX rates.
To understand quantitatively how Ca2+ binding affects the exchange rate, we fit
the kinetic curve with four exchange rate bins (k = 10, 1, 0.1, 0.01 min-1) (Table 3-1).
The results show that the apo state has 79 ± 1 sites with an exchange rate constant of 10
min-1, whereas the holo state has only 26 ± 2 sites with the same rate constant, indicating
that ~53 fast-exchanging sites are affected by Ca2+ binding. In the holo state, these sites
shift to the lower exchange rates including those with an exchange rate constant of 1 min1

where the apo state has 1 ± 1 sites whereas the holo state has 24 ± 2 sites. There are also

significant differences for those amides undergoing exchange with a rate constant of 0.01
min-1; whereas the holo state has 61 ± 3 sites, 37 ± 4 amides in the apo state exchange at
this corresponding low rate. The overall shift to states having low exchange rate constants
is consistent with troponin C possessing a more rigid secondary structure upon Ca2+
binding.
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Kinetic Fit

# of H's per fixed-rate bin

k (min-1 )

10

1

0.1

0.01

Apo

79 ± 1

1±1

16 ± 3

37 ± 4

Holo

26 ± 2

24 ± 2

3±2

61 ± 3

Table 3-1. Numbers of amide hydrogen undergoing exchange for D for apo and holo
troponin C. The kinetic modeling used four fi ed e change rate constants and “binned”
the number of amides with respect to the rate constants.
3.4.2

Affinities for Ca2+ binding of troponin C
Several methods can be used to measure the binding affinities for protein-protein

interactions and protein-small molecule interactions; these methods include FRET
(fluorescence resonance energy transfer) (57), NMR (58), CD (circular dichorism) (59),
calorimetry (60) and SPR (surface plasmon resonance) (61, 62). Because there is a
significant difference in deuterium uptake between apo-TnC and holo-TnC, we can apply
PLIMSTEX (Protein–ligand interactions by mass spectrometry, titration, and H/DX) to
measure the equilibrium constants for Ca2+ binding to TnC (45, 49-51, 63) in a relatively
simple experiment.
Our titration format varies the relative concentration of Ca2+ and monitors by MS
the extent of H/DX as a function of time. Because EF-III and EF-IV are known from
previous studies to be high-affinity sites, they are often saturated with Ca2+. To insure the
protein was in the full apo state (no bound Ca2+), we carried out a two-step dialysis
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procedure (see Experimental). The deuterium uptake of the dialyzed TnC was
comparable to that of TnC in the presence of EGTA (data not shown), indicating the
dialysis was successful in removing Ca2+ from the protein. This purified protein sample
was used as the starting material for the titration (Figure 3-2); the troponin C
concentration for the titration was 0.3 μM, which falls into the range of Kd’s determined
previously (64). The time for H/DX (97% D2O buffer, 10 mM HEPES, 150 mM KCl, pH
7.4) was necessarily constant at 1 h, a time for which H/DX had become relatively
constant, and for which small errors in sampling time would have minimal impact on the
titration. We also performed the titration at high-protein concentration, 15 μM, which is
~100 times the Kd values (Figure 3-3). A titration at this protein concentration will
usually give a “sharp break” curve that reveals the stoichiometry of the ligand binding
(49); in this case, rabbit skeletal troponin C binds four Ca2+, in agreement with previous
findings. The other purpose for conducting this “sharp break” titration is to obtain an
estimate of the ΔD’s values to aid the PLIMSTEX curve fitting process (see
Experimental). At high-protein concentration, the equilibrium shifts toward the proteinligand complex, and the resulting ΔD’s values will be similar to the actual ΔD’s, which
report the change in the protein secondary structure owing to each ligand binding.
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Figure 3-2. PLIMSTEX curve of Troponin C titrated with Ca2+ and followed by MSbased H/DX. The concentration of the protein for the titration was 0.3 μM.

Figure 3-3. “Sharp-break” PLIMSTEX titration curve; protein concentration = 15 μM.
The junction of the two arms of the curves indicates the stoichiometry of Ca2+ binding is
4:1.
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In this manner, we obtained ΔD1, ΔD2, ΔD3, and ΔD4 as 6, 15, 31, and 37,
respectively. These values serve as the initial guesses for the repeat-fitting cycle
described in the experimental section. The relative variations of K2, K3 and K4 all
decreased to ~10% after we performed three cycles of the fitting (Figure 3-4). Although
the relative variation of K1 was not constrained over each fitting cycle, probably because
the number of experimental points is insufficient, its value still is in a reasonable range.
Given that the affinities are known and that the main purpose of the study is to investigate
the order of binding, we did not pursue the titration further because additional
improvements would not affect significantly the determination of the binding order.
Previous studies show that skeletal troponin C has two Ca2+ binding sites, EF-III
and EF-IV, located near the C-terminus; their binding affinities are comparable at (2.1 ±
0.7) x 107 M-1 (64). Two additional sites are located near the N-terminus of skeletal
troponin C, EF-I and EF-II, and their binding affinities for Ca2+ are in the range of 3 x 105
to 5 x 106 M-1 (20, 64). Although the equilibrium constants show variability from study to
study (possibly because the affinities are relatively small), the consensus is that the
equilibrium constants for the N-terminal EF hands are in the range of 105-106 M-1 and
smaller than those for the C terminus (37).
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Figure 3-4. Relative differences between K’s values before and after each cycle of fitting
as a function of the number of fitting cycles.
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We fit the titration curve to a non-linear least squares model that was previously
described (51). The output of the fitting produced four Ka’s (Table 3-2), two with high
values of (5 ± 5) x 107 M-1 and (1.8 ± 0.8) x 107 M-1, which are within a factor of 3 of
previous results. The other two Ka’s have smaller values of (4.2 ± 0.9)

106 M-1 and (1.6

± 0.6) x 106 M-1, which are also within the range of values from previous studies. The
fitting parameter D0 (127 ± 1), which represents the deuterium uptake in the apo state is
in agreement with the experimental results (127 ± 2).
K
Experimental Value
K1
(5 ± 5) x 107 M-1
K2
(1.8 ± 0.8) x 107 M-1
K3
(4.2 ± 0.9) x 106 M-1
K4
(1.6 ± 0.6) x 106 M-1
ΔD4
38 ± 1
D0
127 ± 1
RMS
0.62
2+
Figure 3-2. Four Ca binding constants
titration curves.
3.4.3

Literature Values
2 x 10 M (1);(2.1 ± 0.7) x 107 M-1(64)
2 x 107 M-1 (1);(2.1 ± 0.7) x 107 M-1(64)
5 x 106 M-1 (20);(3.2 ± 1.3) x 105 M-1(64)
5 x 106 M-1 (20) ;(3.2 ±1.3) x 105 M-1(64);
N/A
N/A
7

-1

of troponin C obtained by fitting PLIMSTEX

Fractional species and binding order
The titration study provides us the four equilibrium constants (Ka) for Ca2+

binding to troponin C. These values are not new, and they can be determined by other
approaches. Remarkable, however, is that three of the four values (K2, K3 and K4) can be
extracted with reasonable precision from a single titration, probably because each
addition of Ca2+ to the protein induces a change in conformation that responds to H/DX.
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Because the binding affinities are different, it is likely that Ca2+ binding is cooperative
and occurs, at least in part, in a stepwise manner.
The next level of information is the order of binding, which we sought to
determine by following the H/DX extent at the EF-hand level. One prospect is to examine
the deuterium distribution for the various EF hands as a function of Ca2+ concentration.
These EF-hand regions may be removed from the protein following H/DX as peptides by
pepsin digestion and submitted to LC-MS analysis. When an EF hand binds Ca2+, we
expect the extent of H/DX will decrease. By identifying the state of Ca2+ binding (e.g., 0,
1, 2, 3, 45 for which the change occurs, we should be able to determine in a
straightforward way the order for Ca2+ binding. The interaction between Ca2+ and
troponin C at any titration point, however, results in a mixture of Ca2+-binding states, and
the deuterium distribution of any given EF hand at each titration point is of a mixture of
different Ca2+ bound states. The challenge is to extract from this mixture of states the
deuterium distribution of an EF hand for a single state (Figure 3-5).
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Figure 3-5. Fractional species curves showing the distribution of each TnC:xCa2+ as a
function of Ca2+ concentration (μM). (Blue: zero Ca2+-bound; Pink: 1 Ca2+-bound;,
Yellow: 2 Ca2+-bound; Light blue: 3 Ca2+-bound; Purple: 4 Ca2+- bound).
The four equilibrium constants, determined by PLIMSTEX or any other method,
are a source of fractional species information that allow the determination of the
population of the various Ca2+ states as a function of [Ca2+]. We hypothesized that
knowing these fractional species will lead us to the required deuterium distributions. To
test this hypothesis, we used the previously reported and likely more reliable K1 value
(2.1 x 107 M-1) and the K2, K3, and K4 values (1.8 x 107 M-1, 4.2 x 106 M-1, 1.6 x 106 M-1,
respectively) determined by PLIMSTEX to calculate the fractional species as a function
of total [Ca2+] and determine the population of the five troponin C species, TnC:xCa2+ (x
= 0-4) when the protein concentration was 4.2 μM (Figure 3-5). The reason for choosing
a literature K1 is the precision for our K1 value is not high because the titration is
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underdetermined, and we don’t want that to affect the precision for the fractional-species
determination. We chose seven Ca2+ concentrations from the fractional-species plot,
including [Ca2+] = 0 (100% apo TnC) and Ca2+ = 2 mM (100% holo TnC) (Table 3-3) for
our search for the required deuterium distributions. To obtain the needed experimental
data, we conducted H/DX for 1 h in 90% D2O buffer (10 mM HEPES, 150 mM KCl, pH
7.4), quenched the exchanging solution, digested the protein with pepsin for 3 min on icewater, and analyzed the peptide mixture by LC/MS.

[Ca]
μM

TnC0Ca

TnC1Ca

TnC2Ca

TnC3Ca

TnC4Ca

0

100.0%

0.0%

0.0%

0.0%

0.0%

8.4

7.4%

19.7%

44.5%

23.7%

4.7%

10.4

2.3%

10.4%

39.8%

35.6%

11.9%

12.1

0.0%

4.9%

29.7%

42.6%

22.8%

13.8

0.0%

0.0%

18.2%

43.1%

38.7%

16.7

0.0%

0.0%

0.0%

29.1%

70.9%

2000

0.0%

0.0%

0.0%

0.0%

100.0%

Table 3-3. Various solution concentrations chosen for H/DX to determine the order of
binding of Ca2+ with troponin C. The values are calculated fractional species of each
Ca2+-bound TnC species and are taken from the fractional species curves in Figure 3.
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MS analysis directly gave us the complete isotopic distribution for specific
deuterated peptides, but this distribution represents various states of the protein, not the
single state we sought. Nevertheless, from these distributions, we can calculate the
representative isotopic distribution for each Ca2+-bound troponin C species (see Figure
3-6 for an example of this idea). The upper left spectrum shows the deuterium-containing
isotopic distribution when [Ca2+] = 16.7 μM for the triply charged peptic peptide
FRIFDRNADG, which is from the EF-III region. From Table 3-3, we know that there is
30% TnC-3Ca2+ species and 70% of TnC-4Ca2+ species in the solution when the total
[Ca2+] is 16.7 μM. Because we know the deuterium distribution of this peptide when
[Ca2+] = 2 mM (representing 100% TnC-4Ca2+ species, lower left in Figure 3-6), we can
remove that pattern from the experimental distribution to give the deuterium distribution
for the peptide representing this region of the protein when it exists as TnC-3Ca2+ (right
pattern in Figure 3-6).

- 109 -

Figure 3-6. (A) Deuterium-containing isotopic distribution of the triply charged peptic
peptide 100-109 (FRIFDRNADG). The distribution can be represented as a mixture of
70% holo (TnC-4Ca2+, red area in C) and 30% TnC-3Ca2+ states as shown in (C), which
is an enlarged view of A. (B) Deuterium-containing isotopic distribution of triply charged
peptic peptide 100-109 (FRIFDRNADG). The distribution represents 100% Holo state
(TnC-4Ca2+) in 1 mM CaCl2. (C) Enlarged view of (A). Although the triply charged
peptide is for demonstration, the doubly charged peptide was used for analysis.
To sort out the required isotopic distributions, we implemented an algorithm with
Mathcad 2001 Professional (Math-Soft, Inc., Cambridge, MA). We extracted mass lists
containing all peptide information from each spectrum and input them into MathCAD as
x,y files for peak-finding and fractional-species calculation. The basis for this algorithm
is in matrix algebra as given in equation 1.
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(1)
In this equation, matrix A is the input of the experimental results; that is, the
isotopic abundances for a single peptide, I, from peak 0 to peak n as a function of the
various ligand concentrations. Matrix C provides the fractional species information; that
is, the population of each species, PS, from species 0 to x as a function of the ligand
concentrations. For troponin C, binding to Ca2+, x = 4, and there exist five species: TnC0Ca2+, TnC-1Ca2+, TnC-2Ca2+, TnC-3Ca2+, and TnC-4Ca2+. Matrix B is the output of
isotopic abundances of species, IS, from peak 0 to peak n as a function of various Ca2+
binding states.
In the implementation, we normalized each row of each matrix so that their sum is
equal to 1, and we required that the values in matrix B be positive. We fit the output in
matrix B to the best values; this procedure requires minimizing the differences between
matrix A and the product of matrix B and C. The intensity input can be the intensity of
the peak centroid or its area in a peak-profile mode; the latter was used in this work so
that each part in the isotopic distribution pattern was considered, in principle increasing
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the accuracy of the calculation. By comparing the distribution of the peaks and their area,
we obtained a deuterium isotopic pattern of each peptic peptide as a function of the Ca2+
binding state. Changes in H-bonding or solvent accessibility for various regions of the
protein induced by Ca2+ binding can be determined by simply analyzing the shift of the
isotopic distribution.
3.4.4

Order of Ca2+ binding
Our hypothesis was that changes in the deuterium distributions for peptides from

regions involved in Ca2+ binding as a function of the states of the protein (TnC-0Ca2+ to
TnC-4Ca2+) will report the order of Ca2+ binding. To test this hypothesis, we needed four
abundant peptic peptides each representing one of the four EF hands to follow as a
function of the fractional species calculation, and we were able to obtain these reporter
peptides

by

pepsin

digestion.

The

four

peptides

are

doubly

charged

DADGGGDISVKELGTVM (28-44) containing EF-I; doubly charged, EVDEDGSGTID
(63-73) containing EF-II; doubly charged FRIFDRNADG (100-109) containing EF-III;
and triply charged, MKDGDKNNDGRIDF (136-149) containing EF-IV. The outcome of
the matrix-algebra calculation gave us the deuterium distributions convolved with the
native distribution of C-13, N-15 and O-18 of each EF hand for the five states of Ca2+
binding to troponin C. We then removed all isotope components except D for these four
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unique peptic peptides by using the theoretical isotope ratio provided via the Isotope
Simulation function in Qual Browser 2.0.7 (Xcalibur, Thermo Fisher, San Jose, CA). The
isotope deconvolution process is illustrated in Figure 3-7. Briefly, each deuteriumcontaining isotopic pattern is a mixture of various numbers of deuterium-containing
species (d0, d1, d2…) with their isotopic species. By knowing the chemical formula for a
particular peptide, we can calculate the isotope distribution (except that of D from H/DX)
and remove it from the distribution, leaving a pure deuterium distribution (Figure 3-8).
We submit that any slight change of the deuterium uptake can be readily revealed by this
strategy.

Figure 3-7. Deuterium distribution convolved with the native isotopic distribution of
doubly charged peptide 63-73. Bars represent the different numbers of deuteriums (d0, d1,
d2…) comprising each peak, and their heights include other isotopic contributions (C-13,
N-15, O-18) (dark blue to light blue). Removing the native isotopic distribution leaves
the deuterium distribution (bars outlined with red frames).
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Figure 3-8. Top: Each column represents the deuterium distributions of the peptic
peptide of EF hands: III, IV, II, I (left to right). Each row represents the various Ca2+
bound TnC states: Apo (Absent Ca2+) to 4 Ca2+ bound TnC (top to bottom). Bottom: Xray crystal structure of rabbit skeletal troponin C (PDB: 1TCF) in gray, and the four EF
hands are in black.
Comparing the variation of the deuterium-distribution centroid for the four peptic
peptides as a function of different Ca2+ bound troponin C states (Figure 3-8), we see that
the first shift from higher to lower deuterium content (indicating onset of protection)
occurs for peptic peptide 100-109 containing EF-III for the transition of TnC-0Ca2+ to
TnC-1Ca2+ whereas the deuterium distributions of the peptides representing the other
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three EF hands remain largely unaffected. This indicates that EF-III in skeletal troponin C
is first to bind Ca2+, although the binding may not be complete as the D distribution
continues to shift to more protection as more calcium binds. Peptic peptide 136-149 from
EF-IV showed a similar but more conclusive shift from a centroid of six to four
deuteriums for TnC-2Ca2+, indicating that EF-IV is the second Ca2+ binding site. Similar
to EF-III, the D distribution shows additional minor shifts as the protein continues to take
up calcium. Although the shifts for EF-III and IV do not occur sharply as various states
of Ca2+ binding are achieved, the results clearly show the higher propensity for binding
Ca2+ by EF-III and EF-IV (~107 M-1) than by EF-II and EF-I. Sykes and coworkers (53)
studied the binding of Ca2+ to synthetic EF-III and EF-IV peptides of troponin C by 1HNMR. Their results show that Ca2+ binds to synthetic EF-III peptide; the resulting Ca2+EF-III then associates with the apo-EF-IV peptide to form a heterodimer Ca2+-EF-III/EFIV. The heterodimer then binds the second calcium to give 2Ca2+-EFIII/EFIV. Our results
on the intact protein agree with this general picture of stepwise binding.
Because the N-terminal EF-I and EF-II have lower binding affinities to Ca2+ (~106
M-1), they should bind after EF-III and IV. Indeed, the deuterium content (most abundant
ion) of the peptic peptide containing EF-II shifts from four to two deuteriums at the
transition to TnC-3Ca2+, whereas the peptic peptide representing EF-I shifts from eight to
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six deuteriums at the transition to TnC-4Ca2+. Thus, the third Ca2+ binds at EF-II followed
by the last Ca2+ binding at EF-I. Sykes and coworkers (37) also studied Ca2+ binding to
EF hands in N-terminus of chicken skeletal troponin C by using NMR. Although the
overall binding picture for full length TnC remained unclear, they could conclude that
EF-II is the first site in the N-terminus of troponin C that binds to Ca2+ and EF-I is the last
Ca2+ binding site, a conclusion that is consistent with the results of H/DX presented here.
To illustrate more clearly the order of Ca2+ binding, we normalized the deuteriumuptake values for the four peptides to their most probable deuterium (highest intensity
peak) uptake. This allows us to view the relative deuterium uptake as a function of
different TnC-Ca2+ states (Figure 3-9). The outcome clearly shows that the order of Ca2+
binding to the four Ca2+ binding sites in intact skeletal troponin C is EF-III > EF-IV > EFII >EF-I, although there is likely to be some simultaneous binding of Ca2+ by EF-III and
IV.

- 116 -

Figure 3-9. A plot of the normalized relative deuterium uptake based on the centroids of
the deuterium distributions for four peptic peptides containing the four EF hands as a
function of various Ca2+-bound TnC states.
3.5 DISCUSSION
The advantage of H/DX coupled with MS is that changes in the extent of H/DX,
whether caused by increased H bonding or decreased solvent accessibility or both, can be
used to compare two or more states. The conclusions do not depend highly on the
abundances of the various isotopomers but principally on their m/z. The PLIMSTEX
strategy further extends the advantage of H/DX by affording, via ligand titrations at a
fixed concentration of protein, the protein-ligand binding affinities. The equilibrium
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constants are essential for the design of an experimental approach to extract deuterium
distributions for regions of a protein as a function of its binding state.
We illustrate the approach to determine the binding order of Ca2+ to troponin C.
Although troponin C is a well-studied protein, establishing the order of Ca2+ binding has
proven difficult. The kinetics of HDX at the protein or global level demonstrates that the
protein is considerably stabilized as a consequence of Ca2+ binding. The differences in the
apo and holo states allow the binding affinities of troponin C with Ca2+ to be measured in
a single-titration format. The values of the equilibrium constants allow calculation of
fractional species for troponin C. From H/DX experiments at known fractional species,
we can extract the deuterium distribution of four regions of the protein that bind Ca2+.
Those distributions shift to lower mass when Ca2+ binds at the site, providing a basis for
determining the binding order of the four Ca2+ ions.
Previous studies on Ca2+ binding to troponin C by Ca2+ titration (36, 37, 52, 53, 64)
indicated the binding is cooperative and affected by pH. Those studies, however, did not
give a clear outcome of the binding order of Ca2+ to troponin C probably because the
similar binding affinities of Ca2+ in each terminal region of troponin C cause the states to
coexist at various Ca2+ concentrations. Nevertheless, our results indicate the Ca2+ binding
to skeletal troponin C occurs in the order EF-III > EF-IV > EF-II > EF-I. This
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determination is attributed to the high sensitivity of MS in the H/DX platform and the
ability to extract from the data specific D distributions for the five binding states of the
protein.
The reasons for this trend of binding are not completely understood. Preferential
binding at the C terminus is well-established. Binding details may be an outcome of the
various charge states of the protein in different pH environments or the difference of the
secondary and tertiary structure of the Ca2+ binding sites with respect to individual Ca2+
binding (52). Nevertheless, our results can help understanding the detailed mechanism of
the muscle contraction. It will be of interest to see whether this approach can be applied
to determine binding orders of other proteins and ligands.
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4.1 ABSTRACT

The troponin protein complex exists in the thin filament of striated muscle
myocytes (along with tropomyosin and actin) and plays a regulatory role in muscle
contraction by binding calcium ions released by nerve impulses. The complex is
composed of three subunits; troponin C (TnC), the calcium binder; troponin I (TnI), the
inhibitor; and troponin T (TnT), the anchor and structural support. The interactions within
the troponin complex to produce muscle contraction and the role of the complex plays in
cardiac-related diseases motivate its study. We used solution phase hydrogen/deuterium
exchange (H/DX) monitored by mass spectrometry at both the global and peptide level to
understand better the structural dynamics within the rabbit skeletal troponin complex. We
determined that the major effector of structure in calcium-activated TnC is TnI, and that
TnT plays a minor role in the interactions of TnC. We also compared the binding affinity
between TnC and TnI in the absence or presence of TnT by using PLIMSTEX (proteinligand interaction by mass spectrometry, titration, and H/D exchange). Our titration
curves, when fit with 1:1 binding model, provided binding constants, (1.9 ± 0.4) x 106 M1

; (2.4 ± 0.2) x 106 M-1 in the absence or presence of TnT. The outcomes further confirm
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that TnT has little effect on the binding between TnC and TnI and is a demonstration of
the utility of H/DX in studying the properties of one protein in a complex.
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4.2 INTRODUCTION
Troponin, a 72 kDa protein complex in skeletal and cardiac muscle of mammals,
is composed of three subunits: troponin C (TnC), troponin I (TnI) (1), and troponin T
(TnT) (2, 3). Each subunit has its own unique function, and all are essential for muscle
contraction (4). TnT binds to tropomyosin on the thin filament, serving as a key in
complex formation (5, 6). TnI blocks the actin from interacting with the myosin head by
anchoring its C-terminal region (Inhibitor region) (2). TnC, a calcium sensor, usually has
four Ca2+ binding sites (only three for cardiac TnC). Two sites located at the C-terminal
domain have high Ca2+ binding affinities (~107 M-1), are saturated with Ca2+ under normal
physiological conditions so as to maintain the stability of the complex (3, 7, 8). When the
intracellular free Ca2+ concentration increases, Ca2+ binds to the N-terminal domain of
TnC, changing the conformation of TnC and forming a hydrophobic pocket in the Nterminal region (4, 9, 10). This region then interacts with the “inhibitor region” of TnI
and releases actin, whereby muscle contraction is initiated through the interaction of actin
and the myosin head. Any factor that affects the TnC-TnI interaction will influence the
efficiency of muscle movement and may have implications in cardiac disease. For
example, phosphorylation of TnI may be induced by over-activation of protein kinase A
and C to affect both the binding of Ca2+ to TnC and the interaction between TnC and TnI
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(11-14). To overcome this, some drugs are designed to interact with TnC and adjust its
affinities to Ca2+ (15, 16).
The binding of TnC, TnI and TnT in the complex have been studied by numerous
approaches including NMR (17, 18), calorimetry (6), and fluorescence (19, 20). An X-ray
crystallography study on the chicken-skeletal troponin complex (2) shows that complex
formation utilizes an interaction between the C-terminal region of TnC and the Nterminal region of TnI such that the C-terminal regions of TnI can bind to TnT through a
coiled-coil helical interaction (Figure 4-1). The detailed conformation changes of each
subunit upon the addition of each neighboring subunit, however, are not well understood.

Figure 4-1. X-ray crystal structure of chicken skeletal troponin complex. Blue: troponin
C (TnC); Red: troponin I (1); Yellow: troponin T (TnT 103-248). The complex with
2Ca2+ loaded onto TnC is shown on the left (PDB: 1YVO), and the complex with 4Ca2+
loaded onto TnC is on the right (PDB: 1YTZ)
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We recently studied the binding of Ca2+ to rabbit skeletal TnC, as shown in the
previous chapter, and determined the binding affinities and binding order by using
hydrogen/deuterium exchange (H/DX) coupled with mass spectrometry (21). This
approach is now widely used to study protein conformation, protein-protein, or proteinligand interactions (22-25). With H/DX, one monitors the changes in H-bonding caused
by changes in folding and interactions with ligands and other proteins. Recently, H/DX
was applied to study the regulatory function of human cardiac troponin complex and the
conformational changes of troponin complex induced by Ca2+ binding (26, 27).
To understand more completely the role played by individual subunits in the
troponin complex formation, we extended our study on the physical properties of rabbit
skeletal TnC from that of the protein itself to that of the protein within the troponin
complex. By monitoring the changes of the extent of deuterium uptake of TnC with the
addition of TnI and TnT, we probed changes in H-bonding caused by changes in solvent
accessibility of TnC in the complex. We then examined the binding affinities between
TnC and TnI in the absence or presence of TnT by PLIMSTEX (protein-ligand
interaction by mass spectrometry, titration, and H/D exchange) (28, 29) to determine
whether TnT influences the TnC-TnI interaction. Finally, by conducting enzymatic
digestion and comparing the deuterium uptake of peptide regions from each subunit with
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the addition of neighboring subunits, we verified the interface locations for each
interaction site to assess whether H/DX can determine whether the troponin complex is
stabilized by binding to TnT.
This H/DX study of the skeletal troponin complex is also motivated by our
general goal to develop and implement mass-spectrometry-based methods to determine
biophysical properties of proteins alone and in more complex settings such as in protein
complexes.
4.3 EXPERIMENTAL
4.3.1

Materials
Rabbit skeletal Troponin C (TnC), troponin I (1), troponin T (TnT) were

purchased from Ocean Biologics Inc (Seattle, WA). Porcine pepsin, citric acid, sodium
citrate, sodium chloride, ethanolamine, potassium chloride, calcium chloride, EGTA
tetrasodium salt [ethylene-bis(oxyethylenenitrilo)tetraacetic acid tetrasodium], and
HEPES hemisodium salt [N-(2-hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid)
hemisodium salt] were purchased from Sigma-Aldrich (St.Louis, MO). Deuterium oxide
was purchased from Cambridge Isotope Laboratories Inc (Andover, MA). The synthetic
TnI inhibitor peptide RGKFKRPPLRR was purchased from Genscript (Piscataway, NJ).
4.3.2

Troponin complex preparation
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TnC, TnI, and TnT were dialyzed against HEPES buffer (10 mM HEPES, 150
mM KCl, pH 7.4) for 2 h at 4 °C using Slide-A-Lyzer Dialysis Cassettes 7000 MWCO
(Pierce, CA) followed by exchange with fresh buffer and overnight dialysis. The
concentration of the final protein solution was measured by the BCA protein assay
following the manufacturer’s protocol (Thermo Fisher, Rockford, IL). The protein
solution was aliquoted and stored at -80 °C.
The TnC alone was prepared in the presence of 1 mM CaCl2 or 3 mM EGTA in
HEPES buffer (10 mM HEPES, 150 mM KCl, pH 7.4) to generate Ca2+ absent or
saturated form of TnC. To generate troponin complexes with different compositions of
subunits, TnC, TnI, or TnT was mixed separately in 1:1 ratio in the presence of 1 mM
CaCl2 in HEPES buffer and equilibrated at 25 °C for at least 1 h. All samples were
prepared in 20 μM protein concentration.
4.3.3

H/D exchange (H/DX) protocol
For global protein HDX measurement, 40 pmol of protein sample was diluted

tenfold in D2O buffer (10 mM HEPES, 150 mM KCl) at 25 °C. At various times, the
exchange was quenched by adding sufficient 1 M HCl at 0 °C to give a final pH of 2.5.
The quenched protein solution was then loaded onto a C8 guard column (1 mm x 15 mm,
Optimize Technologies, Oregon, City, OR) via an Agilent 1100 HPLC (Santa Clara, CA)
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operated at 50 μM/min flow rate with 0.1

TFA for 3 min. The protein was eluted by

using a gradient from 5% to 50% solvent B in 0.3 min, 50% to 100% solvent B in 5.2 min
and isocratic flow at 100% solvent B for 0.5 min, then back to 5% solvent B in 0.1 min at
50 μM/min flow rate. All LC connection lines were immersed in a water-ice (0 °C) bath.
(Waters nanoAcquity UPLC, Manchester, U.K; solvent A, water containing 0.1% formic
acid; solvent B, acetonitrile containing 0.1% formic acid).
For peptide-level H/DX measurement, 80 pmole of protein sample was diluted
tenfold in D2O buffer (10 mM HEPES, 150 mM KCl) at 25 °C for 30 min and quenched
by adding 1 M HCl. The quenched sample was injected into an on-line pepsin-digestion
device, immersed in a water-ice (0 °C) bath, containing immobilized pepsin in a 1 mm ×
2 cm guard column (Upchurch Scientific, WA) (30) via an Agilent 1100 HPLC (Santa
Clara, CA) operated at 50 μM/min flow rate with 0.1

TFA for 3 min. The digested

protein solution was trapped on a C18 guard column (1 mm x 1.5 cm, Optimize
Technologies, Oregon City, OR) and separated by a C18 analytical column (1 mm x 5 cm,
Dionex, Bannockburn, IL) via an Agilent 1200 HPLC (Santa Clara, CA) with a gradient
operated under 50 μM/min flow rate. The gradient settings were: 5% to 15% solvent B in
0.3 min, 15% to 50% solvent B in 5.2 min, 50% to 100% solvent B in 0.5 min, and
isocratic flow at 100% solvent B for 1.5 min, then back to 5% solvent B in 0.1 min.
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Solvent A was water containing 0.1% formic acid, and solvent B was 80% acetonitrile in
water containing 0.1% formic acid.
4.3.4

LC-ESI/MS analysis with a Q-TOF mass spectrometer
Global protein H/DX results were acquired on a Waters (Micromass)

(Manchester, U.K.) Q-TOF Ultima spectrometer equipped with a Z-spray ESI source.
The instrument settings were: capillary voltage, 3.2 kV; cone voltage, 80 V; source and
desolvation temperatures, 80 °C and 180 °C; the cone and desolvation gas flow rates
were 40 and 400 L/h. The MS profile used for quadrupole transmission was to scan from
m/z 300, dwell for 5% of the scan time, ramp to m/z 1000 for 45% of the scan time, and
then dwell at m/z 1000 for 50% of the scan time.
Peptide-level H/DX results were acquired on a MaXis (Bruker) (Bremen,
Germany) Q-TOF spectrometer. The instrument settings were: capillary voltage, 3.8 kV;
nebulizer gas, 0.8 Bar; drying gas flow rate and temperature, 5.0 L/min and 200 °C.
4.3.5

LC-ESI/MS/MS analysis of protein digests
To confirm the peptide sequences for peptic peptides of TnC, TnI and TnT, three

protein solutions were subjected to on-line pepsin-digestion separately as described
previously (31) and analyzed on a Thermo LTQ XL ETD Orbitrap (Thermo Fisher, San
Jose, CA). The instrument settings were: spray voltage, 3.5 kV; sheath gas flow rate, 8
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(arbitrary units); capillary temperature, 275 °C; capillary voltage, 35 V; and tube lens,
110 V. One full mass spectral acquisition triggered six MS/MS scans (precursor ion
activation with CID). The peaks in the product-ion spectra (MS/MS) were centroided for
each peptide during the acquisition.
4.3.6

Mascot database search
Thermo RAW files were processed by using extract_msn (2007 version 4.0,

Thermo Fisher, San Jose, CA) with a grouping tolerance of 0.8 Da, an intermediate scan
setting of 1, and a minimum of 1 scan per group. The NCBI non-redundant database
(version 20110722, restricted to mammals) was searched by using MASCOT 2.2.06
(Matrix Science, Oxford, U.K.) with the following settings: enzyme, none; MS tolerance,
10 ppm; MS/MS tolerance, 0.8 Da; maximum number of missed cleavages, 3; peptide
charge of 1+, 2+ and 3+; variable oxidation of methionine.
4.3.7

Data analysis
The uptake of deuterium was determined by the mass-to-charge differences

between the centroid of the isotopic distribution of the deuterated peptide and the
undeuterated peptide, or the average mass differences between the masses of the
deuterated protein and the undeuterated protein. No correction for back exchange was
applied because the time between sample quench and the measurement with the mass
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spectrometer was less than 6 min, and all data were treated consistently. For global
protein analysis, MaxEnt1 algorithm (MassLynX version 4.0) was used to generate
decharged spectra. The parameter settings were: resolution, 1.00 Da/channel; uniform
Gaussian width at half height, 1.00 Da; minimum intensity ratios, 33% for left peaks and
right peaks. For peptide analysis, the centroid of the peptide isotopic distribution was
analyzed using HDExaminer 1.0 (Sierra Analytics, Modesto, CA).
4.3.8

Kinetic modeling
The global protein kinetic data were fitted with a fixed-rate-constant binning

model by using MathCAD (Math-Soft. Inc. Cambridge, MA) as described previously (29,
32). Briefly, all e changeable H’s were separated into four fi ed rate-constant bins (k =
10, 1, 0.1, 0.01 min-1), and the root-mean-square (RMS) was minimized during the fitting
process. Three trials were fit separately, and the results were averaged and reported with
standard deviations.
4.3.9

PLIMSTEX titration
To obtain the binding affinity between TnC and TnI and to examine whether TnT

could affect the interaction between them, the TnC alone and TnC-TnT (1:1) complex
were first incubated at 20 μM protein concentration in HEPES buffer (10 mM HEPES,
150 mM KCl) in the presence of 1 mM CaCl2 for 1 h at 25 °C. The two complex samples
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were than incubated with various TnI concentrations (from 8 μM to 300 μM) for 1 h at 25
°C in the same buffer system. The H/DX experiment was then started, as described in
previous section. The H/DX time was 30 min, chosen because the extent of H/DX had
become relatively constant at that time, and small errors in sampling time would have
minimal impact on the titration accuracy. The method for fitting the titration curve was
described previously (29, 32). A 1:1 protein-ligand binding system was used invoking
three fit parameters: Ka1, D0, ΔD1; where Ka1 is the binding constant; D0 is the deuterium
uptake of protein in the absence of ligands (apo form); and ΔD1 is the difference between
the average of deuterium uptake of the complex in the presence of ligand and that of the
apo form. The parameters were optimized in the searching process to minimize the root
mean square (RMS) of all inputs. MathCAD (Math-Soft. Inc. Cambridge, MA) was used
in this fitting process. Three trials of experiments were fitted separately, and the results
were averaged and reported with standard deviations.
4.4 RESULTS AND DISCUSSION
4.4.1

H/DX kinetics of TnC within the Tn complex
Troponin C (TnC) acts as a calcium sensor in the troponin complex. Two Ca2+

binding sites (EFIII and EFIV) with high binding affinities (~107M-1), located at the Cterminal domain, are often saturated with Ca2+ and stabilize the three-part complex. The
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other two binding sites, located at the N-terminal domain, have lower Ca2+binding
affinities (~106 M-1) (3, 21). Once the four sites are saturated with Ca2+, a “hydrophobic
pocket” forms near the N-terminal region of TnC, providing the location for interaction
with the “inhibitor region” of TnI to initiate muscle contraction.
The solvent accessibility and the hydrogen bonding of TnC are affected
significantly by interacting with Ca2+ as revealed by our earlier H/DX study (21). Most of
the changes occur at the four Ca2+ binding regions (EF-hands). The additional presence of
TnI and TnT are likely to have significant influence on the physical properties of TnC
and its dynamics in solution. Marshall and coworkers (27) studied the conformational
changes of cardiac TnC (cTnC), cTnI and cTnT in the binary (cTnC-cTnI) and ternary
complexes (cTnC-cTnI-cTnT) in the presence and absence of Ca2+ by using H/DX
FTICR MS. They concluded that the amide exchange rates of C-terminal regions of cTnC
are largely affected by the interaction with cTnI and cTnT and that the N-terminal regions
of cTnC are mainly affected by cTnI. Although skeletal troponin is structurally similar to
cardiac troponin, the binding properties between each subunit might be different.
To address how TnI and TnT affect the dynamics and conformation of TnC, we
designed a different H/DX kinetics experiment to study global TnC in the presence or
absence of TnI and TnT (Figure 4-2). We added excess amounts of Ca2+ in the solution
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(1 mM) to stabilize the binary (TnC-TnI; TnC-TnT) and the ternary (TnC-TnI-TnT)
complexes. The ratio for each subunit in solution was 1:1 and the complexes were
equilibrated for 1 h at 25 °C before initiating the H/DX.

Figure 4-2. Kinetics of H/D exchange for rabbit skeletal TnC. Apo-TnC in 3 mM EGTA
(diamonds, red) shows the most extensive D uptake. Ca2+ loaded TnC (squares, green)
and Ca2+ loaded TnC-TnT complexs (squares, blue) show similar D uptake. Ca2+ loaded
TnC-TnI complex (squares, gray) and Ca2+ loaded TnC-TnI-TnT complex (squares,
black) show further decrease of D uptake. The fitted curves are shown as solid lines.
It is obvious that the presence of Ca2+ (green line) affects the conformation of
TnC significantly, as is well known and consistent with the H/DX results reported in the
previous chapter (21). Interestingly, the addition of TnT to TnC has minor impact on the
hydrogen bonding of TnC (blue line); only approximately five amide hydrogens on TnC
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are affected when TnT binds. Thus, the binding of TnT affects in a minor way the solvent
accessibility of TnC, indicating that the interaction between these two subunits is either
weak or highly localized. The addition of TnI to TnC further increases H-bonding,
decreasing the solvent accessibility of TnC (gray line; ~20 D lower than the D uptake of
TnC alone). The decrease shows that the N-terminal regions of TnC can interact with the
inhibitor region of TnI in the presence of Ca2+. Again underscoring the minor effects of
TnT, we find its addition to the TnC-TnI binary complex (black line) produces only
minor effects on TnC.
To probe more deeply how TnI and TnT binding in the complex affects the
exchange kinetics, we fit the kinetic curve with four exchange rate-constant bins (k = 10,
1, 0.1, 0.01 min-1) (Table 4-1). The results are consistent with those reported previously
(21). Ca2+ binding affects 48 fast-exchanging amides of TnC; TnC in the absence of Ca2+
exchanges 96 ± 1 amides with a rate constant of 10 min-1, whereas when loaded with Ca2+,
48

±

2

amides

exchange

with

the

same

rate

constant.

Although the overall kinetics is affected by the addition of TnI and TnT, there is no
significant effect on the number of fast-exchanging amides. There are slower exchanging
amides (k = 1 min-1) that are affected upon TnT binding. Ca2+-loaded TnC has 32 amides
whereas TnC in the Ca2+-loaded TnC-TnT complex has 24 amides that exchange with
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this rate constant. The addition of TnI further affects the number of amides that exchange
with this rate constant: 8 TnC amides in the Ca2+-loaded TnC-TnI complex exchange
with a rate constant of 1 min-1, whereas 12 TnC amides in the ternary complex (TnC-TnITnT) that exchange with this rate constant. The effect of TnI binding on TnC is
principally to slow down the exchange of amides in the k = 1 min-1 rate constant regime,
whereas there is little effect on exchange for TnT binding.
pKinetic Fit

# of H's per fixed-rate bin

Total

k ( min-1 )

10

1

0.1

0.01

TnC-EGTA

96 ± 1

7±1

19 ± 1

13 ± 1

135

TnC-CaCl2

48 ± 2

32 ± 6

14 ± 2

28 ± 4

122

TnC-TnT-CaCl2

49 ± 1

24 ± 1

18 ± 2

26 ± 4

117

TnC-TnI-CaCl2

54 ± 1

8±1

16 ± 1

20 ± 3

98

TnC-TnT-TnI-CaCl2

50 ± 4

12 ± 6

13 ± 2

20 ± 2

95

Table 4-1. The numbers of exchangeable amide hydrogens of five TnC complexes with
respect to four fixed exchange rate constants.
Binding with TnI, on the other hand, reduces further the number of amides
exchanging at k = 1 min-1, producing more hydrogen bonds and presumably reducing
solvent accessibility for a portion of TnC. There are no significant differences for amides
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of TnC that exchange with smaller rate constants (k = 0.1 and 0.01 min-1) as a function of
binding to TnI or TnT. Thus, TnC binding to Ca2+ reduces significantly the number of
fast exchanging amides, and TnI binding reduces further the number of amides
exchanging with k = 1 min-1. The affected amides apparently shift to a very slow
exchange regime where k < 0.01 min-1. We find little effect for the binding of TnT.
4.4.2

PLIMSTEX study of TnI binding of TnC and TnC-TnT complex
TnC-TnI interaction is known to be the key factor in muscle contraction (2, 3, 33).

Swenson and coworkers (19, 20) studied the affinities between skeletal TnC and TnI in
the presence of different metal cations (Ca2+ and Mg2+) by inserting specific fluorosprobes and measured the changes of fluorescence. Given that our global H/DX
measurement on TnC shows significant decrease of deuterium uptake in the presence of
TnI, it is of interest to investigate the TnC-TnI interactions by applying PLIMSTEX (28,
29).
To do this, we titrated TnC, at a concentration of 20 μM, with TnI at
concentration ranging from 8 to 300 μM (Figure 4-3, blue curve) in the presence of 1
mM CaCl2. H/DX was initiated by twenty-fold dilution of the mixtures into D2O buffer
as described in the experimental section. We further examined the influence of TnT on
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the TnC-TnI interaction by first making the TnC-TnT complex in 1:1 ratio, as described
in the experimental section, and titrated with TnI (Figure 4-3, pink curve).

Figure 4-3. PLIMSTEX curve of Ca2+-loaded TnC (blue) and Ca2+-loaded TnC-TnT
complex (34) titrated with TnI. The concentration of the protein for the titration was 1
μM.

Table 4-2. TnC-TnI affinities obtained by PLIMSTEX strategy. The fitting process
utilizes 1:1 binding model and three search parameters (Ka1, D0, ΔD1).
Given that the two curves are similar, we conclude that the presence of TnT has
minor impact on the TnC-TnI interaction. To have a quantitative understanding on the
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strength of the interactions, we fitted the curves to obtain affinities by using 1:1 binding
model in MathCAD, in which three variants were optimized in the searching process
(Ka1, D0, ΔD1) (Table 4-2). The fitted results of ΔD1 are 28 for the TnC-TnI interaction
and 23 for (TnC + TnT)-TnI interaction, which are in good agreement to the experimental
results of 27 and 23, respectively. The values of D0, which are 112 for TnC-TnI
interaction and 109 for (TnC+TnT)-TnI interaction also agree with the experimental
results of 111 and 110, respectively. Fitting the titration curves also afford the affinities
(Ka1). They are (1.9 ± 0.4) x 106 M-1 for the interaction of Ca2+-loaded TnC interacting
with TnI, and (2.4 ± 0.2) x 106 M-1 for Ca2+-loaded TnC-TnT complex interacting with
TnI. When compared to the Swenson fluorescence results (19, 20) for the affinity of
Ca2+-loaded TnC interacting with 5-(iodoacetamido)-eosin (IAE) labeled TnI (1.7 x 109
M-1), our affinity values are three magnitudes smaller. Given that they titrated TnI with
TnC at 25 nM TnI concentration under similar buffer condition (10 mM Pipes, 0.3 M
KCl, 0.01% NaN3, 1 mM CaCl2, pH 7.0) to ours but having the presence of 0.5 mM
dithiothreitol (DTT) or 2-mercaptoethanol (β-ME) and at lower temperature (0 ºC), these
differences may change the stability of the TnC-TnI complex and cause the discrepancy
between our results. The use of reducing agents (DTT and β-ME), for example, reduces
three cysteine residues (Cys-48, 64, and 133) of TnI and one cysteine of TnC (Cys-98),
- 151 -

making them feasible for fluoros-probes labeling. This cysteine reduction, however, may
affect the physical properties of TnC-TnI complex from stability and conformational
point of views.
Swenson also measured the affinity of Ca2+-loaded TnC interacting, with a TnI
inhibitor peptide (residues 104-115, RGKFKRPPLRR) in addition to full-length TnI, and
they obtained a value of (6 ± 1) x 105 M-1. Our H/DX results on the TnC-TnI inhibitor
peptide at a TnC concentration of 20 μM, and peptide-to-TnC ratio of 5:1, however, show
no uptake differences between apo TnC and holo TnC (TnI inhibitor peptide loaded)
(Figure 4-4). This suggests that the interaction between TnC and TnI inhibitor peptide
104-115 is weak and that the presence of full length TnI is essential for the interaction. In
any event, our PLIMSTEX results show that TnT has no significant impact on the TnCTnI interaction, in agreement with our H/DX kinetics measurements.
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Figure 4-4. D uptake of TnC with or without the presence of TnI inhibitor peptide
(residues 104-115, RGKFKRPPLRR). The ratio of peptide to TnC is 5:1. The extent of D
uptake at 30 s exchange time (19) and 30 min exchange time (green) show no detectable
differences between the apo and holo states.
4.4.3

H/DX reveals structural changes of TnC, TnI and TnT within the
complex
To expand the global studies of TnC-TnI, TnC-TnT, and TnC-TnI-TnT

interactions, we followed the conformational changes of each subunit in the presence of
additional subunits with site specificity by conducting pepsin digestion and examining
the H/DX of the released peptides. Eight different protein mixtures were prepared: TnCEGTA; Ca2+ loaded TnC; TnI alone; TnT alone; TnI-TnT; Ca2+ loaded TnC-TnI; Ca2+
loaded TnC-TnT; and Ca2+ loaded TnC-TnI-TnT. Each subunit was mixed with 1:1 ratio
at 20 μM protein concentration and equilibrated for 1 h at 25 °C before conducting the
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H/DX for 30 min and then digesting with pepsin. The extent of D uptake on each subunit
was analyzed separately and plotted as a function of peptide regions from N to C-terminal
domain (Figure 4-5).

Figure 4-5. Peptide level D uptake diagrams. Each diagram shows the relative D uptake
(%) with respect to peptide sequence from N-terminal to C-terminal (Left to right). (A)
Peptide level D uptake of TnC, (B) peptide level D uptake of TnI, (C) peptide level D
uptake of TnT. The deuterium exchange time was 30 min.
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For TnC, it is obvious that the addition of Ca2+ alters the H-bonding and solvent
accessibility of the four EF hands (Figure 4-5A, blue curve). In the presence of TnI,
regions comprising EFI and EFIII show significant increases in protection (Figure 4-5A,
gray and black curves). These D uptake differences indicate that the interface between
TnC and TnI involves these EF hands. Swenson and coworkers (19) also studied the
interactions of TnI to TnC fragments, and they concluded that TnI interacts to both N and
C-terminal domain of TnC. Our results provide a more detailed picture of their
interaction. The addition of TnT to make a three-part complex, however, doesn’t have
structural impact on the TnC exchange, which agrees well with our global measurement
(Figure 4-5A, green curve).
For TnI, the binding with TnC imparts major protection to two regions of TnI, the
N-terminal region (23-30) and the C-terminal region (101-119). The latter is known to be
the inhibitor region (Figure 4-5B, blue and black curves). Interestingly, two regions, the
N-terminal region (13-22) and the middle regions of TnI (71-83), show more D uptake or
more solvent exposure in the presence of TnC. This structural protrusion of TnI could be
an outcome of the TnC-TnI interactions located at the N and C-terminal domains. The
presence of TnT only imparts protection on residues 84-100 of TnI (Figure 4-5B, green
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and black curves). These results are consistent with the view that this region is the TnITnT coiled-coil interface (2).
For TnT, the presence of TnC has only minor effects in the extent of H/DX,
further confirming that there are no significant interactions between TnC and TnT. The
addition of TnI to TnC and TnT, however, shows a significant decrease of in H/DX
extent in the region 229-268 of TnT (Figure 4-5C, green and black curves). This region
is also known to be the TnI-TnT coiled-coil interface.
To afford a structural view of the conformational changes of each subunit in the
various complexes, we mapped our peptide level H/DX results onto the X-ray crystal
structure of chicken skeletal troponin (PDB: 1YTZ) (2) (Figure 4-6). Given that the
sequence homology of skeletal troponin between rabbit and chicken is high (>82%), we
mapped our H/DX results in regions where there is amino-acid sequence identity. The
interfaces between each subunit, as determined by H/DX, agree well with the crystal
structure (Figure 4-6, regions shown in gray or black). Moreover, our studies show that
regions 13-22 and 71-83 of TnI protrude more when bound to TnC.
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Figure 4-6. A map of the peptide-level H/DX onto X-ray crystal structure of chicken
skeletal troponin complex (PDB: 1YTZ). Different colors represent different extents of
H/DX or protection—see figure legend. “Protection” was defined as the relative D uptake
differences (%) between two states. A decrease of relative D uptake was defined as
positive protection.
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4.5 CONCLUSIONS
Improving our knowledge of TnC-TnI-TnT interactions is important in
understanding the detailed mechanism of muscle contraction. We began our study, as
shown in the previous chapter, of the skeletal TnC-Ca2+ interactions and the binding
orders of Ca2+ to TnC by conducting H/DX-MS and PLIMSTEX (21). We then extended
our H/DX study to the dynamics of skeletal TnC within the whole complex and their
interactions for two reasons: to improve our understanding of the TnC-TnI-TnT
interactions and to test further the ability of H/DX and PLIMSTEX to provide insight into
protein complexes. Although H/DX is now established as a structural tool for protein
dynamics, protein-ligand, protein-protein interactions (24), its applications to complexes
are limited. Here is an area where NMR and X-ray crystallography may not succeed.
Unlike other covalent labeling strategies, H/DX can “mark” all amide hydrogens except
proline and reveal changes of H-bonding at the peptide level, many of which are related
to solvent accessibility-associated, even for proteins in complexes. The potential of H/DX
has been successfully applied to study the biophysical properties of the whole cardiac
troponin complex (26) and that of the individual subunit in the skeletal troponin complex,
as shown here.
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By utilizing H/DX on the rabbit skeletal troponin complex, we conclude that TnC
is largely affected by TnI but not by TnT within the complex. We further examined the
TnC-TnI binding affinities with or without the presence of TnT. Our results show that the
affinities are in the range of 106 M-1, which, when compared to previous fluorescence
measurements (19, 20), show a discrepancy of three orders of magnitude. This difference
may be an outcome of the different stability of protein complex in different
environments. The minor influence of TnT on the TnC-TnI interaction, however, agrees
with our global H/DX measurements and with previous X-ray crystallography.
By the addition of enzymatic digestion in the H/DX work flow, we can refine the
spatial resolution to the peptide level and reveal the interfaces between each subunit. This
provides more detailed information on the conformational changes of each subunit within
the complex in a systematic way. This high-resolution information is difficult to achieve
by X-ray crystallography.
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Chapter 5*

Hydrogen/Deuterium Exchange and Electron-Transfer Dissociation
Mass Spectrometry Determine the Interface and Dynamics of
Apolipoprotein E Oligomerization

*

This chapter is based on recent publication: Reproduced with permission from Huang, R.
Y. C., Garai, K., Frieden C., and Gross, M. L. Hydrogen/Deuterium Exchange and
Electron-Transfer Dissociation Mass Spectrometry Determine the Interface and
Dynamics of Apolipoprotein E Oligomerization. Biochemistry, 2011, 50, 9273-9282.
Copyright 2011 American Chemical Society
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5.1 ABSTRACT

Apolipoprotein E, a 34 kDa protein, plays a key role in triglyceride and
cholesterol metabolism. Of the three common isoforms (ApoE2, 3 and 4), only ApoE4 is
a risk factor for Alzheimer’s Disease. All three isoforms of wild-type ApoE self-associate
to form oligomers, a process that may have functional consequences. Although the Cterminal domain, residues 216-299, of ApoE is believed to mediate self-association, the
specific residues involved in this process are not known. Here we report the use of
hydrogen/deuterium exchange (H/DX) coupled with enzymatic digestion to identify those
regions in the sequence of full-length apoE involved in oligomerization. For this
determination, we compared the results of H/DX of the wild-type proteins and those of
monomeric forms obtained by modifying four residues in the C-terminal domain. The
three wild type and mutant isoforms show similar structures based on their similar H/DX
kinetics and extents of exchange. Regions of the C-terminus (residues 230-270) of the
ApoE isoforms show significant differences of deuterium uptake between oligomeric and
monomeric forms, confirming that oligomerization occurs at these regions. To achieve
single amino acid resolution, we examined the extents of H/DX by using electron transfer
dissociation (ETD) fragmentation of peptides representing selected regions of both the
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monomeric and the oligomeric forms of ApoE4. From these experiments, we could
identify the specific residues involved in ApoE oligomerization. In addition, our results
verify that ApoE4 is composed of a compact structure at its N-terminal domain. Regions
of C-terminal domain, however, appear to lack defined structure.
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5.2 INTRODUCTION
Apolipoprotein E (ApoE), a 299-residue, 34 kDa protein, a major lipid transporter
in plasma and the central nervous system (1-3), is intimately involved in triglyceride and
cholesterol metabolism (2). There are three major isoforms, ApoE2, ApoE3 and ApoE4,
that differ only by single amino acid changes (3). ApoE3 has a cysteine at position 112
and an arginine at 158, whereas ApoE2 has cysteines, and ApoE4 has arginines at these
two positions. These single amino acid differences cause significant differences in their
biochemical and functional properties (2, 3). For example, ApoE4 is a major risk factor
for Alzheimer’s disease and cardiovascular diseases, whereas ApoE2 serves a protective
role (4).
Lipid-free ApoE consists of a 22 kDa N-terminal domain (1-191), which harbors
the LDL receptor binding site, and a 10 kDa C-terminal domain (216-299), which has
high affinity for lipids (5-7), linked by a protease-sensitive hinge region (3, 8). Structures
of full length, wild-type ApoE are unknown, although x-ray crystallography of the Nterminal domain shows it is a monomer comprised of a four-helix bundle (9). The lack of
structure of the wild-type proteins is probably due to a high tendency for them to
aggregate at the high concentrations needed for crystallization (8, 10) and the likely
presence of amphipathic helices in the full length protein (11, 12). Recently, however, an
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NMR structure of a monomeric mutant of ApoE3 was determined (13). Lipid-free ApoE
e ists predominantly as a tetramer at μM concentrations and dissociates to dimers and
monomers at nM concentrations (1, 2, 10, 14-17). A form of ApoE3 that remains
monomeric at 600 μM can be obtained by making four or five substitutions in the Cterminal region without apparently affecting the overall secondary structure or function
(18). This monomeric form is a reference point for our study to analyze the structure and
oligomerization properties of ApoE isoforms.
We chose hydrogen/deuterium exchange (H/DX) coupled with mass spectrometry
(MS) (19-22) as a structural tool to measure the relative rates of exchange of amide
hydrogens with deuteriums from D2O and draw conclusions based on the measured m/z
and their changes, rather than ion abundances. The experimental outcome allows
inferences on the stability of the hydrogen bonding, the extent of which is inverse to
relative solvent accessibilities. To achieve a high-resolution comparison of the three
isoforms of ApoE and their monomeric mutants, we coupled H/DX with enzymatic
digestion and analyzed the exchanged peptides.
H/DX with digestion affords spatial resolution at the “peptide level” (i.e., to
regions of the protein that are 6-10 amino-acid residues in length (23)) Although one can
sometimes incorporate multiple enzymatic digestions to generate overlapping peptide
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fragments and improve the resolution to one or a few amide sites, we chose gas-phase
fragmentation of the deuterated peptides released upon pepsin digestion because it has
greater potential to achieve resolution at the amino-acid level. Fragmentation cannot be
collisionally induced dissociation (CID) (collision-activated dissociation (CAD)), as
indicated in chapter 1, because it causes scrambling of H and D (24-29). To overcome
this, we fragmented the peptides with electron-transfer dissociation (ETD) (30) under
experimental conditions that we determined to be sufficiently “gentle” to avoid
scrambling.
To insure minimal scrambling, we followed Jørgensen, who established a set of
standard peptides as tests (several other methods were also established for the same
purpose (31, 32)), using a bottom-up H/DX (23) to afford resolution at a single-amide site.
The latter allowed us to improve the resolution to the single amide level so that we can
identify those residues involved in self-association. This approach also affords an
opportunity to continue the development of a structural model for the full-length, wildtype ApoE proteins.
5.3 EXPERIMENTAL PROCEDURES
5.3.1

Protein expression
Apolipoprotein E was expressed in E. coli and purified as described previously by
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Garai et al. (33). Briefly, ApoE proteins were expressed in Escherichia coli (Strain BL21,
DE3 competent cells, Stratagene), which was grown in LB media to OD600 = 0.6.
Mutations were introduced into the c-DNA of ApoE using the QuikChange site-directed
mutagenesis kit (Stratagene). All sequences were verified by using DNA sequencing. In
all cases, the monomeric mutants contained the following four substitutions:
F257A/W264R/L279Q and V287E.
5.3.2

Materials
Potassium chloride, HEPES hemisodium salt [N-(2-hydroxyethyl)piperazine-N′-

(2-ethanesulfonic acid) hemisodium salt], tris(2-carboxyethyl)phosphine hydrochloride
(TCEP), porcine pepsin, citric acid, sodium citrate, sodium chloride, and ethanolamine
were purchased from Sigma-Aldrich (St.Louis, MO). The synthetic peptide
HHHHHHIIKIIK used to test the extent of H/D scrambling was purchased from
Genscript (Piscataway, NJ). D2O was from Cambridge Isotope Laboratories Inc
(Andover, MA), and high purity guanidine hydrochloride was from Pierce (Rockford,
IL).
5.3.3

Preparation of ApoE stock solution
ApoE, dissolved in 4 M GdnCl, 0.1

β-mercaptoethanol, was dialyzed against 10

mM HEPES and 150 mM KCl containing 100 μM TCEP disulfide reductant by using
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Slide-A-Lyzer Dialysis Cassettes 7000 MWCO (Pierce, CA) for 2 h. The buffer was
exchanged for fresh buffer, and the solution was dialyzed overnight at 4 °C. The
concentration of the final protein solution was established by absorbance at 280 nm (ε =
44950 cm-1M-1) (34). The protein solutions were stored at -80 °C as 50 L aliquots.
5.3.4

H/D Exchange (H/DX) Protocol
The protein stock solution was first diluted in buffer (10 mM HEPES, 150 mM

KCl, pH 7.4) to prepare a 4 μM final analytical concentration and equilibrated at 25 °C
for 2 h. H/DX was initiated by diluting the protein solution 1:10 into D2O buffer (10 mM
HEPES, 150 mM KCl, pD 7.4) at 25 °C. At varying times, the H/DX was quenched by
adding sufficient 1 M HCl at 0 °C to give a final pH of 2.5.
For peptide-level H/DX experiments, the quenched solution was injected into an
on-line pepsin-digestion device (Figure 5-1) containing immobilized pepsin in a 1 mm
diameter × 2 cm length guard column (Upchurch Scientific, Oak Harbor, WA), which
was prepared as described previously (35). The quenched solution was injected into the
pepsin column in 0.1% formic acid via an Agilent 1100 HPLC (Santa Clara, CA)
operated at 50 μL/min flow rate for 3 min. The digested protein solution was trapped on a
C18 guard column (1 mm diameter x 1.5 cm length, Optimize Technologies, Oregon
City, OR). The peptide mixture was then eluted from the trap column and separated with
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a C18 analytical column (1 mm diameter x 5 cm length, Dionex, Bannockburn, IL) via an
Agilent 1200 HPLC (Santa Clara, CA) with a gradient operated at 50 μL/min flow rate.
Solvent A was water containing 0.1% formic acid, and solvent B was 80% acetonitrile,
20% water containing 0.1% formic acid. The gradient settings were: 5% to 15% solvent
B in 0.3 min, 15% to 50% solvent B in 5.2 min, 50% to 100% solvent B in 0.5 min, and
isocratic flow at 100% solvent B for 1.5 min, then returned to 5% solvent B in 0.1 min.
All LC connection lines were immersed in a water-ice (0 °C) bath.

Figure 5-1. Diagram for on-line pepsin digestion device.
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5.3.5

LC-ESI/MS Analysis with a Q-TOF Mass Spectrometer
Peptide-level H/DX results were acquired on a Maxis (Bruker, Bremen, Germany)

quadrupole time-of-flight (Q-TOF) mass spectrometer. The settings were: capillary
voltage, 3.8 kV; nebulizer gas, 0.4 bar; drying gas flow rate and temperature, 4.0 L/min
and 180 °C, respectively; funnel RF, 400 V(pp).

Figure 5-2. ETD product ion spectrum of standard peptide HHHHHHIIKIIK.
5.3.6

Test of hydrogen scrambling
In the test procedure, described previously by Jørgensen and coworkers (30), 100

μM of synthetic peptide, HHHHHHIIKIIK (Figure 5-2), was prepared in D2O and kept at
4 °C overnight to allow complete deuterium exchange. The solution was diluted 50-fold
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with cold H2O buffer (50% MeOH, 0.5 M acetic acid, pH 2.5) and frozen on dry ice to
quench the exchange reaction. When needed for analysis, the peptide solution was
manually thawed and injected into the ESI source via a pre-cooled 500 μL syringe
(Hamilton, Reno, V) operated at 50 μM/min flow rate.
Three instrumental conditions were chosen: (1) capillary temperature, 50 °C;
capillary voltage, 20 V; tube lens, 50 V; (2) capillary temperature, 100 °C; capillary
voltage, 50 V; tube lens, 50 V, and (3) capillary temperature, 200 °C; capillary voltage,
100 V; tube lens, 100 V. The active hydrogens of the test peptide were exchanged with
deuterium and submitted to back exchange for approximately 1 min. The maximum
number of deuteriums remaining in the peptide was approximately 4.5, which agreed
with Jørgensen’s results under similar conditions (29). Upon fragmenting the peptide by
ETD, we found the deuterium content for the c5 ion to be low (~0.6 D) under the first
condition, indicating low H/D scrambling. As the capillary temperature and voltage were
increased, increasing deuterium content was found in the N-terminal c5 ion (deuterium
uptakes for the c ions are in Figure 5-3), indicating that the first set of instrument
parameters were optimum. Another advantage for tuning the experiment by using this
standard peptide was that the solution flow rate and other instrument parameters were
easily optimized to afford good peptide ion signals.
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Figure 5-3. The deuterium uptake of C ions of the standard peptide HHHHHHIIKIIK
after performing the H/DX-ETD. Three different ESI conditions were marked in different
colors (blue, pink, and green).
5.3.7

LC-ESI/MS/MS Analysis with an Orbitrap-ETD Mass Spectrometer
To confirm the sequence for each peptic peptide, the protein was digested as

described previously and analyzed on a Thermo LTQ XL Orbitrap (Thermo Fisher, San
Jose, CA). The settings were: spray voltage, 3.5 kV; sheath gas flow rate, 8 (arbitrary
units); capillary temperature, 275 °C; capillary voltage, 35 V; and tube lens, 110 V. One
full mass spectral acquisition triggered three scans of MS/MS (precursor ion activation to
give CID) whereby the most abundant precursor ions were activated for sequencing. The
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peaks observed in the product-ion spectra (MS/MS) were centroided for each peptide
during the acquisition.
H/DX-ETD MS was performed on a Thermo LTQ XL Orbitrap (Thermo Fisher,
San Jose, CA), using the fluoranthene radical anion to cause ETD. One full massspectrum acquisition was used to trigger three scans of ETD. The parameters were: spray
voltage, 3.5 kV; sheath gas flow rate, 8 (arbitrary units); capillary temperature, 50 °C;
capillary voltage, 20 V; tube lens, 50 V; tandem MS selection threshold, 1000 counts;
activation time, 100 ms for ETD. For ETD, the isolation width was 6.0 m/z, and the
reaction time was “charge-state” dependent. A precursor mass list was generated based
on the deuterated peptides’ centroid m/z, and MS/MS data were centroided during
acquisition.
5.3.8

Mascot database search
Thermo RAW files were processed by using extract_msn (2007 version 4.0,

Thermo Fisher, San Jose, CA) with a grouping tolerance of 0.8 Da, an intermediate scan
setting of 1, and a minimum of 1 scan per group. The NCBI nonredundant database
(version 20101004, restricted to human) was searched by using MASCOT 2.2.06 (Matrix
Science, Oxford, U.K.) employing the following settings: enzyme, none; MS tolerance,

- 179 -

10 ppm; MS/MS tolerance, 0.8 Da; maximum number of missed cleavages, 3; peptide
charge of 1+, 2+ and 3+; oxidation of methionine was set as variable modification.
5.3.9

Data analysis
For peptide-level H/DX, the uptake of deuterium for each peptide was measured

as the average differences between the centroid masses of the deuterated peptide and the
undeuterated peptide. The back-exchange was measured to be one deuterium loss per
minute. No correction for back exchange was applied because the time between sample
quench and the measurement with the mass spectrometer was less than 6 min, and all data
were treated consistently. The centroid and width of the deuterium containing isotopic
distribution for each peptide was analyzed using HX-Express software (36).
For H/DX-ETD, the centroid of the deuterium-containing isotopic distribution for
each product ion was obtained through MagTran 1.03 (Amgen, Thousand Oaks, CA). A
minimum of 10% relative ion abundance threshold was applied in the data processing.
The deuterium uptake for nth amino acid was determined as the difference between the
centroid of cn-1 and cn-2 ions or the difference between the centroid of zn+1 and zn ions. All
experiments were performed in at least triplicate.
5.4 RESULTS AND DISCUSSION
5.4.1

Regions involved in ApoE self-association revealed by H/DX kinetics study
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Apolipoprotein E isoforms e ist predominantly as tetramers at μM concentrations
and dissociate into dimers and monomers at nM concentrations (17). The C-terminal
domain seems to play the major role in this self-association (10). At analytical
concentrations higher than M, the protein tends to aggregate (17, 37), hindering the
elucidation of the full-length structure. Wang and coworkers (18) showed that a
monomeric form of ApoE3 could be generated by substituting in the C-terminal region
four to five bulky hydrophobic residues with either smaller hydrophobic or polar/charged
residues. Although these substitutions prevent oligomerization, an understanding of the
key residues involved in the self-association process and the differences between the
ApoE isoforms remains to be achieved.
In this study, we performed peptide-level H/DX kinetic measurements at seven
different exchange times (0.5, 1, 3, 5, 10, 30, 60 min) on all three isoforms of ApoE
including the wild-type proteins and their monomeric mutants. Starting with protein
solutions for which the analytical concentration was 4 μM (where ApoE e ists
predominantly as tetramer), the proteins were equilibrated at 25 °C for 2 h followed by
introduction of D2O to initiate exchange and MS analysis to afford the kinetics of
exchange at the peptide level for ApoE4 (Figure 5-4). Although the extents of H/DX for
all regions of the wild-type proteins and the monomeric mutants located in the N-terminal
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domain are similar, as revealed by peptic peptides, significant differences between the
wild type and monomeric mutant occur in the C-terminal region for peptides 230-243 and
262-270, and small differences for peptide 271-279. These differences are most obvious
at early exchange times (0.5-1 min). We suggest that this behavior is a consequence of
the time-dependent dissociation of tetramer to monomer as discussed below. Interestingly,
two substitution sites used to produce the monomeric mutant are located in two of these
regions (W264R and L279Q) (18). Information for the peptide containing residue F257A
(Peptide 257-261) was missing because the peptide signal intensity was low, and the
signal dropped even more caused by further dispersion of signals by uptake of deuterium.
Peptide 230-243 showed a dramatic decrease in deuterium uptake for this region of the
wild type compared to the monomer. Overall, the regions that are affected by selfassociation are near the C-terminus, and this is consistent with previous findings that the
C-terminal domain contains the residues important for ApoE oligomerization.
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Figure 5-4. Peptide-level H/DX kinetics of ApoE4. A comparison between wild type
(blue) and monomeric mutant (pink) shows significant differences in H/DX only for
peptides 230-243 and 262-270 and small difference for peptide 271-279.
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Figure 5-5. Comparison of H/DX kinetics of peptide 230-243 and 262-270 among all
three isoforms (ApoE2, ApoE3, and ApoE4). An example of the mass spectra of peptide
262-270 of ApoE4 as a function of H/DX time is shown on the right (the red, dotted line
is a reference to guide the eye).
The deuterium uptake of the two regions represented by peptides 230-243 and
262-270 of all the wild-type isoforms are time-dependent as shown in Figure 5-5. This
slow H/DX of the C-terminal peptide fragments (residues 230-243 and 262-270) of the
wild-type ApoE isoforms may be consistent with the slow dissociation of the ApoE
oligomers. Garai and Frieden (17) showed that association-dissociation of ApoE isoforms
fit a monomer-dimer-tetramer model and that the rate for dissociation at neutral pH is
slow. The H/DX experiments were carried out by diluting ApoE from 4 µM to 400 nM
analytical concentration in the D2O buffer; the result is dissociation of the tetramers to
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monomers. Although wild-type ApoE exists as a mixture of monomers, dimers and
tetramers at 400 nM (17), deuterium uptake by the wild-type ApoE at this concentration
reaches completion owing to the reversibility of the monomer-dimer-tetramer process.
The dissociation rate constants for the isoforms, as measured by Garai and Frieden, are
approximately 10-4 s-1 for dimer-monomer and 10-3 s-1 for tetramer-dimer conversion, the
equilibrium constants for both processes are in the range of 107 M-1 (17). We fit the
H/DX kinetic data with a fixed-rate-constant binning model by using MathCAD (MathSoft. Inc. Cambridge, MA), as previously described (38, 39), whereby iterations were
continued until the root mean square (RMS) was minimized. We chose three fixed rateconstant bins (k = 10, 1, 0.1 min-1); the latter bin on the basis of the time needed to effect
nearly complete exchange (Table 5-1). According to the model, nearly all the amide
hydrogens in these two regions of the wild-type ApoE exchange in 0.1 min-1 (1.6 x 10-3 s1

) rate-constant bin, whereas all amide hydrogens of the monomeric mutants undergo fast

exchange rate (k = 10 min-1), indicating that the mutants are flexible in these two regions.
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Kinetic Fit
-1

Peptide 230-243 k ( min )
WT

MM

ApoE2
ApoE3
ApoE4
ApoE2
ApoE3
ApoE4

Peptide 262-270 k ( min-1 )

# of H's per fixed-rate bin
10

1

0.1

0±0
0±0
1±0
9±1
10 ± 1
10 ± 1

2±1
3±1
1±0
0±0
0±0
0±0

8±1
7±1
8±1
0±0
0±0
0±0

10

1

0.1

ApoE2
1±0
0±0
2±0
WT
ApoE3
0±0
1±0
3±1
ApoE4
1±0
1±0
2±1
ApoE2
4±1
0±0
0±0
MM
ApoE3
4±1
0±0
0±0
ApoE4
4±1
0±0
0±0
Table 5-1. Numbers of amide hydrogen undergoing H/D exchange for wild-type (WT)
and monomeric-mutant ApoE’s isoforms. The kinetic modeling used three fi ed
e change rate constants and “binned” the number of amides with respect to the rate
constants.
The H/DX kinetics do not reveal the two-step behavior observed by Garai et al.
(17) but instead are an integrated view of the various states of the protein. Given that the
peptide-level H/DX kinetics for the wild-type ApoE’s C-terminal regions (~10-3 s-1)
agrees well with the average dissociation constant determined for tetramer-dimermonomer process (17), we suggest that the oligomeric proteins must first dissociate to
monomers and then undergo H/DX in the two C-terminal regions.
ApoE2 and ApoE3 show similar H/DX behavior (Figures 5-6 and 5-7). A
comparison of the H/DX kinetics for monomeric mutant of all three isoforms (Figure 5-8)
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reveals that some regions have minor differences among the three isoforms (peptide 1530, 116-123, and 271-279) where ApoE4 takes up slightly more deuterium than ApoE2
and ApoE3. Overall, the three isoforms must share similar structures and properties with
respect to oligomerization. These properties as revealed by H/DX are also consistent with
the differences found in our study using fast photochemical oxidation (FPOP) (40).

Figure 5-6. Peptide-level H/DX kinetics of ApoE2. The extent of deuterium uptake is
plotted as a function of exchange time. Wild type is marked in blue and monomeric
mutant is marked in pink.
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Figure 5-7. Peptide-level H/DX kinetics of ApoE3. The extent of deuterium uptake is
plotted as a function of exchange time. Wild type is marked in blue and monomeric
mutant is marked in pink.

Figure 5-8. Peptide-level H/DX kinetics of ApoE2, ApoE3 and ApoE4 monomeric
mutant. The extent of deuterium uptake is plotted as a function of exchange time. ApoE2
is marked in blue, ApoE3 is marked in pink, and ApoE4 is marked in green.
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5.4.2

H/DX-ETD reveals residues involved in self-association of ApoE4
Peptide-level H/DX kinetics, as shown in this study, can reveal not only those

regions that are involved in protein:protein interactions but also the dynamics of the
interactions. To improve the resolution of the H/DX experiments, we chose a bottom-up
strategy whereby, following H/DX of the protein and proteolysis, we subjected the
peptide to ETD fragmentation (Figure 5-9). This approach is more appropriate than a
top-down one because our ApoE samples contain several post-translational oxidations
that disperse the signal and increase the difficulty of the top-down H/DX experiment.
Furthermore, extensive sequence coverage for any 34 kDa protein is difficult to achieve
in a top-down experiment.

Figure 5-9. A diagram of the H/DX-ETD procedure. A peptide of interest produced from
on-line pepsin digestion is subjected to ETD fragmentation. Peptide coverage (~89%) of
ApoE4 by applying this strategy is shown in right (four substitution sites to achieve the
MM are marked in red).
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Bottom-up H/DX-ETD experiments were performed under the same conditions as
for peptide-level H/DX e periments in which a 4 μM (analytical concentration) protein
solution was equilibrated at 25 °C for 2 h followed by diluting the protein solution 1:10
into D2O buffer for 1 min, a time at which there is a large difference in H/DX between
wild types and the monomeric mutants of ApoE. After quenching the exchange, the
protein solution was submitted to on-line pepsin digestion, and the peptides were
analyzed by MS and ETD whereby the selection of the precursor ion was directed by a
precursor-mass list containing the peptides of interest. This list utilized the centroid m/z
of the deuterium-containing isotopic distribution of the peptides of interest. ETD usually
generates a product-ion spectrum of good signal-to-noise for those peptides that are
doubly or more highly charged. Peptides that are +4 or higher, however, will show
increased H/D scrambling due to the more energetic collisions they undergo upon
acceleration in the ESI declustering field than do lower charged ions (30). Therefore, we
selected doubly and triply charged peptides that had sufficient ion signal for ETD
fragmentation.
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Figure 5-10. ETD product-ion spectra of peptide 206-214 of ApoE4 after H/DX. The
centroid of the distribution of C ions from MM is shown as red dotted line, showing there
are no significant differences in H/DX between WT and MM.

Figure 5-11. ETD product-ion spectra of peptide 262-270 of ApoE4 after H/DX. The
centroid of the distribution of c ions from monomeric mutant shows there are significant
differences in the extent of H/DX between WT and MM for this region.
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Although the c ions of peptides 206-214 show no significant differences in H/DX
for wild type ApoE4 and monomeric mutant forms after 1 min (Figure 5-10), the region
262-270 (Figure 5-11) undergoes significantly different H/DX. We measured the extent
of deuteration at each amide site, using the difference of the isotopic-distribution centroid
between two adjacent product ions (c or z ions). For example, the extent of deuterium on
the nth amino acid is the difference between the centroid of cn-1 and cn-2 ions or between
the centroid of zn+1 and zn ions. The outcome is a deuterium-uptake diagram for each
amide of each residue of the ApoE4 wild type and its monomeric mutant. We analyzed
132 out of 274 amides with exchangeable backbone hydrogens (excluding proline and the
N-terminal amine hydrogens for each peptide), giving a coverage of ~ 50%. The coverage
depends highly on the quality of the product-ion spectra; that quality was reduced when
working under ESI conditions that minimize scrambling. No correction for back
exchange was made because all experiments were treated consistently. Although three of
four substitution sites of the ApoE4 monomeric mutant are located on C-terminal peptic
peptides, which we selected for ETD fragmentation, these sites are located separately on
different peptides; thus, the extents of back exchange should be similar for the same set
of peptides from the two protein isoforms and will not affect conclusions about the
relative differences of H/DX.
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Figure 5-12. The extent of deuterium uptake of various amino-acid residues in the Cterminal domain of ApoE4 (Residue 220-299). Several residues of wild type (blue) have
lower level (<0.3D) of deuterium uptake compared to the monomeric mutant (pink).
Note: The gaps correspond to missing information.
There are clearly no significant differences for all the amides examined in the Nterminal region of the wild type and the monomeric mutant form of ApoE4 (the complete
extents of deuteration are in Table 5-2). Not surprisingly, several amides in the Cterminal region underwent relatively low deuterium uptake (< 0.3 D) for the wild type
ApoE4 whereas they exchanged more deuterium (> 0.7 D) for the monomeric mutant
(Figure 5-12). The residues associated with these amides are: Val232, Lys233, Gln235,
Glu238, Val239, Arg240, Ala241, Leu243, Gln246, Ser263, Trp264 (Arg in the
monomeric mutant form), Phe265, Leu268, Glu270, and Leu279 (Gln in the monomeric
mutant form). Interestingly, two of the substitution sites (Trp264Arg and Leu279Gln) are
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on the list, indicating the important roles played by the two residues in the selfassociation process. Several residues (e.g., Glu234 and Lys242) showed no significant
differences in deuterium uptake between the wild-type and monomeric-mutant forms,
indicating that these two residues are minimally affected by the self association of ApoE4.
Weisgraber and coworkers (10), who studied the ApoE oligomerization by truncating
various sites in the C-terminal region, found that residues within 267-299 are critical for
tetramerization. Our study, using the full-length protein, show that three residues within
this region are important in the ApoE self asoociation. Moreover, 12 additional residues,
which are close to this region, also play a role in self association. A potential spinoff of
this work is the use of H/DX results as a basis for designing future mutation studies in
ApoE and other proteins.
5.4.3

The structure of ApoE4
Before mapping the H/DX-ETD results onto a structure of ApoE that contains the

X-ray crystal structure of the N-terminal domain (PDB: 1GS9) (41), we wished to
establish that a low extent of deuteration for a specific amide indicated low solvent
accessibility and not extensive back exchange. Thus, we prepared a nearly 100%
deuterium-exchanged ApoE4 monomeric mutant by diluting the protein solution into
D2O buffer at 25 °C and exchanging for 24 h. After submitting the protein to on-line
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pepsin digestion and ETD-MS analysis (42), we found that the average percent back
exchange was (13 ± 4)%. (Each deuterium uptake for a single amide was normalized to
its corresponding D100% value, and the normalization was treated separately for each trial
of experiments—see table 5-2).

Figure 5-13. The extent of deuterium uptake of each amide of ApoE4 monomeric mutant
after correcting for back exchange (pink). Most of the amides in the C-terminus have
high extent of deuterium uptake, indicating a flexible structure in this region. The extent
of deuterium uptake in N-terminal region are consistent with the known secondary
structure (top). (flexible loop, black line; flexible helix, gray box; rigid helix, black box).
Note: The gaps correspond to missing information.
The deuterium uptake at a single amide of the ApoE4 monomeric mutant (Figure
5-13), show that the ApoE4 structure is primarily compact in the N-terminal region and
more flexible in the C-terminal region, as previously assumed (43). Previous studies
indicated that the C-terminal domain should contain amphipathic helices and several
flexible loop regions (11, 12). Four possible helices, represented by peptide regions 190- 195 -

199, 210-223, 238-266, and 271-276, exist in the C-terminal domain, as determined by
Wang and coworkers (5). Their recent NMR structure of ApoE3 monomeric mutant
shows that these helices are in the middle of long, unstructured regions (44). Our amidelevel H/DX results, when mapped onto a schematic secondary structure of the C-terminal
domain of ApoE (Figure 5-14), show that peptide regions 190-199 and 271-276 undergo
extensive H/DX, consistent with being flexible helices. Although deuterium uptake
information is missing for peptide regions 215-222 and 249-262, those regions adjoin
those helices in C-terminal domain that also undergo extensive H/DX and should be
flexible.
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Figure 5-14. Structure of ApoE4 on which residue-level H/DX of ApoE4 monomeric
mutant is mapped. Left: X-ray crystal structure of N-terminal region of ApoE4 (PDB:
1GS9). Right: Proposed secondary structure of C-terminal region of ApoE (5). Possible
helices are shown in dotted boxes. Different colors represent different levels of deuterium
uptake for each residue (lower left).
In another peptide-level H/DX e periment, we treated the three ApoE’s isoforms
with 0.5 M guanidine hydrochloride (GdnCl) (Figure 5-15), a concentration at which the
protein could lose some tertiary/quaternary structure while maintaining its secondary
structure (43). The results show that this low concentration of denaturant has more impact
on the C-terminal than the N-terminal region of ApoE. This is additional evidence that
ApoE is composed of a flexible C-terminal region, making it susceptible to denaturation.
Morrow and coworkers (45), who studied the denaturation of ApoE at various
- 197 -

concentrations of GdnCl, showed that the regions nearby the C-terminus and in the
presence of low concentration of GdnCl, unfold prior to those close to the N-terminal
domain. Our results are consistent with their findings.

Figure 5-15. Peptide-level H/DX of ApoE2, ApoE3, and ApoE4 with or without the
presence of 0.5 M GdnCl. The relative deuterium uptake difference is plotted as different
peptide regions. The large difference indicates the regions (red) having less stable Hbonding or more relative solvent accessibilities in the presence of denaturant.
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The structure of the N-teminal domain of ApoE was determined by X-ray
crystallography and NMR to be a four helix-bundle (5, 9, 41). Our results, when
compared to the X-ray crystal structure of N-terminal domain (Figure 5-14), show that
amides in the regions of residues 6-25, 76-91, 124-125, and 165-191 undergo extensive
deuterium uptake, consistent with their location at or near the flexible-loop regions and as
part of the flexible-helix region (170-180). The amides in regions 70-75 and 92-103,
which are located in a rigid helix, undergo low extents of deuteration, in accord with the
strong H-bonding in that region of the protein.
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Table 5-2. A complete list of deuterium uptake for 132 residues in ApoE4.
Amino
acid
V6
E7
T8
E9
E11
E13
L14
Q16
Q17
T18
E19
W20
Q21
S22
R25
W26
E45
E70
L71
K72
A73
Y74
K75
S76
E77
L78
E80
Q81
T83
V85
A86
E87
E88

WT

STD

MM

STD

D 100%

0.76
0.78
0.87
0.15
0.98
0.99
0.99
1.01
0.84
1.00
0.90
0.20
0.77
0.83
0.97
0.94
0.09
0.10
0.10
0.17
0.16
0.13
0.05
0.95
0.88
0.89
0.95
0.20
0.92
0.86
0.18
0.79
0.92

0.11
0.07
0.06
0.14
0.02
0.12
0.02
0.09
0.04
0.17
0.05
0.08
0.03
0.13
0.12
0.05
0.02
0.02
0.04
0.01
0.05
0.07
0.07
0.02
0.09
0.10
0.05
0.08
0.04
0.14
0.07
0.04
0.04

0.79
0.88
0.87
0.22
0.76
0.82
0.90
0.94
0.79
0.83
0.93
0.08
0.90
0.97
0.93
0.90
0.01
0.06
0.06
0.18
0.15
0.16
0.17
0.98
0.92
0.95
0.99
0.16
0.97
1.09
0.15
0.80
0.87

0.08
0.10
0.08
0.18
0.11
0.07
0.03
0.02
0.08
0.11
0.07
0.03
0.07
0.04
0.07
0.02
0.02
0.02
0.06
0.04
0.02
0.03
0.02
0.02
0.08
0.03
0.03
0.02
0.05
0.02
0.04
0.08
0.13

0.78
0.93
0.82
0.31
1.01
0.98
1.00
0.99
0.80
0.88
0.95
0.11
0.93
0.98
1.00
0.98
0.98
0.94
1.08
0.89
1.00
1.02
1.00
0.97
0.99
0.98
0.99
1.00
0.98
0.99
1.02
0.95
0.85
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Normalized
MM
1.01
0.95
1.06
0.71
0.75
0.84
0.90
0.95
0.99
0.94
0.98
0.73
0.97
0.99
0.93
0.92
0.01
0.06
0.05
0.20
0.15
0.16
0.17
1.01
0.93
0.97
1.00
0.16
0.99
1.10
0.15
0.84
1.02

STD
0.10
0.11
0.10
0.11
0.11
0.07
0.03
0.02
0.10
0.13
0.07
0.02
0.08
0.04
0.07
0.02
0.02
0.02
0.06
0.05
0.02
0.03
0.02
0.02
0.08
0.03
0.03
0.02
0.05
0.02
0.04
0.08
0.15

T89
R90
A91
R92
L93
L97
Q98
R103
L104
Q117
Y118
R119
E121
V122
Q123
A124
M125
L133
Q163
A164
G165
A166
R167
E168
G169
A170
E171
R172
G173
L174
S175
A176
E179
R180
G182
V185
Q187

0.98
0.89
0.95
0.10
0.08
0.17
0.07
0.72
0.92
0.18
0.13
0.76
0.14
0.15
0.13
1.01
0.75
0.83
0.02
0.99
0.96
0.77
0.77
0.88
0.89
0.74
0.86
0.91
0.92
0.70
0.07
0.84
0.89
0.23
0.88
0.74
1.01

0.06
0.14
0.02
0.08
0.04
0.01
0.11
0.02
0.08
0.01
0.08
0.07
0.10
0.04
0.02
0.07
0.04
0.08
0.01
0.01
0.10
0.12
0.02
0.01
0.10
0.04
0.02
0.06
0.04
0.08
0.06
0.01
0.02
0.07
0.13
0.08
0.05

0.94
0.91
0.96
0.06
0.16
0.12
0.08
0.79
1.05
0.15
0.04
0.73
0.15
0.13
0.11
1.00
0.75
0.87
0.01
1.07
0.91
0.78
0.74
0.89
0.90
0.71
0.84
0.93
0.97
0.99
0.08
0.86
0.89
0.22
0.80
0.99
0.98

0.03
0.05
0.02
0.07
0.08
0.04
0.06
0.02
0.05
0.03
0.11
0.03
0.08
0.02
0.03
0.05
0.08
0.02
0.01
0.00
0.06
0.03
0.03
0.07
0.03
0.08
0.12
0.11
0.08
0.11
0.03
0.03
0.06
0.02
0.02
0.06
0.03
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0.95
0.92
0.93
1.02
1.03
0.99
0.98
1.00
0.99
0.98
0.78
1.04
0.89
0.88
0.66
0.99
0.72
0.89
0.77
0.99
1.00
0.81
0.70
1.01
1.00
0.74
0.93
0.97
0.99
1.00
0.33
0.88
0.99
0.31
0.84
0.97
0.93

0.99
0.99
1.03
0.06
0.16
0.12
0.08
0.79
1.06
0.15
0.05
0.71
0.17
0.15
0.17
1.02
1.05
0.98
0.01
1.08
0.91
0.96
1.06
0.88
0.90
0.96
0.91
0.96
0.98
0.99
0.24
0.98
0.90
0.71
0.95
1.02
1.05

0.03
0.05
0.02
0.07
0.07
0.04
0.06
0.02
0.05
0.03
0.14
0.03
0.09
0.02
0.05
0.05
0.11
0.02
0.01
0.00
0.06
0.04
0.04
0.06
0.03
0.11
0.13
0.11
0.08
0.11
0.10
0.04
0.06
0.06
0.02
0.06
0.03

G188
R189
V190
R191
T194
S197
L198
A199
G200
Q201
L203
Q204
E205
Q208
A209
W210
G211
E212
R213
L214
S223
R224
T225
R226
D227
L228
V232
K233
E234
Q235
E238
V239
R240
A241
K242
L243
E244

0.82
0.76
0.94
0.74
0.28
0.98
0.91
0.08
0.08
0.16
0.86
0.41
0.85
0.33
0.75
0.01
0.97
0.40
0.73
0.99
0.02
0.19
0.79
0.97
0.91
0.94
0.02
0.11
0.83
0.10
0.09
0.08
0.03
0.13
0.87
0.03
0.97

0.07
0.11
0.02
0.10
0.06
0.04
0.03
0.05
0.04
0.12
0.06
0.09
0.03
0.03
0.08
0.02
0.11
0.01
0.04
0.08
0.05
0.05
0.09
0.05
0.03
0.08
0.01
0.02
0.02
0.04
0.03
0.04
0.01
0.03
0.01
0.01
0.10

0.85
0.83
0.97
1.00
0.32
0.77
0.90
0.14
0.03
0.08
0.88
0.35
0.99
0.31
0.66
0.04
0.41
0.32
0.67
0.98
0.06
0.05
1.00
0.77
0.99
0.80
0.90
0.91
0.86
0.92
0.83
0.85
0.78
0.82
0.82
0.97
0.95

0.08
0.11
0.05
0.02
0.01
0.05
0.02
0.04
0.02
0.04
0.03
0.01
0.06
0.01
0.06
0.01
0.03
0.02
0.07
0.10
0.04
0.01
0.04
0.13
0.08
0.11
0.10
0.10
0.03
0.10
0.05
0.09
0.06
0.05
0.03
0.04
0.12
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0.99
0.88
0.98
1.02
0.47
0.98
0.96
0.91
0.76
0.98
1.02
0.35
1.01
0.33
0.94
0.05
0.58
0.32
0.88
1.01
0.93
0.89
1.00
0.95
1.02
0.98
1.02
0.96
0.96
1.01
0.95
0.85
0.92
1.00
0.93
1.02
1.00

0.86
0.94
0.99
0.99
0.69
0.79
0.93
0.15
0.04
0.08
0.87
1.00
0.98
0.94
0.70
0.80
0.71
1.00
0.76
0.97
0.06
0.05
1.00
0.81
0.97
0.82
0.88
0.95
0.90
0.91
0.88
1.01
0.85
0.82
0.88
0.95
0.95

0.08
0.12
0.05
0.01
0.02
0.05
0.02
0.05
0.03
0.04
0.03
0.03
0.06
0.03
0.06
0.10
0.05
0.06
0.08
0.10
0.04
0.01
0.04
0.13
0.08
0.11
0.10
0.10
0.03
0.10
0.05
0.11
0.07
0.05
0.03
0.04
0.12

E245
Q246
A247
Q248
S263
W264R
F265
L268
V269
E270
Q275
W276
A277
G278
L279Q
A285
G288
T289
S290
A291
A292
V294
D297
N298
H299

0.15
0.09
0.90
0.06
0.14
0.13
0.09
0.05
0.08
0.03
0.78
0.82
0.31
0.94
0.07
0.95
0.70
1.08
0.84
0.42
0.91
0.87
0.63
0.93
0.79

0.04
0.07
0.06
0.05
0.03
0.02
0.01
0.01
0.03
0.03
0.05
0.06
0.08
0.02
0.06
0.08
0.02
0.03
0.10
0.07
0.06
0.06
0.10
0.04
0.04

0.10
0.98
1.01
0.12
0.87
0.94
0.77
0.32
0.10
1.01
0.98
0.73
0.89
0.89
0.95
0.83
0.99
0.70
1.05
0.82
0.81
0.87
0.44
0.82
0.76

0.01
0.10
0.04
0.02
0.06
0.03
0.03
0.01
0.01
0.05
0.04
0.06
0.06
0.01
0.04
0.10
0.10
0.03
0.03
0.05
0.04
0.03
0.05
0.03
0.04
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0.16
0.99
0.95
0.31
0.92
0.99
0.89
0.45
0.10
0.99
0.99
0.81
0.93
0.92
1.02
0.89
0.93
0.71
1.01
0.81
0.89
0.92
0.58
0.89
0.99

0.64
1.00
1.07
0.39
0.95
0.95
0.87
0.71
1.00
1.02
0.99
0.90
0.96
0.97
0.93
0.93
1.06
0.98
1.04
1.01
0.90
0.95
0.76
0.92
0.77

0.06
0.10
0.04
0.07
0.07
0.03
0.03
0.03
0.10
0.05
0.04
0.07
0.06
0.01
0.04
0.11
0.10
0.04
0.03
0.06
0.04
0.03
0.09
0.03
0.04

5.5 CONCLUSIONS
The observation that ApoE has a high tendency to aggregate has hindered
determination of the full-length structures of the three wild-type isoforms. We are
approaching structure analysis of the three isoforms and their monomeric mutants by
chemical footprinting (46) including H/DX coupled with MS. Unlike other covalent
protein footprinting methods, H/DX is general, marking all the amino acids except
proline and covering nearly the entire protein backbone, provided the proteolysis and
LC/MS efficiencies are high.
Our H/DX results not only confirm the role of the C-terminal domain in the
oligomerization process but also reveal the dissociation rate of oligomers to give
monomers. We found that the three wild-type isoforms largely share oligomerization
properties. A bottom-up H/DX-ETD experiment also located deuterium on lipid-free
ApoE4 including its wild type and monomeric mutant form and afforded information on
approximately 50% of the amides. We obtained clear, single-amide-level H/DX results
for ApoE4, identified the residues involved in self-association, and showed they are
located in the C-terminal domain (i.e., residues 232-272).
The region of apoE that shows differential H/DX between the wild-type protein
and the monomeric mutant includes the residues 244-272, which harbor the lipid-binding
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site (47) and are involved in A binding, with implications for understanding
Alzheimer’s Disease (47). In addition, residues 241-272 mediate the toxic effects of
ApoE4 in neuroblastoma cells (48). Thus, the residues 232-272 in the C-terminal domain
seem to be involved in the multiple processes that are crucial for biological function and
that mediate toxicity. Additional studies along these lines should increase our
understanding of ApoE interactions with itself and with various ligands, an understanding
that will be difficult to obtain by NMR and X-ray crystallography. Furthermore, H/DX
and other footprinting strategies should not only provide information for the design of
other ApoE monomeric mutants that contain a minimum number of mutation sites but
also be a means for evaluating their equivalency.
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Chapter 6

Hydrogen/Deuterium Exchange Mass Spectrometry Probes the
Apolipoprotein E-Amyloid-β (Aβ 40) Interactions
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6.1 ABSTRACT

Apolipoprotein E (ApoE), which may be involved in the clearance of amyloid from the brain, is an important factor in various diseases including Alzheimer’s
Disease (AD). It is a 34 kDa protein consisting of two domains separated by a region of
random structure. Each domain has a distinct function and structure. The N-terminal
domain, for example, contains receptor-binding and heparin (proteoglycan)-binding
regions, whereas the C-terminal domain contains the major lipid-binding site. Although
the C-terminal domain (residues 216-299) of ApoE is believed to be the potential region
that binds to, the specific regions involved in this interaction are not yet known. Here
we report the use of hydrogen/deuterium exchange (H/DX) coupled with mass
spectrometry to identify those regions that are involved in ApoE-interactions. Given
that the C-terminal regions of ApoE contain the interfaces for its oligomerization, the
interaction between ApoE and  may be shifted to other sites.Our results suggest,
however, that oligomerization of ApoE does compete with the interaction with
Interestingly, region 52-60 of ApoE, located at the N-terminal domain, show some
decrease of deuterium uptake in the presence of  This finding provides additional

- 216 -

support for the importance of the N-terminal region of ApoE in the ApoE-complex
formation.
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6.2 INTRODUCTION
The aggregation and deposition of  as plaques in the brain may be key to
understanding the early processes causing Alzheimer’s Disease (AD) (1). Amyloidis formed after sequential cleavage of the amyloid precursor protein (2) by α-, βand γ-secretases. The propensity of  aggregation is different for different sequence
lengths of the cleavage products. For example,  has higher tendency to form
oligomers in solution than (3). Recently, an NMR structure of shows
it has a helix in the middle region (residue 12-23) whereas the N and C-terminal regions
of are unstructured (4). Understanding the processes of aggregation so that one
can modulate the population of the various aggregation states of in the brain may be
crucial for the treatment of Alzheimer’s Disease.
Apolipoprotein E (ApoE), a major lipid transporter in plasma and the central
nervous system (5-7), may affect both the deposition and clearance of  from the brain
and, hence, play a role in the pathogenesis of Alzheimer’s Disease (1). There are three
major isoforms, ApoE2, ApoE3 and ApoE4, differing in the progression by only single
amino-acid substitutions (7). These small differences alter significantly their biochemical
properties. For example, ApoE4 is a major risk factor for Alzheimer’s disease and
cardiovascular diseases. In fact, the expression of ApoE4 in humans results in greater 
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and amyloid deposition than for expression of ApoE3 (1). ApoE2, on the other hand,
seems to play a protective role (8).
The ApoE proteins consist of a 22 kDa N-terminal domain and a 10 kDa Cterminal domain (9-11), linked by a protease-sensitive hinge region. Each domain has a
unique function. Whereas the N-terminal domain harbors the LDL receptor binding site,
the C-terminal domain binds to lipids with high affinity and forms oligomers through
self-interactions in this region (6, 7, 12).
ApoE may mediate the level of free in the brain by forming ApoEcomplexes. Complex formation, however, is different among different isoforms of
ApoE and under different conditions (i.e., temperature, pH). Lipidated ApoE4, for
example, binds preferentially to an intermediate aggregation form of with 2-3 fold
higher affinity than do ApoE2 and ApoE3 under the same conditions (13). Lipid-free
ApoE3, on the other hand, forms an ApoE-complex with apparent higher affinity with
respect to ApoE4 (14). The C-terminal regions of ApoE (244-272) and the N-terminal
regions of (1-28) are believed to be involved in the ApoE- interactions (15, 16).
These same regions of are likely to be involved also in self-association (17). A recent
study of the ApoE- interactions by MD simulation, however, suggests the interactions
occur on helix I and IV of the N-terminal domain of ApoE (18). Although these studies
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led to controversial conclusions on the regions of ApoE that are involved in ApoE-
complex formation, the importance of ApoE in the etiology of Alzheimer’s disease is
certain. Therefore, understanding the interactions between ApoE and  is essential for
the study of this disease.
The oligomerization properties of ApoE were recently studied in our group, as
shown in chapter five, by using hydrogen/deuterium exchange (H/DX) and fast
photochemical oxidation of proteins (FPOP), both in combination with MS (19, 20). The
results show that the interfaces for ApoE oligomerization are mainly located at the Cterminal region of ApoE. Given that this region contains potential binding sites with 
as shown in the previous study (15), it is our interest to extend the H/DX MS strategy to
the study of ApoE- complex formation.
H/DX coupled with MS (21-24) has become a powerful tool that can probe both
protein conformational changes associated with protein-ligand interactions (ligand:
protein, DNA, peptide, drug etc) and also protein dynamics. Given that ApoE3 appears to
form a stable complex with  in a lipid-free environment and that 40 has lower
tendency to self-aggregate in solution, we chose these two as our first target in this study.
The outcomes may lead to an improved understanding of the ApoE- complex
formation and serve as a useful reference point for future studies of A and ApoE.
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6.3 EXPERIMENTAL PROCEDURES
6.3.1

Protein expression
Wild type apolipoprotein E3 (ApoE3WT) was expressed in E. coli and purified as

described previously by Garai et al. (25). Briefly, ApoE proteins were expressed in
Escherichia coli (Strain BL21, DE3 competent cells, Stratagene), which was grown in
LB media to OD600 = 0.6.
6.3.2

Materials
HEPES hemisodium salt [N-(2-hydroxyethyl)piperazine-N′-(2-ethanesulfonic

acid) hemisodium salt], Tris(2-carboxyethyl)phosphine hydrochloride (TCEP), porcine
pepsin, citric acid, sodium citrate, sodium chloride, potassium chloride, and ethanolamine
were purchased from Sigma-Aldrich (St.Louis, MO).40 was from Keck
biotechnology resource laboratory (Yale University, New Haven, CT). D2O was
purchased from Cambridge Isotope Laboratories Inc (Andover, MA).
6.3.3

Preparation of ApoE3-40 complex
40 was dissolved in 3 mM NaOH, 150 mM NaCl, 1 mM TCEP, and the

monomeric 40 was purified by using size-exclusion chromatography. ApoE3WT40 complex was made by mixing ApoE3 and 40 in a ratio of 1:5, a ratio that
ensures the interaction was saturated and the ion intensity of ApoE3 was not suppressed
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by 40, at 0.5 µM analytical concentration of ApoE3WT in HEPES buffer (10 mM
HEPES, 150 mM NaCl, 100 µM TCEP, pH 7.4). The mixture was incubated at 25 °C for
various times (30 s, 5 min, 20 min, 1 h, 8 h, 24 h, 52 h) prior to submitting the system to
H/DX.
6.3.4

H/D Exchange (H/DX) Protocol
For global H/DX pulse labeling experiments, the ApoE3WT-40 complex was

diluted 1:4 in D2O buffer (10 mM HEPES, 150 mM NaCl, pD 7.4) at 25 °C for 1 min.
The H/DX was quenched by adding sufficient 1 M HCl at 0 °C to give a final pH of 2.5.
The quenched protein solution was then loaded onto a C8 guard column (1 mm x 15 mm,
Optimize Technologies, Oregon, City, OR) via an Agilent 1100 HPLC (Santa Clara, CA)
operated at 50 μM/min flow rate with 0.1

TFA for 3 min. The protein was eluted by

using a Waters nanoACQUITY UPLC (Manchester, U.K) with the following gradient
settings: 5% to 50% solvent B in 0.3 min, 50% to 100% solvent B in 5.2 min and
isocratic flow at 100% solvent B for 0.5 min, then back to 5% solvent B in 0.1 min at 50
μM/min flow rate. All LC connection lines were immersed in a water-ice (0 °C) bath.
(solvent A, water containing 0.1% formic acid; solvent B, acetonitrile containing 0.1%
formic acid).
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For peptide level H/DX experiments, the ApoE3WT-40 complex was diluted
1:3 in D2O buffer (10 mM HEPES, 150 mM NaCl, pD 7.4) at 25 °C. At various times (30
s, 3 min, 5 min, 10 min, 30 min, 1 h), the H/DX was quenched as described above. The
quenched solution was then injected into an on-line pepsin-digestion device containing
immobilized pepsin in a 1 mm diameter × 2 cm length guard column (Upchurch
Scientific, Oak Harbor, WA), which was prepared as described previously (26). The
quenched solution was injected into the pepsin column in 0.1% formic acid via an
Agilent 1100 HPLC (Santa Clara, CA) operated at 50 μL/min flow rate for 6 min. The
digested protein solution was trapped on a C18 guard column (1 mm diameter x 1.5 cm
length, Optimize Technologies, Oregon City, OR). The peptide mixture was then eluted
from the trap column and separated with a C18 analytical column (1 mm diameter x 5 cm
length, Dionex, Bannockburn, IL) via a Waters nanoACQUITY UPLC (Manchester, U.K)
with a gradient operated at 50 μL/min flow rate. Solvent A was water containing 0.1%
formic acid, and solvent B was 80% acetonitrile, 20% water containing 0.1% formic acid.
The gradient settings were: 5% to 15% solvent B in 0.3 min, 15% to 50% solvent B in 5.2
min, 50% to 100% solvent B in 0.5 min, and isocratic flow at 100% solvent B for 1.5 min,
then returned to 5% solvent B in 0.1 min. All LC connection lines were immersed in a
water-ice (0 °C) bath.
- 223 -

6.3.5

LC-ESI/MS Analysis with a Q-TOF Mass Spectrometer
All H/DX results were acquired on a MaXis (Bruker, Bremen, Germany)

quadrupole time-of-flight (Q-TOF) mass spectrometer. The settings were: capillary
voltage, 3.8 kV; nebulizer gas, 0.5 bar; drying gas flow rate and temperature, 8.0 L/min
and 200 °C, respectively; funnel RF, 400 V(pp).
6.3.6

LC-ESI/MS/MS Analysis with an Orbitrap Mass Spectrometer
The sequence of each peptic peptide was confirmed by analyzing the digested

peptides on a Thermo LTQ XL Orbitrap (Thermo Fisher, San Jose, CA). The settings
were: spray voltage, 3.2 kV; sheath-gas flow rate, 8 (arbitrary units); capillary
temperature, 275 °C; capillary voltage, 35 V; and tube lens, 110 V. One full mass spectral
acquisition triggered three scans of MS/MS (CID fragmentation) whereby the most
abundant precursor ions were activated for sequencing. The peaks observed in the
product-ion spectra were centroided to provide the mass for each peptide during the
acquisition.
6.3.7

Mascot database search
Thermo RAW files were processed by using extract_msn (2007 version 4.0,

Thermo Fisher, San Jose, CA) with a grouping tolerance of 0.8 Da, an intermediate scan
setting of 1, and a minimum of 1 scan per group. MASCOT 2.2.06 (Matrix Science,
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Oxford, U.K.) was used to analyze the results by searching through the NCBI
nonredundant database (version 20101004, restricted to human). The MASCOT settings
were: enzyme, none; MS tolerance, 10 ppm; MS/MS tolerance, 0.8 Da; maximum
number of missed cleavages, 3; peptide charge of 1+, 2+ and 3+; oxidation of methionine
was set as variable modification.
6.3.8

Data analysis
The uptake of deuterium for each protein or peptide was measured as the average

mass differences between the masses of the deuterated protein and the undeuterated
protein, or the average differences between the centroid of all the mass peaks of the
deuterated peptide and the undeuterated peptide. Back-exchange was measured to be one
deuterium loss per minute. No correction for back exchange was applied because the time
between sample quench and the measurement with the mass spectrometer was within 10
min and conclusions were drawn based on comparisons of data taken consistently. The
deconvoluted protein mass spectrum was generated with MagTran 1.03 (Amgen,
Thousand Oaks, CA). The centroid of the peptide isotopic distribution was analyzed
using HDExaminer 1.0 (Sierra Analytics, Modesto, CA). All experiments were
performed in at least triplicate.
6.4 RESULTS AND DISCUSSION
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6.4.1

Examination of the ApoE3-40 complex formation by H/DX pulse labeling
Apolipoprotein E isoforms exist predominantly as tetramers at low μM

concentrations and dissociate into dimers and monomers at high nM concentrations (27).
At analytical concentrations higher than M, the protein starts to aggregate (27, 28). It is
known that the C-terminal domain plays a major role in this self-association (29). An
important question is whether self association competes with the ApoE- interactions.
To monitor the formation of ApoE3WT- complex, we first measured global H/DX
kinetics in which the ApoE3WT was mixed with  in 1 to 5 ratio at 25 °C for 1 h
followed by allowing H/DX for various times (30 s to 24 h) (Figure 6-1). The outcome,
however, is no significant differences in deuterium uptake of ApoE3WT in the absence or
presence of  This suggests that these two proteins do not form a stable complex
under these conditions.

Figure 6-1. Global H/DX kinetics of ApoE3WT. A comparison between apo-ApoE3WT
(Aβ40 free, blue) and holo-ApoE3WT (Aβ40 bound, red) shows no differences in H/DX.
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One explanation of the above is that the kinetics of complex formation are too
slow to allow detection of a complex under those conditions. If so, a more informative
way may be to monitor complex formation as a function of the incubation times for these
two proteins by using a pulsed H/DX labeling strategy. In this experiment, we mixed
ApoE3WT with  under same conditions as described above and incubated the
resulting solution for various times (30 s to 52 h). The resulting solution was then
submitted to pulsed H/DX for 1 min. Pulsing the H/DX allowed it to be a reporter and
present a “snapshot” of any slow-forming states of  bound to ApoE3WT (Figure 62).

- 227 -

Figure 6-2. Global H/DX pulse labeling of ApoE. (A) A comparison between apoApoE2WT (Aβ40 free, blue) and holo-ApoE2WT (Aβ40 bound, red) shows no
differences in H/DX. (B) A comparison between apo-ApoE3WT (Aβ40 free, blue) and
holo-ApoE3WT (Aβ40 bound, red) shows significant differences in H/DX after 24 h of
incubation.
Carter and coworkers (13) studied the ApoE- interactions among the ApoE
isoforms by ELISA, and they concluded that the non-lipidated ApoE isoforms interact
with  without isoform specificity. To test this interpretation, we incorporated
ApoE2WT into our study. Surprisingly, there are no differences in deuterium uptake of
ApoE2WT in the presence or absence of  (Figure 6-2A). ApoE3WT, on the other
hand, showed a significant decrease in deuterium uptake for the  bound state after
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24 h incubation (Figure 6-2B). Because our longest incubation time was 52 h, which
might not be long enough for ApoE2 to form stable complex with , we cannot rule
out the possibility of their interactions. Our results, however, indicate that ApoE3WT
interacts more strongly with  than ApoE2WT.
Interestingly, a significant decrease in deuterium uptake also occurred for apoApoE3WT ( free) after 24 h of incubation as compared to 8 h, and the D uptake
decreased further at longer times (52 h), finally reaching the same level as that for
ApoE3WT in the presence of  bound. This suggests that ApoE3WT itself forms a
more complex structure after long incubation, and its self-interaction interfaces may be
shared in any ApoE3WT- complex. Moreover, ApoE3WT may have a higher
tendency to form this complex than does ApoE2WT, as the latter does not show this
phenomenom. Given that there is a significant difference in deuterium uptake between
apo-ApoE3WT and holo-ApoE3WT at 24 h incubation, we chose this condition to
conduct H/DX at the peptide-level to provide a more detailed picture of their interactions.
6.4.2

Peptide-level H/DX kinetics reveals the regions of ApoE3WT involved in
ApoE3WT-40 interactions
The higher resolution achievable with bottom-up H/DX may allow localization of

some minor changes in the solvent assessibility/H-bonding due to ligand binding.
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Peptide-level H/DX kinetics, as shown in our previous study of ApoE (19), can not only
identify those regions that are involved in protein-protein or protein-ligand interactions
but also reveal the dynamics of the interactions. Therefore, we applied this strategy to the
ApoE3WT- complex under the conditions determined by the global measurement in
which a 0.5 μM (analytical concentration) ApoE3WT solution containing 2.5 μM
was equilibrated at 25 °C for 24 h followed by diluting the protein solution 1:3 in
D2O buffer for various times (30 s to 1 h). After quenching the exchange, we submitted
the protein to on-line pepsin digestion and analyzed the peptides by LC/MS.

Figure 6-3. Peptide-level H/DX kinetics of the N-terminal regions of ApoE3WT (1-176).
A comparison between apo-ApoE3WT (Aβ40 free, blue) and holo-ApoE3WT (Aβ40
bound, red) was plotted for different peptic peptides as a function of H/DX times.
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Figure 6-4. Peptide-level H/DX kinetics of the C-terminal regions of ApoE3WT (177299). A comparison between apo-ApoE3WT (Aβ40 free, blue) and holo-ApoE3WT
(Aβ40 bound, red) was plotted for different peptic peptides as a function of H/DX times.
A sequence coverage of ~89% of ApoE3WT ensures a nearly complete picture of
the protein. We normalized the value of deuterium uptake of each peptide to the
theoretical maximum uptake, as described previously (30), and corrected the fraction of
deuterium present in the exchanging solution to evaluate the relative deuterium uptake of
each peptide (Figure 6-3 and 6-4). Figure 6-3 shows peptide-level H/DX kinetics of
peptides located at the N-terminal domain of ApoE3WT (residue 1-176). The kinetics
plots of apo-ApoE3WT present two categories of deuterium uptake: (1) regions showing
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low deuterium uptake at early exchange times and increasing uptake at longer times, (2)
regions showing extensive deuterium uptake at the early exchange time and the uptake
stays relatively constant at longer times. There are three regions of ApoE3WT
represented by peptide 37-45, 65-78, and 116-125 that undergo H/DX characteristic of
the first category. These regions, when mapped onto the ApoE3 NMR structure (2L7B)
(31), are all located, not surprisingly, on rigid helices that should show slow dynamics.
Other regions, having the characteristic of the second category, are all located at or near
the flexible loop regions. Our results of the N-terminal regions of ApoE3WT agree well
with its tertiary structure.
Interestingly, one peptide (residue 52-60) showed a significant decrease (~10%)
of deuterium uptake upon the  binding. Peptide regions 37-45, on the other hand,
showed reverse trends of H/DX, implicating an increase in flexibility upon binding.
These results implicate, for the first time, the interfaces of the N-terminal domain of
ApoE3WT in the ApoE-complexes
The H/DX kinetics of peptide regions located at the C-terminal domain of
ApoE3WT, shown in Figure 6-4 (177-299), show there are almost no H/DX differences
in this region between apo-ApoE3WT and ApoE3WT in the presence of excess A.
Peptides located in region 230-272, however, showed a slow increase in H/DX with time,
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indicating a region that exhibits slow protein dynamics. This was observed in our
previous study of ApoE oligomerization (19) and suggests there may be a slow
dissociation of the ApoE oligomers as reported by the slow uptake of D in this region.
Given that wild-type ApoE exists as a mixture of monomers, dimers, and tetramers at 500
nM (27), and the association constants of ApoE itself and ApoE- are similar (~107 M-1)
(14, 27), the reversible association and dissociation processes of monomer-dimertetramer may compete with any ApoE3WT-interactions located at the C-terminal
regions of ApoE, and hinder investigation of the interfaces of A and apoE by H/DX.
Strittmatter and coworkers (15) studied the ApoE-interactions by native-gel
chromatography and concluded that region 244-272 of ApoE is crucial for binding with
The ratio of to ApoEused in their study, however, is 70 times higher than that
used in our experiments. We could not use this relatively high amount of because it
will seriously suppress ApoE peptide ions in the H/DX-MS experiment and prevent doing
H/DX experiments at this level.
Among all the peptides representing full-length ApoE3WT, only peptide region
52-60 shows protection upon the binding of and only two amide hydrogens in this
region are affected by this binding. The global H/DX measurement, however, shows that
approximately 10 amide hydrogens of ApoE3WT are affected by binding of .
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Given that the peptide sequence coverage is not complete (i.e., nearly 90%), the other
differences may be located in these 10% missing regions or lost by back exchange during
the LC separation. Nevertheless, our results indicate a weak interaction of  with
ApoE3WT at region 52-60 in the N-terminal domain.
6.4.3

H/DX mapped on a ApoE3 monomeric mutant structure

Figure 6-5. H/DX mapping on the ApoE3MM (F257A/W264R/L279Q and V287E)
NMR structure (PDB: 2L7B). Region 52-60, having significant decrease of D uptake in
the presence of Aβ0 is shown in red. Residue W34 and Y36, having significant decrease
of labeling in the presence of Aβ42 by FPOP, are shown in red. Regions 37-45, having
allosteric behaviors in the presence of Aβ40 is shown in yellow. The C-terminal domain
is shown in blue.
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The high propensity of ApoE to oligomerize has hindered determination of the
full-length structures of the three wild-type isoforms. Wang and coworkers (31), however,
recently elucidated the solution NMR structure of a monomeric mutant of ApoE3
(F257A/W264R/L279Q and V287E) (PDB: 2L7B). To provide a clearer picture of the
interfaces between ApoE3WT and  we mapped our H/DX results onto this
structure (Figure 6-5).
Interestingly, peptide region 52-60 together with regions 37-45, are proximate to
each other in the actual protein structure (Figure 6-5). Given that Brian Gau of the Gross
lab used fast

photochemical

oxidation

of proteins

(FPOP)

on ApoE3WT-

complexes (32) and observed a significant decrease in oxidative modification on
the side chains of W34 and Y36 of ApoE3WT when was present. Peptides
containing these residues were unfortunately not detected in the H/DX experiments.
These two residues, when mapped onto the ApoE3MM NMR structure (Figure 6-5)
(helix I), are located on adjoining peptide region 52-60 (helix II). Although
andhave different tendencies to self-associate, they may share the same
interfaces in the ApoE-complexes. Our results show that these two helices of
ApoE3WT are the potential binding sites to . Moreover, once they bound to , the
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structures of region 37-45 may be allosterically affected and become more solvent
accessible (Figure 6-5, yellow).
6.5 CONCLUSIONS
Apolipoprotein E seems to play an important role in the clearance from the brain
of , which is the major risk factor in Alzheimer’s disease. The interaction between
ApoE and however is complicated by the self-association properties of both of these
proteins solution. Lipidation of ApoE alters its oligomerization properties, modulating its
interaction with (13, 33). Lipid-freeApoE, on the other hand, may form a stable
ApoE-complex in the presence of excess  (15). Wild-type ApoE presents as a
mixture of monomer, dimer, and tetramer at low uM concentrations, and the selfassociation involves C-terminal regions (19), which may be the same regions that interact
with  Thus, the populations of different oligomers of ApoE and in solution may
be crucial in determining their interactions.
Our H/DX results are not only consistent with the structure of the N-terminal
domain of ApoE3WT but also reveal the regions that are affected in the presence of
40. All of them are located at the N-terminal domain of ApoE3WT. Our results also
show that self-association of ApoE3WT occurs at the C-terminal domain and that self-
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association may compete with the interaction of 40 and hinder detection of these
interactions at the C-terminal domain.
Future studies should be aimed at increasing the population of the ApoE monomer
in solution to enhance the interactions of ApoE with H/DX and other MS-based
footprinting approaches may provide the needed insights that will be difficult to obtain by
high-resolution methods of NMR or X-ray crystallography and certainly by the lowresolution methods including CD, absorbance, and fluorescence.
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Chapter 7*

Hydrogen-deuterium exchange mass spectrometry reveals the
interaction of Fenna-Matthews-Olson protein and chlorosome CsmA
protein

*

This chapter is based on recent publication: Reproduced with permission from Huang, R.
Y. C., Wen, J., Blankenship R. E., and Gross, M. L. Hydrogen-deuterium exchange mass
spectrometry reveals the interaction of Fenna-Matthews-Olson protein and chlorosome
CsmA protein. Biochemistry, 2012, 51, 187-193. Copyright 2012 American Chemical
Society (Huang, R. Y. C., and Wen, J. contributed equally to this work.)
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7.1 ABSTRACT

In green-sulfur bacterial photosynthesis, excitation energy absorbed by a
peripheral antenna structure known as the chlorosome is sequentially transferred through
a baseplate protein to the Fenna-Matthews-Olson (FMO) antenna protein and into the
reaction center, which is embedded in the cytoplasmic membrane. The molecular details
of the optimized photosystem architecture required for efficient energy transfer are only
partially understood. We address here the question of how the baseplate interacts with the
FMO protein by applying hydrogen/deuterium exchange coupled with enzymatic
digestion and mass spectrometry analysis to reveal the binding interface of the FMO
antenna protein and the CsmA baseplate protein. Several regions on the FMO protein,
represented by peptides consisting of 123-129, 140-149, 150-162, 191-208 and 224-232,
show significant decreases of deuterium uptake after CsmA binding. The results indicate
that the CsmA protein interacts with the Bchl a #1 side of the FMO protein. A global
picture including peptide-level details for the architecture of the photosystem from green
sulfur bacteria can now be drawn.
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7.2 INTRODUCTION
Billions of years of evolution allowed photosynthetic species to achieve not only
an optimized structure for an individual light-harvesting complex but also an appropriate
architecture for the overall photosystem to facilitate efficient energy transfer and
regulation (1). Investigations of the structure and function of the antenna components and
their optimized overall architecture are needed to understand their energy-transfer
mechanism and to provide a sound basis for the design of artificial and bio-hybrid solar
devices.

Advances

in

biochemical

and

biophysical

approaches

(e.g.,

X-ray

crystallography, cryo-EM, and ultrafast spectroscopy) have greatly enhanced our
understanding of the workings of individual antenna complexes. The exploration of the
overall architecture of the photosystem, however, lags behind owing to their complex
architecture and the lack of a more complete suite of approaches than is now available to
study proteins in complex milieu.
In photosynthetic green-sulfur bacteria, photons are absorbed by the large
peripheral chlorosome antenna complex (2), which is located on the cytoplasmic side of
the membrane. Chlorosomes are attached to the cytoplasmic membrane through a
pigment-protein complex known as a baseplate (3). The baseplate and the FennaMatthews-Olson (FMO) antenna protein (4) form a bridge to transfer sequentially the
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energy collected by chlorosomes to the reaction center (RC). The baseplate consists of
the CsmA protein with Bchl a pigments embedded within. The structure of the refolded
CsmA protein was determined by NMR, demonstrating that it contains only two small
alpha helices connected by a small turn (3).
The chlorosome is one of the largest antenna systems known; it contains hundreds
of thousands of Bchl c, d or e per chlorosome and is enclosed by a lipid monolayer (5).
The architecture of chlorosomes has evolved to enable certain organisms to live at
extraordinary low-light intensities under which no other phototrophic organism can grow
(6). Unlike other light-harvesting antennas, efficient energy transfer is achieved by selfassembly of the Bchl c/d/e pigments in the chlorosome to yield stable structures without
the requirement of a scaffold protein (6). Understanding this arrangement is important
because it can guide the design of artificial light-harvesting systems. Progress in
understanding the chlorosome can occur by taking advantage of recent biochemical and
biophysical approaches (7, 8).
These recent approaches show that the light energy collected by the Bchl
aggregates is funneled to the baseplate protein, which is located at the side of chlorosome
closest to the cytoplasmic membrane (9). The baseplate protein is a 2D paracrystalline
structure that is believed to consist of CsmA (chlorosome protein A) and Bchl a.
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Chemical crosslinking revealed that CsmA forms oligomers in chlorosomes (10). The
NMR structure of apo-CsmA (without bound Bchl a) from Chlorobaculum tepidum (59
amino acids) shows a large extent of alpha helical content. The N-terminal helix (6-36),
which has the putative Bchl a binding site, is thought to be immersed in the lipid
monolayer of the chlorosome, whereas the C-terminal helix (41-49) sticks out of the
membrane and may interact with the FMO protein at that point. The existence of the
baseplate is predicted to enhance significantly the energy-transfer rate from the
chlorosome Bchl aggregates to the RC (2) (Figure 7-1).

Figure 7-1. Structure model of the photosystem (A), the FMO trimer (B) and the CsmA
from baseplate (C). The synthetic peptide of the C-terminal region of CsmA
(MRINRNAYGSMGGGSLRGS) used in this study is shown in red.
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The FMO protein, which is located between the baseplate and the cytoplasmic
membrane (11), exists as a trimer, with a three-fold symmetry axis perpendicular to the
membrane. This water-soluble protein has been a model system for studies aimed at
understanding

the

structural

and

functional

relationships

of

pigment-binding

photosynthetic antenna complexes (12-15). The number of pigments embedded in FMO
is important for its function, and recently an 8th Bchl a was identified in each monomer
(16, 17). Several lines of evidence suggest that the side of the protein where this 8 th Bchl
is located faces the baseplate/chlorosome (11, 18, 19).
The connection between the baseplate, the FMO protein, and the RC is likely to
be optimized so that excitation energy can be efficiently transferred at high quantum
yield. Previous results from SPR studies (20) suggest that the C-terminal region of
CsmA, especially the conserved INRNAY residues, interact with the FMO protein. The
molecular details of their interactions, however, remain unclear. The interaction region
between the FMO and the RC is also unknown, although homology modeling with a
divergent FMO protein has suggested a possible binding site (18).
In this chapter, we describe the use of hydrogen/deuterium exchange (H/DX)
coupled with mass spectrometry (MS) (21-24) to study the interaction interface and
dynamics between FMO and CsmA. With H/DX, we followed the relative rates of
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exchange of amide hydrogens, which are measured on the basis of m/z, not abundance.
Experimental outcomes are a measure of changes in the stability of the hydrogen bonding
and the surrounding relative solvent accessibilities of the amides. To achieve resolution at
the peptide level of FMO and the complex, we coupled H/DX with enzymatic digestion.
The FMO/CsmA binding information obtained through H/DX not only provides novel
insights into the interaction interfaces between the proteins but further confirms the
orientation of FMO in the photosystem.
7.3 MATERIALS AND METHODS
7.3.1

Materials
The FMO protein from Chlorobaculum tepidum was purified following a

previously described protocol (17). An ESI spectrum of FMO is shown in Figure 7-2.
The

CsmA

C-terminal

peptide

containing

19

amino

acids

(MRINRNAYGSMGGGSLRGS) was purchased from Biomatik LLC (Wilmington,
Delaware).
Potassium chloride, calcium chloride, and HEPES hemisodium salt [N-(2hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) hemisodium salt] were purchased
from Sigma-Aldrich (St.Louis, MO). Deuterium oxide was purchased from Cambridge
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Isotope Laboratories Inc (Andover, MA). Immobilized pepsin on agarose was purchased
from Pierce (Rockford, IL).

Figure 7-2. ESI mass spectrum of denatured FMO (A) and the deconvoluted spectrum
(B).
7.3.2

H/DX Protocol
To achieve good signal-to-noise ratios for the protein signal of FMO, the final

concentration of FMO was optimized to 6 M, and the FMO:CsmA ratio was 1:20 to
ensure the interaction was saturated.
For global H/DX measurements, 6 L of protein was mixed with 74 L of D2O
buffer (92.5% D2O) (10 mM HEPES, pD = 7.0, 150 mM KCl) and held for various times
at 25 °C before quenching by adding 2 L of 1 M HCl to lower the pH to 2.5. To
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generate the FMO complex with CsmA a modified condition was employed as that used
by Miller and coworkers (20); the FMO and the CsmA peptide were incubated 4 h at
room temperature in the dark (in 20 mM Tris/HCl, pH = 8.0, with 150 mM KCl) and then
kept at 4 °C overnight before conducting the H/DX.
For the peptide-level H/DX, the quenched solution was added with 15 L of
immobilized pepsin on agarose. The digestion was conducted on ice for 3 min. After
digestion, the beads were quickly centrifuged (2-3 s) to pellet the pepsin beads, and the
supernatant was analyzed by LC/MS.
7.3.3

LC-ESI/MS Analysis with a Q-TOF Mass Spectrometer
The quenched protein solution from global-protein and peptide-level H/DX

experiments was loaded onto a C18 guard column (1 mm x 15 mm, Optimize
Technologies, Oregon, City, OR), pre-equilibrated with 100 L of 0.2% formic acid in
water (0 °C), and washed with 300 L of 0.2% formic acid in water (0 °C) to backexchange the labile side-chain functional groups of the protein and the peptides. The
peptides and any remaining protein were eluted with a fast gradient in 8 min starting from
0% solvent B to 90% solvent B at 40 uL/min (Waters nanoACQUITY UPLC,
Manchester, U.K; solvent A, 95% water and 5% acetonitrile containing 0.3% formic acid;
solvent B, 5% water and 95% acetonitrile containing 0.3% formic acid). To minimize
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back exchange, all LC connection lines, injection valve, and sample loop were immersed
in water-ice slush (0 °C).
All ESI mass spectra were acquired in the positive-ion mode on a Maxis (Bruker,
Billerica, MS) Q-TOF spectrometer equipped with a standard ESI source. The capillary
voltage was 3.6 kV, the end-plate offset -500 V, and the dry gas flow rate and
temperature at 4L/min and 180 °C, respectively. The MS profiles used for transmission
were as follows: funnel RF, 400 Vpp; multipole RF, 400 Vpp; collision cell voltage, 10 V;
collision RF, 3000 Vpp; transfer time, 140 us; ion cooler RF, 800 Vpp; pre-pulse storage,
25 s.
7.3.4

LC-ESI-MS/MS Analysis of Protein Digest
Peptides produced by pepsin cleavage of FMO were identified by their accurate

masses and product-ion sequencing on a LTQ-FTMS instrument (Thermo, San Jose, CA).
The peptide solution from pepsin digestion of 100 pmol FMO was loaded onto a C18
column, 75 μm diameter, which was prepared with a laser-based column puller (Sutter
Instruments, Novato, CA) and packed with 12 cm of Magic C18AQ reverse phase media
(Michrom Bioresources, Auburn, CA). The peptides were separated over 70 min by using
an Eksigent (Dublin, CA) NanoLC-1D column with an LC gradient from 3 to 97%
acetonitrile containing 0.1% formic acid at 260 nL/min. The solution was sprayed into
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the mass spectrometer by using a PicoView PV-500 nanospray source (New Objective,
Woburn, MA) attached to the LTQ-FTMS instrument. One full mass spectral acquisition
in the FT mode, operating at a mass resolving power of 100,000 at m/z 400, triggered six
scans of MS/MS whereby the most abundant precursor ions were activated for
sequencing. The MS/MS experiments carried out in the LTQ instrument utilized wideband activation and dynamic exclusion. The product-ion spectra (MS/MS) data were
centroided during the acquisition.
7.3.5

Mascot Database Search
Thermo RAW files were processed by using extract_msn (2007 version 4.0,

Thermo Fisher, San Jose, CA) with a grouping tolerance of 0.8 Da, an intermediate scan
setting of 1, and a minimum of 1 scan per group. The NCBI non-redundant database
(version 20090623, restricted to Other Bacteria) was searched by using MASCOT 2.2.06
(Matrix Science, Oxford, U.K.) with the following settings: enzyme, none; MS tolerance,
10 ppm; MS/MS tolerance, 0.8 Da; maximum number of missed cleavages, 3; peptide
charge of 1+, 2+ and 3+; oxidation of methionine was included as a variable modification.
7.3.6

Data Analysis
For global-protein H/DX experiments, the mass spectrum at each H/D exchange

time point was deconvoluted by using MagTran 1.03 (Amgen, Thousand Oaks, CA). The
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deuterium uptake levels at each time point were taken as the average differences of the
centroided masses of the undeuterated protein and the deuterated protein. The protein
deuterium uptake was not corrected for back-exchange because the time from quench to
observation in the mass spectrometer was less than 6 min, and only relative deuterium
levels needed to be compared in all experiments. All of the experiments were conducted
in triplicate.
For peptide-level H/DX experiments, each mass list from three experimental trials
was extracted from their individual spectra as an x,y file (x: mass-to-charge ratio; y:
intensity). The centroid and width of the deuterium-containing isotopic distribution for
each peptide was analyzed using HX-Express software (25).
7.3.7

Kinetic Modeling
The global protein kinetic data were fit with a fixed-rate-constant binning model

by using MathCAD (Math-Soft. Inc. Cambridge, MA) in which the root mean square
(RMS) was minimized (26, 27). Four rate constants (k = 10, 1, 0.1, 0.01 min-1) were
selected because the kinetic data span 0.5-60 min, hence the brackets of 10 min-1 (fast
exchangers, half-life ~0.07 min) and 0.01 min-1 (slow exchangers, half-life ~69 min).
Three trials were fit separately, and the results were averaged and reported with standard
deviations.
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7.4 RESULTS
7.4.1

H/DX kinetics of FMO and FMO/CsmA

Figure 7-3. H/DX kinetics for FMO from Chlorobaculum tepidum. Apo-FMO
(diamonds, dark red) shows more extensive D uptake than does holo FMO (CsmA:FMO,
20:1) (squares, black). The fitted curves are shown as solid lines.
Previous SPR studies (20) suggest that the interaction between the FMO protein
and the chlorosome CsmA protein is primarily on the C-terminal helix of CsmA,
especially with the conserved INRNAY residues (28). The interaction regions on FMO,
however, remain unclear. Given that the protein conformation and the relative solvent
accessibilities of FMO will change upon the binding of CsmA, we chose measurements
of the H/DX kinetics of FMO alone and as the FMO/CsmA complex to examine globally
their interaction and dynamics (Figure 7-3). Given the highly hydrophobic nature of
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CsmA, we utilized for interaction a peptide representing the C-terminal region of CsmA,
which contains 19 amino acids (MRINRNAYGSMGGGSLRGS) and the highly
conserved INRNAY motif.
Each FMO monomer has 348 exchangeable amide protons (excluding 19
prolines). Because the percentage of D2O in the experiment was 92.5%, the maximum
number of observable exchange events was 322. After 10 min of H/DX, the mass of
FMO shifted by 89 ± 1 Da, indicating that ~27% of the amides exchanged at this time
point. Even after 60 min of H/DX, the extent of exchange had only increased to ~30%
(96 ± 1 amides) at a time when the exchange had leveled off and became relatively
constant. The small difference is consistent with a compact and stable FMO trimer in
solution. Approximately 2/3 of the amides of each monomer are protected because they
form hydrogen bonds, or exist inside each monomer, or they are involved in forming a
compact trimer. The remaining 1/3 of the amides are solvent-exposed and highly
dynamic.
In the presence of CsmA peptide, the number of amides undergoing H/DX
decreased to 80 ± 2 after 10 min of exchange, indicating that ~9 amides now exchange
more slowly as a consequence of CsmA binding. The number of amides affected by the
CsmA binding is relatively small, consistent with the small size of the CsmA peptide and
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its limited effect on (i) overall FMO stability, (ii) the extent of hydrogen bonding, and (iii)
the solvent accessibility of FMO.
Kinetic
Number of H’s per fixed-rate-constant bin
Fit
k ( min-1 )

10

1

0.1

0.01

apo

25 ± 3

29 ± 4

39 ± 3

4±1

holo

29 ± 2

20 ± 2

29 ± 1

15 ± 1

Table 7-1. Numbers of amide hydrogen undergoing deuterium exchange for apo and holo
FMO. The kinetic modeling used four fi ed e change rate constants and “binned” the
number of amides with respect to the rate constants.
To understand better how CsmA binding affects the exchange rate in a
quantitative way, we fit the kinetic curve with four exchange rate-constant bins (k = 10, 1,
0.1, 0.01 min-1) (Table 7-1). The results show that apo FMO (native FMO trimer without
the binding of CsmA) has 25 ± 3 sites that exchange with a rate constant of 10 min -1,
whereas after binding with the CsmA peptide (holo FMO), FMO has 29 ± 2 amides that
exchange with the same rate constant. Although the number of amides exchanging at this
rate constant are similar for the apo and holo states, there are significant differences for
those amides that exchange with smaller exchange rate constants. For those exchanging
with rate constants of 1 min-1 and 0.1 min-1, the numbers of exchangeable amides for holo
FMO are lower than for apo by ~10. Some of these sites exchanged with the smallest rate
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constant of 0.01 min-1 as can be seen for the holo state, for which 15 ± 1 sites exchanged.
For the apo state, only 4 ± 1 amides exchanged with this smallest rate constant. These
results indicate that CsmA binding slows down the exchange at some sites of the FMO
protein with medium exchange rate constants and causes FMO either to form a more rigid
secondary structure or to lose solvent accessibility at certain amide sites.
7.4.2

The FMO/CsmA binding interface
Global H/DX of the FMO/CsmA complex shows clear uptake differences

compared to apo FMO. To locate the interaction regions, we conducted H/DX at the
peptide level by using pepsin digestion and LC/MS analysis. We expected that changes of
the peptide-level deuterium uptake of FMO in the presence of CsmA could locate regions
implicated in CsmA binding.
We used the same experimental conditions for H/DX as for the global protein
measurements. After 10 min of exchange, the H/DX at the protein level had become
relatively constant; further, there is a significant difference in D uptake between apo and
holo FMO at this time. We were able to identify FMO peptic peptides, as confirmed by
accurate mass measurement and tandem-MS sequencing that show sequence coverage of
80% (Figure 7-4). This high coverage ensures that we can localize regional (peptidelevel) changes associated with CsmA binding.
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Figure 7-4. Sequence coverage (~80%) of peptic peptides from FMO achieved in a
peptide-level H/DX study.
There are approximately 10 amides on the FMO protein that are affected by
CsmA binding. We found five peptic FMO peptides (123-129, 140-149, 150-162, 191208, and 224-232) that show decreased deuterium uptake upon the CsmA binding. The
level of deuterium uptake difference for each of these five peptides is generally small (~
2D), which is consistent with the total difference in H/DX measured on the global level.
To examine these differences in a comparable way, we converted them to the relative
deuterium uptake based on equation 1 and plotted them as a function of peptic peptides
(Figure 7-5).

deuterium uptake
%D =

(#aa’s - Nterm - #Pro)

(1)
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In the equation, %D is the relative deuterium uptake for each peptide; #aa’s is the
total exchangable hydrogens on each peptide; Nterm is the number of hydrogens on the Nterminus of the peptide.

Figure 7-5. Relative deuterium uptakes for peptic peptides from N- to C-terminus of
FMO after 10 min of H/DX. Peptide regions showing significant differences in D uptake
(>5 difference; a value of p < 0.05 was considered significant by Student’s t-test) in the
presence of CsmA are labeled in red font and marked with red stars.
The plot (Figure 7-5) shows that three regions of the FMO represented by
peptides 140-149, 150-162, and 224-232 undergo decreased H/DX in the presence of
CsmA by at least 10% with respect to the apo state. Two other regions (represented by
peptides 123-129 and 191-208) show smaller changes, ~5% differences. All the other
detected peptic peptides show virtually no difference with and without CsmA binding.
Although we didn’t e amine the e tent of e change on the CsmA, given that the CsmA
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peptide utilized in this study is short and specific, our results conclude that the C-terminal
region of CsmA, indeed interacts with FMO.
7.4.3

FMO structural mapping

Figure 7-6. FMO monomer structure mapping (PDB: 3ENI) with the deuterium uptake
patterns. Peptide regions of FMO undergoing significant D uptake differences between
apo and holo states are in red. Peptide 233-239 located in the center of the trimer
underwent low D uptake (blue), whereas peptide 2-17 located on the outer shell of the
protein underwent relatively extensive D uptake (black).
To locate the regions on FMO that are implicated in binding with CsmA, we
mapped the five peptic peptides onto the X-ray crystal structure of FMO from
Chlorobaculum tepidum (PDB: 3ENI) (16) (Figure 7-6). Interestingly, all sites that
exchange differently are located on one side of the FMO protein, which is referred to as
the Bchl a #1 side of the protein (shown in red) (11). This finding agrees well with results
from a previous study on the membrane orientation of FMO in green-sulfur bacteria (11);
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those results also show the Bchl a #1 side of the FMO interacts with the chlorosome. This
study of the peptide-level H/DX further confirms and refines the spatial resolution to a
region extending over five peptides of FMO.
On the basis of the relative peptide-level deuterium uptakes, we can identify
three categories of deuterium uptake for FMO: (1) regions showing large extents of
deuterium uptake (>30%) and significant differences when CsmA binds; (2) regions
showing small extents of deuterium uptake (<10%) and no significant differences in the
presence and absence of CsmA; and (3) regions showing large extents of deuterium
uptake (>30%) but no significant differences in the absence or presence of CsmA. These
results, when mapped onto the structure of FMO (Figure 7-7), show that category #3
regions include, for example, peptide 2-17 (shown in black in Figure 7-6 and Figure 7-7),
which is located at or near flexible helices or loops mainly on the outer surface of FMO.
Those category #2 regions (e.g., peptide 233-239) are located at or near the interface of
the FMO trimer (shown in blue in Figure 7-6 and Figure 7-7).
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Figure 7-7. Map of H/DX on the FMO trimer structure (PDB: 3ENI). Peptide regions
showing relatively extensive H/DX (>30%) and significant differences on D uptake when
CsmA was bound are in red. Peptide regions showing relatively low D uptake (<10%) are
in blue. Peptide regions undergoing relatively extensive H/DX (>30%) are in black.

Figure 7-8. Orientation of the FMO trimer structure (PDB: 3ENI). Peptide regions
undergoing significantly different D uptake in the presence of CsmA are in red. (A) Top
view of the FMO trimer. (B) Side view of FMO trimer. (C) Bottom view of FMO trimer.
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7.5 DISCUSSION
One important link in the green-sulfur bacterial photosystem is a light-harvesting
chlorosome that absorbs light and transports the energy through a baseplate protein and
the FMO protein to the reaction center where energy conversion takes place. A gap
existed in our understanding of the interaction between the baseplate and FMO and
motivated this study.
CsmA, a major component in the baseplate, contains the putative Bchl a binding
site in its N-terminal region and may be immersed in the lipid monolayer of the
chlorosome, whereas a region near its C-terminal helix protrudes from the membrane and
may interact with the FMO protein. A previous SPR study (20) shows that the conserved
residues (INRNAY) of the C-terminal region of CsmA interact with the FMO protein.
To investigate this interaction, we chose H/DX because it is a general approach,
“marking” all the amino acids e cept proline and covering nearly the entire protein
backbone. H/DX is sensitive to the solution environment surrounding the protein,
enabling one to capture even minor changes in protein conformation and solvent
accessibility caused by the changes in hydrogen bonding occurring when peptides bind to
proteins. In this study, we used a model synthetic peptide of 19 amino acids
(MRINRNAYGSMGGGSLRGS) from the C-terminal region of CsmA to probe the
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FMO/CsmA interaction. The peptide, which contains the conserved INRNAY region,
forms a small alpha helix, as does CsmA itself, and interacts with the FMO protein (3).
Global-level H/DX shows that only ~10 amides of FMO are affected by the CsmA
binding. Although the stoichiometry and the binding affinity between FMO and CsmA
are unknown, this small extent of exchange in a large protein makes a determination of
the binding affinity by PLIMSTEX (Protein Ligand Interaction by Mass Spectrometry,
Titration and H/D Exchange) difficult at the protein level (26, 27). Nevertheless, their
interaction should be strong in vivo possibly because CsmA forms oligomers in the
baseplate (10), and the oligomeric CsmA interacts more strongly with FMO than does the
monomer. In addition, the tail of the 8th Bchl a in the FMO protein may play a role in
vivo by interacting with the carotenoid/Bchl a in the CsmA or with hydrophobic regions
of CsmA (17). The involvement of oligomeric states further complicates determining a
relevant affinity by PLIMSTEX or other methods.
Peptide-level H/DX affords further refinement of the binding interfaces between
FMO and CsmA. Five regions of FMO, represented by peptides 123-129, 140-149, 150162, 191-208, and 224-232, show clear decreases of relative deuterium uptake in the
presence of CsmA. Interestingly, these regions are all located on the Bchl a #1 side of the
FMO, and the outcome agrees well with the previous finding that the baseplate interacts
- 267 -

with the Bchl a #1 side of the FMO (11, 18). Moreover, our results also localize the Cterminal region of CsmA that plays an important role in FMO/CsmA interaction.
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